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Chromatin compaction is a hallmark property of apoptosis, a highly coordinated
suicide mechanism generally believed to be confined to vertebrates. However,
invertebrates such as the budding yeast, Saccharomyces cerevisiae, display an
apoptotic-like phenotypes including chromatin condensation, although its
functions and mechanism are unclear. One mechanism that alters chromatin
structure is the covalent modification of histones, which associates with DNA to
form the nucleosome, the fundamental unit of chromatin. Phosphorylation of
histone H2B at serine 14 (H2BS14ph), catalyzed by Mst1 kinase, has been linked
to chromatin compaction during mammalian apoptosis. I extended these results
to yeast by demonstrating that Ste20 kinase, a yeast orthologue of Mst1, directly
phosphorylates H2B at serine 10 (H2BS10ph) in a hydrogen peroxide-induced
cell death pathway. Unlike Mst1, Ste20 translocates into the nucleus in a
caspase-independent fashion to mediate phosphorylation of H2B. H2BS10ph is
dependent on the removal of acetylation mark on adjacent lysine residue,
(H2BK11ac), which exists in growing yeast. During yeast apoptosis, the HDAC
Hos3 deacetylates K11, which in turn, mediates H2BS10ph by Ste20 kinase. My
studies underscore a concerted series of enzyme reactions governing histone
modifications that promote a switch from cell proliferation to cell death.
Moreover, the conservation of targeted H2B phosphorylation and the enzyme

system point to an ancient, late-stage chromatin remodeling event that likely
governs cellular homeostasis in a wide range of organisms.
H2B phosphorylation may mediate apoptotic chromatin compaction by 1)
directly affecting internucleosomal contacts and histone DNA interaction (“cis
mechanism”), or 2) recruiting binding partners that then induce and direct
downstream functions (“trans” mechanisms). Peptides corresponding to the
phosphorylated form of yeast H2B and human H2B have the intrinsic ability to
form “aggregates” in SDS polyacrylamide gel electrophoresis. In addition,
nucleosome array containing yeast S10E or human S14E H2B fold into
compacted conformation as measured by analytical ultracentrifugation.
Moreover, an interaction between the forkhead homology-associated domain 1
(FHA1) of Rad53 and H2BS10ph was uncovered. This interaction inactivates the
DNA damage checkpoint pathway and promotes apoptotic chromatin
condensation. Thus, both mechanisms may contribute to chromatin remodeling
event that govern apoptotic chromatin compaction in a pathway conserved from
yeast to humans.
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CHAPTER 1

GENERAL INTRODUCTION

The faithful packaging of chromatin, the repeating polymer of DNA and
associated histone proteins (H2A, H2B, H3 and H4), is an essential step in the
accurate execution of proliferation, differentiation and apoptosis in eukaryotic
cells.

Each of these biological processes is characterized by elaborate

mechanisms that involve different, but poorly understood, levels of chromatin
compaction. Thus far, there are three well-documented molecular mechanisms
that introduce meaningful variations into chromatin fiber: 1) by altering DNAhistone contacts within a nucleosome through the enzymatic activities of ATPdependent chromatin-remodeling complexes, 2) by specific incorporation of
histone variants, 3) by the addition and subtraction of covalent post-translational
modification of the histones (reviewed in Felsenfeld and Grouding, 2003; Iizuka
and Smith, 2003; Peterson and Laniel, 2004). Together, these variations may form
a “histone code” (Strahl and Allis, 2000; Turner, 2000; de la Cruz et al., 2005), a
signaling platform to specify unique downstream biological functions
particularly for specialized forms of chromatin that include apoptotic and
damaged DNA (Redon et al., 2002; Cheung et al., 2000).
Histones are subject to a large number of covalent modifications (van
Holde, 1988). One of these modifications, phosphorylation, where a phosphate
moiety is added onto serine/threonine residues in histones by an appropriate
kinase, is the focus of my thesis.

However, to understand how histone
1

phosphorylation can regulate chromatin structure, the general aspects of DNA
organization in eukaryotic cells including chromatin and nucleosome, and their
structures will be discussed in this Chapter. I will also address the role and
functional mechanism of histone variants and histone modifications both of
which introduce variation into the repetitive nucleosomal array. Since the
majority of my work involves studying chromatin changes during apoptosis, I
will also summarize the fundamental implications of chromosome dynamics
during apoptosis and comment upon how yeast is emerging as a new model
system for studying the apoptosis-induced signaling cascade. Finally, I will
describe the functional roles for histone modifications in apoptosis.

Eukaryotic DNA is organized into chromatin
First described by Robert Brown in 1831, the cell nucleus is one of the best known
but least understood of cellular organelles. Around 1900, it was recognized that
heredity was based on the transmission of nuclear material from one cell to its
descendants. At that time, intensive studies involving chromosomes were
started. Only in 1944 was it realized that the heredity information was encoded
into DNA (Avery et al., 1944), and in 1953, the structure of DNA was postulated
by Watson and Crick (Watson and Crick, 1953).
Eukaryotic cells contain from 107-11 DNA base pairs (bp) in a nucleus just
5-7 µm in diameter (van Holde, 1988). The DNA molecules that comprise the
human genome span about 2 meters in length if they are laid end to end (van
Holde, 1988). This vast quantity of DNA is packaged by the histone proteins into
a hierarchical structure called chromatin (reviewed in Kornberg and Lorch,
1999). DNA in chromatin is compacted over 10,000-fold (Luger et al., 1997;
2

Davey et al., 2002). The nucleosome is the universal repeating-element of
chromatin, and it accounts for the first level of DNA organization in the cell
nucleus (Felsenfeld and Groudine, 2003). This level is also referred to as the
“beads-on- a-string” because of its resemblance under the electron microscope
(Bram and Ris, 1971; Olins and Olins, 1974; Figure 1). The “30-nm” chromatin
fiber consists of nucleosome arrays in their most compact form, and is typically
posited as the secondary structural level of DNA organization (Richmond and
Widom, 2000; Felsenfeld and Groudine, 2003; Figure 1). The hierarchy continues
with increasing DNA packing density until the metaphase chromosome is
ultimately attained (Belmont et al., 1999; Strukov et al., 2003; Figure 1).
The total genetic information stored in the chromosomes of an organism
constitutes its genome. The chromosome structure and activities in the cell
change according to the stage of the cell-division cycle (reviewed in Ahmad and
Henikoff, 2002).

In mitosis, or M phase, they are highly condensed and

transcriptionally inactive. Whereas in the other, much longer part of the division
cycle, called interphase, they are less condensed and transcriptionally active
(reviewed in Horvath et al., 2001). Replication of the genome occurs during a
specific part of interphase, called S phase. After replication, chromatin structure
is reassembled by the addition of new histones to the old histones, which are
deposited on both parental and daughter DNA molecules (reviewed in Mello
and Almouzni, 2001; Gunjan et al., 2005).

The nucleosome
The nucleosome is the fundamental repeating unit of chromatin, occurring
generally every 156-240 base pairs (Kornberg, 1974). The nucleosome core
3
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Figure 1. Packaging of nucleosome

Figure 1

The most fundamental level of DNA packaging is the nucleosome, in which
two superhelical turns of DNA are wound around the outside of a histone
octamer. Nucleosomes are connected to one another by short stretches of
linker DNA. In the next level of organization, the string of nucleosomes
(“bead-on-a-string”) is folded into a fiber about 30 nm in diameter and these
fibers are then further folded into higher-order structures. At levels of
structure beyond the nucleosome, the details of folding are still uncertain
(adapted from Felsenfeld and Groudine, 2003).
4

comprises 147 base pairs of DNA, a histone octamer containing a pair of each of
the core histone proteins H2A, H2B, H3 and H4, and a linker histone H1 (Luger
et al., 1997). The structure of the nucleosome core particle (NCP) has been solved
by X-ray crystallography at high resolution (Davey et al., 2002; Luger et al., 1997;
Figure 2).

Figure 2. Crystal structure of the nucleosome core particle
Front (A) and side views (B) of nucleosome core particle.

Histones are

represented as ribbons (H3 blue, H4 green, H2A yellow, H2B red). The DNA
superhelix is shown in brown and turquoise. (adapted from Luger et al., 1997).

Histones
Histone proteins were first isolated from erythrocytes of geese by Kossel in 1884
(Kossel, 1884). Histones are small basic proteins and fall into five classes- H1,
H2A, H2B, H3 and H4 – derived from their amino acid composition and
sequence (Johns, 1967). Each histone class includes some gene variants or
subtypes which are likely to provide tissue-specific and developmental-stage5

dependent variation of chromatin structure (Franklin and Zweidler, 1977;
reviewed in Sarma and Reinberg, 2005). The histones H2A, H2B, H3, and H4
have molecular masses of 10–16 kDa and are known as the “core histones”, since
DNA wraps around histones to form the nucleosome core of chromatin (van
Holde, 1988; Luger et al., 1997; see Figure 1). The interactions between the DNA
and histones are mainly due to electrostatic forces since histones can be extracted
from chromatin with a high concentration of salt (Kornberg, 1974). The complete
set of core histone proteins is essential for cell viability, as shown by genetic
experiments using yeast (Kim et al., 1988). The core histone proteins are found in
the same equal molar stoichiometry, with histone H1 in half this amount, in all
eukaryotic organisms (Hayashi et al., 1978).
Histones are remarkably well conserved throughout evolution in both
primary sequences and length. For example, histone H4 of human and pea differ
in only two conservative amino acid replacements. H2A and H2B are conserved
to a lesser extent especially in the non-structural tail domains (78% and 71%
overall identity between human and yeast H2A and H2B, respectively). The
higher degree of conservation of H3 and H4 is probably a reflection of their
central role in keeping nucleosome structure and the biological processes in
which they are involved. Structurally, each of the core histones contain an amino
(N-) terminal tail and a histone fold domain containing three a-helixes separated
by short loops (Arents et al., 1991; Ramakrishnan et al., 1993; Cerf et al., 1994).
Since histone fold domains are important for mediating histone-histone and
histone-DNA interactions, they are indispensable in the formation of the
nucleosome (Arents et al., 1991) and the conservation between the histone-fold
domains between organisms is very high. Enriched with charged residues, the
6

N-terminal tails are targets for various post-translational modifications (Figure
3). It is now well appreciated that these chemical marks on the histone tails
function by either directly affecting accessibility of DNA or serving as modules
to recruit structural or nuclear proteins that alter chromatin conformation for
particular cellular functions (Hecht et al., 1995; Strahl and Allis, 2000; Bannister et
al., 2001; Roth et al., 2001).
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Histone octamer
Histones H2A and H2B form a heterodimer as do histones H3 and H4 (CameriniOtero et al., 1976; Hayes et al., 1991; Arents and Moudrianakis, 1993). All
histones are a-helical proteins and the dimers are formed though a histonespecific interaction, the histone-fold domains (Arents et al., 1991). Two H3/H4
dimers associate into a tetramer that forms the core of the histone octamer (Luger
et al., 1997). The H2A/H2B dimmers are added symmetrically on each side of
the tetramer, thereby giving the histone octamer a shape that resembles a helical
spool onto which the DNA is wound (Klug et al., 1980; Richmond et al., 1984;
Arents et al., 1991).

Nucleosome core particle structure
The structure of the nucleosome core particle (NCP) has been determined to near
atomic resolution (Luger et al., 1997; Davey et al., 2002; Figure 2). It shows how
the histone octamer interacts with the 147 bp of DNA to form 1.67 turns of a
superhelix. The H3/H4 tetramer organizes the central 60 bp of the nucleosome
whereas the H2A/H2B dimer binds to the 30 bp adjacent to the central region.
DNA binding occurs mainly over short stretches of the sugar-phosphate
backbone whenever it is facing the octamer. The interactions are predominantly
nonspecific and include extensive salt bridges, hydrogen bonds and non-polar
contacts to the DNA sugar. The linker DNA that connects the nucleosome core is
associated with H1. Thus, the nucleosome core, linker DNA and histone H1
make up the complete nucleosome.
The flexible tails of the histones reach out between and around the gyres
of the DNA superhelix (Luger et al., 1997) and seems to be required for higher8

order folding of the chromatin fibers (Allan et al., 1982). The fact that tandem
nucleosomal arrays were not able to adapt to a higher-order structure without
the tails of core histones in vitro further support this notion (Garcia-Ramirez et
al., 1992). Alternatively, tail to tail interactions between different nucleosomes
were observed in the crystal studies (Luger et al., 1997; White et al., 2001). For
instance, a “basic patch” from lysine 16 (K16) to asparagine 25 (R25) in H4 Nterminal tail makes extensive contact with an acidic region on an H2A/H2B
dimer of an adjacent nucleosome (Luger et al., 1997).

This interaction is

important for crystallization of the Xenopus nucleosome (Luger et al., 1997).
Consistently, this basic patch is important for maintaining silent chromatin in
yeast suggesting that this tail might be critical in forming a higher-order
condensed structure to silent gene expression (Megee et al., 1990; Johnson et al.,
1990).
The structures of nucleosomes composed of Xenopus histone (Luger et al.
1997), yeast histones (White et al., 2001), and even one with a histone variant
H2A.Z (Suto et al., 2000) are all super-imposable on one another, despite some
sequence variation between species. Therefore, the fundamental structural
information is well preserved throughout evolution.

Linker histone H1
Histone H1 is called the “linker histone” because it associates with the DNA
connecting the nucleosome cores (Allan et al., 1980). Only one copy of H1 is
found per nucleosome, and H1 is less strongly incorporated into chromatin than
core histones (reviewed in Luger, 2003). Furthermore nucleosome core particles
can be reconstituted without H1, whereas all four core histones are absolutely
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required (Thomas, 1984). Biochemical results demonstrate that the H1 fold
domain binds near the center of the nucleosomal DNA in the vicinity of DNA
entry and exit, while the C-terminal domain is most likely associated with 10-20
bp of linker DNA (Zhou et al., 1998). However, other experiments suggest that
H1 binds in the inside of only one DNA gyre (reviewed in Thomas, 1999).
Therefore, the location of H1 in the nucleosome is still controversial.

The higher-order structure
The higher-order structure, also referred to as 30-nm chromatin fiber, is the next
packaging level of DNA after the nucleosome (Figure 1). In a non-dividing cell,
chromosomes are decondensed and appear as a diffuse mass in the nucleus,
separated into heterochromatin and euchromatin (reviewed in Pardue and
Henning, 1990; van Holde, 1988). Most of the interphase chromosomes exist
largely in the form of the 30-nm chromatin fibers (reviewed in Lamond and
Earnshaw, 1998). This means that the chromatin fiber is the natural substrate for
processes such as transcription, DNA repair and replication (during S phase).
Hence it is of great interest to gain detailed insight into the dynamics and
structure of this fiber.

Chromatin fiber dynamics
The chromatin fiber is a dynamic macromolecular entity that is intimately
involved in nuclear function. In the last three decades, many attempts have been
made in examining the structural properties of the chromatin fiber, or its subunit,
the nucleosome. Despite this intense effort, many aspects of chromatin structure
remain poorly understood. One such area is the conformational dynamics of the
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chromatin fiber. Multiple, independent mechanisms are involved in the control
of chromatin fiber formation and stability (reviewed in Hansen, 2002). The
molecular determinants and mechanisms responsible for chromatin fiber
dynamics remain elusive and are the subject of continued debate.
The folding of nucleosome arrays from 10 nm into the condensed 30 nm
diameter chromatin fiber in solution is complex. Early electron microscopic
studies of isolated chromatin fragments in vitro revealed that chromatin fibers
would undergo a reversible cation-dependent compaction in response to changes
in solution conditions (Thoma et al., 1979). In the presence of monovalent salt
(10-200 mM NaCl), nucleosome arrays appear to equilibrate between the
extended beads-on-a-string conformation (see Figure 1) exclusively present in
low salt, and a partially folded zigzag-like conformation (Garcia-Ramirez et al.,
1992; Hansen et al., 1989). Upon addition of low amounts of divalent cations (1-2
mM MgCl2), regularly spaced nucleosome arrays fold into a compacted
conformation that is equivalent to a 30-nm chromatin fiber in its extent of
compaction (Schwarz and Hansen, 1994).

Analytical ultracentrifugation

experiments show that defined nucleosome arrays exhibit continuous increases
in their average sedimentation coefficient with increasing divalent cation
concentration (Hansen, 2002). If the divalent cation concentration is increased
further, the equilibrium is shifted toward oligomerization (Schwartz et al., 1996).
However, oligomerization is not obligatorily coupled to intramolecular folding in
vitro, since it can occur in extended or only moderately folded nucleosome arrays
(Schwarz et al., 1996). Importantly, removal of salt leads to reestablishment of a
single 10 nm fiber, indicating that all the transitions in the folding and selfassociation pathway are reversible (Hansen, 2002). The contribution of the
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highly-basic core histone tail domains to the folding and dynamics of the
chromatin fiber has been determined by sedimentation analysis (Garcia-Ramirez
et al., 1992; Fletcher and Hansen, 1995; Schwarz et al., 1996; Tse and Hansen,
1997; Dorigo et al., 2004; Shogren-Knaak et al., 2006). To date, the N-terminal tail
of H4 is uniquely associated with the formation of the chromatin fiber (Luger et
al., 1997; Dorigo et al., 2004; Shogren-Knaak et al., 2006; see “cis mechanism”).
Although for many years it was thought that formation of the chromatin
fiber depended on the presence of H1, sedimentation analysis of defined
nucleosome arrays in MgCl2 has shown that compact fibers can form in the
absence of H1 (Carruthers et al., 1998). Rather, H1 seems to play a significant
role in the stabilization of the chromatin fiber. The linker histones stabilize the
folded and oligomeric states of chromatin fibers in vitro; less MgCl2 when
compared to H1-less nucleosome arrays is required to induce folding (Carruthers
et al., 1998). In addition, studies of endogenous nucleosome arrays reassembled
with linker histone indicate that the highly basic C-terminus provides localized
charge neutralization for the chromatin fiber stabilization (Allan et al., 1986).
These observations suggest that the formation of highly folded chromatin
structure is mainly directed by the core histones rather than by H1.

Histone Variants
Changing the constituent of the nucleosome at specialized chromatin domains
can also introduce variations into the chromatin fiber and consequently, affect
the DNA dependent processes occurring there (Falsenfeld and Groudine, 2003).
This can be established by having core histones (H2A, H2B, H3 and H4)
specifically substituted by histone variants.
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Their incorporation into the

nucleosome provides a means of specifying and inheriting an alternative
chromatin state. Histone variants are also referred to as replacement histones
because some variants exchange with the pre-existing histones during
development and differentiation (Brandt et al. 1979; Wunsch et al. 1991; Bosch
and Suau 1995).

Therefore, histone variants have specialized functions

regulating chromatin dynamics that have high impact on cell cycle and
developmental growth (Felsenfeld and Groudine, 2003).
All the histones are encoded by several different genes. The histone H2A
family is the most diverse and has the largest number variants including H2A.X
(reviewed in Ausio and Abbott, 2002; Redon et al. 2002; Fernandez-Capetillo et
al. 2004b). Histone H3 has major variants including CENP-A, H3.3 and hv2
(Kurokawa and MacLeod, 1985; Earnshaw et al., 1985; Marvin et al., 1990; Palmer
et al., 1991). While no variants are known for H4, a few variants of H2B are
known, which play important roles in spermatogenesis (reviewed in Poccia and
Green 1992; Green et al. 1995). In this section, I will describe H2A.X and testisspecific H2B variant and how they are specifically correlated with different
biological processes.

H2A.X
H2A.X is a histone variant in higher eukaryotes, which is the “normal” histone
H2A in budding yeast (Downs et al., 2000). The yeast H2A and the higher
eukaryote H2A.X histones contain an extension at the C-terminus, which
includes the conserved amino-acid sequence SQ(E/D)f, where f denotes a
hydrophobic residue. H2A.X is phosphorylated (ph) on the serine (S) in this
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unique C-terminal region (S139 in higher eukaryotes, S129 in yeast; see “H2A.X
phosphorylation”) in response to DNA double-strand breaks (DSBs) (Rogakou et
al., 1998). This phosphorylation at the site of DSBs then spreads rapidly to other
H2A.X along the chromosome and recruits repair machinery (Rogakou et al.,
1998; reviewed in Fernandez-Capetillo et al., 2004b).

In addition, the

phosphorylation of H2A.X is essential for the formation of efficient repair foci in
cells (Celeste et al., 2002; Celeste et al. 2003). Therefore, H2A.X has become a
marker for DNA damage.

TSH2B
Histone H2B is markedly deficient in variants.

The few that have been

documented completely replace the core histone H2B and appear to have very
specialized functions in chromatin compaction and transcriptional repression,
particularly during spermatogenesis (Poccia and Green 1992; Green et al., 1995).
Spermatogenesis is a complex process in which diploid stem cells divide,
differentiate and mature into haploid, highly specialized spermatozoa (Poccia
and Green 1992). During meiotic phase of spermatogenesis, testis-specific
histone H2B (TH2B) is synthesized in testis and replace core H2B, which is
expressed in somatic cells (Meistrich et al., 1985; Kim et al., 1987; Schumperli,
1988). The first TH2B was cloned from rat (rTH2B) (Kim et al., 1987). There is
extensive sequence divergence in the N-terminus of the rTH2B and core H2B, but
the rest is highly conserved (Kim et al., 1987). The N-terminus of rTH2B
interacts with DNA and their interaction increases DNase I sensitivity of the
nucleosomes perhaps to loosen the structure for meiotic recombination and
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facilitate replacement of histones with more basic, transitional proteins and
protamines later during spermatogenesis (Rao and Rao, 1987).
TH2B is also found in human, except it is found in both testis and sperm,
hence, this protein is referred as a human testis/sperm-specific H2B (hTSH2B;
Zalensky et al., 2002). Protein sequence comparison reveals a strong (95%)
homology of hTSH2B with testis-specific H2B from rat and mouse and a weaker
homology with somatic histone H2B (85%) (Zalensky et al., 2002). The most
pronounced differences between somatic and spermatogenic cell-specific H2Bs
are found in their N-terminal regions (Zalensky et al., 2002), suggesting that the
divergent N-terminus might provide a means of specifying and inheriting an
alternative chromatin state. Immunofluorescence studies show that hTSH2B is
localized in basal nuclear area of sperm cells (van Roijen et al., 1998; Zalensky et
al., 2002).

Since the basal nuclei of sperm cells is where chromatin

decondensation occurs first after fertilization (Terada et al., 2000), hTSH2B may
associate with active chromatin.

Post-translational modifications of histones
Besides changing nucleosomes by replacing the core histones with variants, posttranslational modifications of the core histones can also modify the nucleosome
to enhance or inhibit access of DNA by nuclear factors (reviewed in Henikoff et
al., 2004; Kamakaka and Biggins, 2005). Histones are subject to vast array of
post-translational modifications such as acetylation and methylation (me) of
lysines (K) and arginines (R), phosphorylation (ph) of serines (S) and threonines
(T), ubiquitination (ub) and sumoylation (su) of lysines (K), as well as
ribosylation (ar) (reviewed in Fischle et al., 2003a; de la Cruz et al., 2005).
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Adding to the complexity is the fact that each lysine residue can accept one
(me1), two (me2) or even three methyl groups (me3), and an arginine can be
either mono- (me1) or di-methylated symmetric (me2s) or asymmetric (me2a) (de
la Cruz et al., 2005). In most cases, these modifications are found in the Nterminal tails, but recently modifications in the histone-fold domain have been
found as well (reviewed in van Leeuwen et al., 2002; Fuchs et al., 2006). Given
the number of new modification sites that are identified each year, it seems likely
that nearly every histone residue that is accessible to solvent is a likely target for
post-translational modification (Figure 3).
Since chromatin is the physiological template for all DNA-mediated
processes, histone modifications are though to affect the function of the
chromatin fiber through two distinct mechanisms. First, nearly all modifications
alter the electrostatic charge of the histone and this, in principle, could change
the structural properties of the histone or its binding to the DNA. Indeed, recent
studies have shown that site-specific combinations of histone modifications
correlate well with particular biological functions.

For instances, the

combination of H4K8 acetylation (H4K8ac), H3K14 acetylation (H3K14ac), and
H3S10 phosphorylation (H3S10ph) is often associated with transcription
(Mahadevan et al., 1991; Kuo et al., 1996; Lo et al., 2000; Agalioti et al., 2002).
Conversely, tri-methylation of H3K9 (H3K9me3) and the lack of H3 and H4
acetylation correlate with transcriptional repression in higher eukaryotes
(reviewed in Fuks, 2005; Fuchs et al., 2006;). Particular patterns of histone
modifications also correlate with global chromatin dynamics, as deacetylation of
histone H4 at K5 and K12 is associated with histone deposition at S phase
(Jasencakova et al., 2001), and phosphorylation of histone H2A (at S1 and T119)
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and H3 (at T3, S10 and S28) appears to be a hallmark of condensed mitotic
chromatin (Wei et al., 1998; Goto et al., 1999; Hsu et al., 2000; Aihara et al., 2004;
Polioudaki et al., 2004; Barber et al., 2004). Second, modifications could create
binding surfaces for protein recognition modules and thus recruit specific
functional complexes to their proper sites of action (see “Functional mechanisms
of histone covalent modification”).
Some of the best-known histone modifications (acetylation, methylation
and ubiquitination) that have been characterized will be discussed below, and
then a more detailed description of histone phosphorylation will follow. In
addition, I will describe specific histone modification, the DNA process often
associated with it, and the enzyme(s) responsible for bringing it about, where
known. Finally, the potential mechanism of each modification and how that
impacts on the nuclear process will be discussed.

Acetylation
An acetyl group neutralizes a positive charge on the basic residues such as lysine
or arginine of histones and thus is expected to weaken histone-DNA interactions.
Acetylation of the e-amino group of lysine residues on histones was first
described by Allfrey and colleagues (Allfrey et al., 1964). In the same report, they
indicated that acetylated histones were less repressive for RNA synthesis,
leading to the idea that histone acetylation may prime chromatin for active
transcription.

The discovery that acetylated histones correlate with

transcriptionally active regions such as the macronucleus of Tetrahymena, the
majority of the yeast genome, the X-chromsomes in male Drosophila, and the b-
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globin gene in chicken erythrocytes has firmly established the link between
histone acetylation and transcriptional activation (Vavra et al., 1982; Hebbes et
al., 1992; Clarke et al., 1993; Bone et al., 1994; Hebbes et al., 1994). Conversely,
histone deacetylation has been correlated with transcriptionally inactive regions
such as the micronucleus of Tetrahymena, silent regions of the yeast genome, and
the inactive X chromosome in female mammalian cells (Vavra et al., 1982;
Braunstein et al., 1993; Braunstein et al., 1996; Jeppesen and Turner, 1993).
The functional link between acetylation and transcription was greatly
reinforced when many transcriptional activators and repressor complexes were
found to possess histone acetyltransferase (HAT) and deacetylase (HDAC)
activity, respectively (Brownell et al., 1996; Taunton et al., 1996; Grunstein, 1997;
Struhl, 1998; Berger, 1999; Roth et al., 2001). For example, yeast Gcn5, a positive
transcriptional regulator of many genes, has HAT activity and stimulates the
acetylation of histone H3 at K14, H4 at K8, and K16 (Kuo et al., 1996; Sterner and
Berger, 2000). In contrast, the yeast HDAC, Rpd3, deacetylates lysine residues
including H3K14, H4K8 and H4K16, and facilitates transcriptional repression
(Suka et al., 2001; see “Deacetylation”). One possible mechanism of acetylated
histone tails in regulating transcription is that acetylated histone tails can
decrease the interaction between tails and nucleosomal DNA allowing
transcription factors and co-activators to gain access to the DNA (Lee and Hayes,
1997; Cary et al., 1982). Consistent with this notion, acetylated histone tails were
shown to directly bind to bromodomain-containing transcriptional co-activators
(Dhalluin et al., 1999; Jacobson et al., 2000; Zeng and Zhou, 2002; see
“Bromodomain”). This suggests that histone modifications (e.g. acetylation)
might be a signal/code for factors to bind and perform specific nuclear functions,
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including transcription (Strahl and Allis, 2000; Turner, 2000; Jenuwein and Allis,
2001).
Acetylation of H2A and H2B in yeast has been implicated in aspects of
heterochromatin and euchromatin formation for some time. Recently, antibodies
developed to selectively recognize the specific sites of acetylation of H2A and
H2B demonstrated that Gcn5 is responsible for acetylating both K11 and K16 in
H2B, whereas Esa1 is responsible for H2AK7 and H2BK16 and functions in
transcriptional activation (Suka et al., 2001). Acetylation of both H2BK11
(H2BK11ac) and K16 (H2BK16ac) are also observed in exponentially growing
yeast cells (Suka et al., 2001), suggesting that they might play a role in cell
growth.

Whether H2B tail acetylation is required for the cell viability is

unknown.

Deacetylation
The dynamic process of histone acetylation is reversed by histone deacetylases
(HDACs). They remove the acetyl moiety from the e-amino groups of lysine
residues. Yeast cells contain a group of related HDACs that include Rpd3, Hda1,
Hos1, Hos2, Hos3, and Sir2 (Rundlett et al., 1996; Taunton et al., 1996; Denu,
2005). In the latter case, Sir2 has NAD+ dependent histone deacetylase activity
towards H3K14, H3K9 and H4K16 (Imai et al., 2000).

All of the known

deacetylases, except for Hos3, occur in multiprotein complexes with important
functional consequences. First, the HDAC complexes are able to deacetylate
histones in nucleosomes, whereas the isolated deacetylase subunits cannot;
second, the complexes contain other proteins previously implicated in
transcriptional repression and chromosome transactions; and finally, the
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deacetylase complexes interact with DNA-binding proteins, bringing the
deacetylases to promoters (reviewed in Grunstein, 1997; Struhl, 1998; de Ruijter
et al., 2003; Ekwall, 2005). Hos3, on the other hand, has intrinsic catalytic activity
as a homodimer when expressed in Escherichia coli in the absence of other
deacetylase components (Carmen et al., 1999). However, Hos3 is found in a large
multi-complex, therefore, the factors that interact with Hos3 has been proposed
to sequester the catalytic subunit at specific cellular sties (Carmen et al., 1999).
In general, increased levels of histone acetylation activity
(hyperacetylation) are associated with increased transcriptional activity, whereas
decreased levels of acetylation (hypoacetylation) are associated with repression
of gene expression (reviewed in Kurdistani and Grunstein, 2003; Luo and Dean,
1999). As discussed earlier, the deacetylation-repression connection is clearly
demonstrated by yeast Rpd3, which is a member of the class I HDACs, the
mammalian orthologues of which include HDAC1, HDAC2, and HDAC3. In
yeast, Rpd3 is a repressor of INO1, a gene involved in inositol biosynthesis
(Kadosh and Struhl, 1997). The mechanism for this chain of event involves the
recruitment of the Rpd3 to a specific DNA element (URS1) in the INO1 promoter
through Sin3, which is a part of the Rpd3 complex (Kadosh and Struhl, 1997). In
fact, the Rpd3 complex is physically enriched at the INO1 promoter (Kurdistani
et al., 2002) where it deacetylates all sites of acetylation on histones H4, H3, H2A
and H2B N-terminal tails (Rundlett et al., 1998; Kadosh and Struhl, 1998; Suka et
al., 2001).

This highly localized deacetylation of histones might repress

transcription by destabilizing the binding of multi-protein chromatin remodeling
complexes such as SWI/SNF, SAGA and the basal transcription factor TATAbinding protein (TBP) at the promoter (Deckert and Struhl, 2002).
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Yeast Hda1, which is a member of the class II HDACs, is related to
HDAC4, HDAC5, and HDAC6 in mammals (Rundlett et a., 1996). Hda1 is
recruited to its target promoters through Tup1, a yeast repressor that is a part of
Hda1 complex (Wu et al., 2001). Unlike the broad substrate specificity of Rpd3,
the Hda1 complex only deacetylates lysine residues in histone H3 and H2B Nterminal tails (Wu et al., 2001).
Hos3, which is distantly related to both class I and II HDACs, has intrinsic
HDAC activity and remarkable resistance against HDAC inhibitors like
trichostatin A (TSA) when recombinantly expressed in an E. coli host system
(Carmen et al., 1999; Trojer et al., 2003). Hos3 has a distinct specificity in vitro for
histone H4 sites K5 and K8, H3 sites K14 and K23, H2A site K7, and H2B site K11
(Carmen et al., 1999). Although Hos3 is required primarily for deacetylation in
the ribosomal DNA locus, it is not known whether it represses rDNA
transcription or whether it affects promoters throughout the yeast genome, a role
identified for Rpd3 and Hda1 (Robyr et al., 2002).

Methylation
Histone methylation was first described in 1964 (Murray, 1964). Histones can be
methylated either on their arginine or lysine residues. Many recent discoveries
of lysine- and arginine- directed histone methyltransferases (HMT), and now
histone demethylases activities have increased our understanding of methylation
in regulating chromatin structure and functions (reviewed in Zhang and
Reinberg, 2001; Iizuka and Smith, 2003; Holbert and Marmorstein, 2005;
Shilatifard, 2006).
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Lysine methylation and demethylation
Each e-amino group of lysine can be mono- (me1), di- (me2), or tri-methylated
(me3) in vivo and these states of methylation are functionally different (Rice et al.,
2003; Peters et al., 2003; reviewed in Martin and Zhang, 2005). Methylation of
lysine does not alter the overall charge, but increases the basicity and
hydrophobicity of the histone tail (Rice and Allis, 2001). This is chemically
different from lysine acetylation which neutralizes a positive charge of the amino
group (Rice and Allis, 2001). Although mutually exclusive, both acetylation and
methylation can occur on lysines (e.g. H3K9) and the difference in chemistry
could function as a “switch” for opposing cellular processes (Jenuwein and Allis,
2001). The founding member of H3K9-specific HMTs, human Suv39h1 HMTases
(Rea et al., 2000), are homologues of Drosophila Su(var)3-9 and of S. pombe Clr4,
both of which are encoded by genes that are important for the establishment of
transcriptionally silent heterochromatin (reviewed in Grewal, 2000). Swi6, a
homolgue of HP1, is localized to heterochromatin depending upon the HMT
activity of Clr4 (Nakayama et al., 2001). Independently, biochemical studies
demonstrate that the chromodomains of HP1 and Swi6 preferentially associate
with H3 peptides carrying a K9me3 (Lachner et al., 2001; Bannister et al., 2001;
Jacobs et al., 2001). These results suggest that H3K9me3 bound to Swi6 plays a
role in transcriptional repression.
Interestingly, H3 methylation at K4 functions distinctly from methylation
at K9. In the transcriptionally active macronucleus of Tetrahymena and b-globin
gene in erythrocytes, H3K4 was determined to be methylated and was proposed
to be involved in active transcription (Strahl et al., 1999; Litt et al., 2001). Both
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H3K4me2 and H3K4me3 are enriched at actively transcribed genes in variety of
eukaryotes (Santos-Rosa et al., 2002; Bernstein et al., 2002; Ng et al., 2003;
Bernstein et al., 2005). These different methylation states, however, do not
overlap completely. While the H3K4me2 seems to be generally distributed
across the body of active genes, H3K4me3 is strongly and preferentially
associated with promoter and transcribed regions of active genes (Santos-Rosa et
al., 2002; Schneider et al., 2004). In yeast, the K4 methylation is mediated by the
Set1 complex, whose catalytic subunit, the SET domain protein Set1, is
homologous to the Drosophila trithorax protein and to a family of related human
proteins, hSet1, MLL1, and MLL2 (Roguev et al., 2001; Miller et al., 2001; Nagy et
al., 2002; Milne et al., 2002; Nakamura et al., 2002; Wysocka et al., 2003; Hughes et
al., 2004; Yokoyama et al., 2004). Human SET-1 like complexes such as MLL1
complex is structurally and functionally similar to the yeast Set1 complex and is
capable of methylation H3 at K4 (Wysocka et al., 2003; Goo et al., 2003; Hughes et
al., 2004; Yokoyama et al., 2004), suggesting that MLL1 mediated H3K4
methylation establishes and maintains transcription. Recently, two different
proteins, Chd1 and Wdr5 have been shown to interact specifically and directly
with methylated H3K4 to mediate transcription (Pary-Grant et al., 2005; Wysocka
et al., 2005). Chd1 binds to H3K4me2 (Pary-Grant et al., 2005) and Wdr5 binds to
both H3K4me2 and H3K4me3 (Wysocka et al., 2005).
The identification of enzymes that are responsible for demethylating
lysine within histones has lagged behind the identification of the HMTs. In fact,
the very existence of such an enzyme was questioned.

For the lysine

demethylase, the first breakthrough came with the identification of Lsd1. Lsd1
demethylates mono- and di-methylated H3K4 in an amine oxidase reaction,
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thereby leading to transcriptional repression (Shi et al., 2004; Lee et al., 2005).
Conversely, LSD1 can relieve repressive histone marks by demethylation of
histone H3 at K9, thereby leading to de-repression of androgen receptor target
genes (Metzger et al., 2005). These conflicting observations seem to be explained
by the existence of interacting proteins that can modulate the substrate specificity
of Lsd1. For example, an association with the androgen receptor was shown to
be capable of conferring H3K9 demethylase activity to Lsd1 (Metzger et al.,
2005). Further studies will be required to identify the mechanism underlying the
switching of substrate specificity of Lsd1. Recently, two JmjC domain-containing
proteins, JHDM1 and JHDM2, have been shown to specifically demethylase
histone H3K36 and H3K9 (me1 and me2), respectively (Tsukada et al., 2006;
Yamane et al., 2006).

Arginine methylation and demethylation/citrullination
The arginine residue in histone proteins can only be mono- (me1) or
dimethylated (me2s or me2a) by protein arginine methyltransferases, PRMT
(reviewed in Wysocka et al., 2006; Bedford and Richard, 2005). It is now known
that histones are substrates of CARM1, PRMT1 and PRMT5 (reviewed in
McBride and Silver, 2001). The first PRMT found to have specificity toward
histones is CARM1 (Chen et al., 1999), which catalyzes methylation of H3 at R2,
R17, R26 in vitro (Schurter et al., 2001). CARM1 was identified as a coactivatorassociated arginine methyltransferases for its ability to interact with a
transcription co-activator and to stimulate transcription in a methylationdependent manner (Chen et al., 1999). Similar to CARM1, PRMT1 also activates
transcription by specifically methylating R3 of H4 (Wang et al., 2001a; Strahl et
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al., 2001). Both CARM1 and PRMT1, when co-expressed with p160 coactivator,
can synergistically activate transcription of a reporter gene in a nuclear receptor
dependent manner (Bedford and Richard, 2005). These finding provide a
positive link between histone arginine methylation and transcriptional
activation.
A major group of deiminated proteins are the core histones H2A, H3, and
H4 (Nakashima et al., 2002). The peptidyl arginine deiminase Pad4 can block
methylation on an arginine residue by converting it to citrulline (Cuthbert et al.,
2004; Wang et al., 2004). Pad4 catalyzes the deimination of both arginine and
mono-methyl arginine, but not di-methyl arginine, to citrulline.

Peptidyl

arginine deiminases are not true “demethylases,” as they do not convert monomethyl arginine back to arginine (Wang et al., 2004). However, these enzymes
may prevent the proposed recruitment of binding proteins to H3R17 or H4R3
upon dimethylation by CARM1 and PRMT1, respectively (Wang et al., 2004).

Ubiquitination and deubiquitination
Ubiquitin, a 76 residue of amino acid polypeptide found in most living
organisms, is conjugated to the e-amino group of specific lysine residues of H2A,
H2B, H3, and H2A variant H2A.X and H2A.Z (Rechsteiner, 1988). Unlike for
other proteins, ubiquitination (ub) of histones does not result in degradation of
histones (Seale, 1981; Wu et al., 1981). In budding yeast, ubiquitination of H2B
on K123 by the Rad6-Bre1 complex is found to be important in the cellular
response to DNA damage (Robzyk et al., 2000; Sun and Allis, 2002; Giannattasio
et al., 2005). In the presence of DNA damage, rad6D (Rad6 deletion), bre1D (Bre1
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deletion), and H2BK123A (K123 mutated to alanine) mutants showed impaired
activation of the central checkpoint kinase Rad53, probably due to defects in
Rad9 phosphorylation (Giannattasio et al., 2005). In addition, H3K4 methylation
is eliminated in a strain where K123 has been mutated to R, whereas H3K4 to R
retains H2BK123 ubiquitination (Sun and Allis, 2002). Mutation of K123 also
disrupted silencing at the telomere (Sun and Allis, 2002), providing a link
between ubiquitination of H2BK123, H3K4 methylation and transcriptional
silencing. Recently, H2B ubquitination was shown to be required for the
H3K4me2 and H3K4me3, but not H3K4me1 (Shahbazian et al., 2005; Dehe et al.,
2005).
Ubiquitination is a reversible process and several studies have recently
demonstrated deubiquitination by the enzyme Ubp8 (Henry et al., 2003; Daniel
et al., 2004). Because Ubp8 is a component of the SAGA histone acetyltransferase
complex (Daniel et al., 2004), it has been proposed that the Rad6-catalyzed monoubiquitination of histone H2B is followed by the recruitment of SAGA to the
unubiquitinated nucleosomes and subsequent deubiquitination of histone H2B,
which is required to initiate transcription. In support of this observation,
mutations affecting Ubp8 lead to a rise in global histone H2B ubiquitination and
decrease in the transcription of SAGA-regulated genes (Henry et al., 2003; Daniel
et al., 2004).

Phosphorylation
Phosphorylation (ph) at serine and threonine residues of histones has been
shown to occur on linker histone H1, H2A variant H2A.X and all the core
histones in vitro and/or in vivo (van Holde, 1988). This long-appreciated histone
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modification is often associated with chromosome/chromatin condensation that
includes mitosis, meiosis, apoptosis, and DNA damage, events regulated by
different histone kinases (Fuchs et al., 2006; Wurtele and Verreault, 2006;
Peterson and Laniel, 2004).

Phosphorylation also closely correlates with

chromosome decondensation events (Cheung et al., 2000), suggesting a “split
personality” for certain modifications that remains to be fully understood.

H1 phosphorylation
Early studies on the cell cycle of the slime mold Physarum and mammalian cells
show that H1 phosphorylation is highest during metaphase, suggesting a role for
this modification in mitotic chromatin condensation (Gurley et al., 1973;
Bradbury et al., 1974). However, other experiments suggest that H1 itself is not
required for chromatin condensation (Ohsumi et al., 1993; Shen et al., 1995;
reviewed in Roth and Allis, 1992). Since faithful cell division is essential to life, it
is possible that additional phosphorylation events on other histones may provide
a redundant role to H1 phosphorylation.

In addition to H3S10ph, H3 is

phosphorylated at S28 (Goto et al., 1999), T11 (Preuss et al., 2003), and T3
(Polioudaki et al., 2004) during mitosis. Recently, H4 and H2A phosphorylation
at their respective S1 was linked to mitosis (Barber et al., 2004). These additional
sites of phosphorylation may share redundant functions with H1
phosphorylation in the process of chromosome condensation during mitosis.
H1 phosphorylation has been linked to transcriptional regulation (Roghi
et al., 1998); however, mechanisms underlying this process remain unclear. One
of the effects of phosphorylation is the alteration of the electrostatic charge of the
surrounding region (Roth and Allis, 1992). Given that there are many “basic
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patches” that flank potential phosphorylation sites within histone tails (Cheung
et al., 2000), these short stretches of basic amino acids may engage acidic residues
on other histones.

The reversible phosphorylation may disrupt these

electrostatic interaction and thereby unfold the chromatin polymer. Indeed, the
regulation of “charge patches” in H1 by reversible phosphorylation can regulate
transcription, presumably through the alteration of higher-order chromatin
structure (Dou and Gorovsky, 2000).

H2A.X phosphorylation
As discussed earlier, the C-terminal domains of the mammalian histone variant
H2A.X and the yeast core H2A are rapidly phosphorylated in response to DSBs
(reviewed in Iizuka and Smith, 2003). This phosphorylation is also present at
directed DNA DSB such as V(D)J recombination in lymphocytes, meiotic
recombination in mice, and apoptotic DNA fragmentation (Rogakou et al., 2000;
Mahadevaiah et al., 2001). The phosphorylation of H2A.X is mediated by
members of the phosphoinositide-3-kinase-related protein kinase (PIKK) family
(Rogakou et al., 1999). Of these PIKKs, ataxia telangiectasia mutated (ATM) and
DNA-dependent protein kinase catalytic subunit (DNA-PKcs) phosphorylate
H2A.X in response to DSBs in higher eukaryotes (Falck et al., 2005; Stiff et al.,
2004). In yeast, the PIKK family members, Mec1 and Tel1 in budding yeast,
phosphorylates H2A at S129 (Downs et al., 2000; Redon et al., 2003; Shroff et al.,
2004). The phosphorylation by these kinases takes place very rapidly after DNA
damage, within minutes of ionizing radiation (IR) (Celeste et al., 2003; Celeste et
al., 2002; Pilch et al., 2003).
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In mammalian cells, the phosphorylation is detected in the vicinity of the
DNA lesions by immunoflouoresence in combination with “laser scissors” (Paull
et al., 2000; Rogakou et al., 1999), and is present in megabase chromatin domains
(Rogakou et al., 1999). In addition, the phosphorylation of the budding yeast
H2AS129 (H2AS129ph) occurs on the DNA extending from an induced doublestrand break in both directs (Shroff et al., 2004; Downs et al., 2000) covering
regions of 50-100 kb of chromatin (Unal et al., 2004), demonstrating a direct role
of H2A.X phosphorylation in facilitating repair at the site of the break.
H2A.X phosphorylation is important for promoting efficient repair in both
mice and yeast. H2A.X-/- knockout mice are viable yet sensitive to IR (Celeste et
al., 2002). H2A.X-/- mouse embryonic fibroblasts (MEFs) have more spontaneous
chromosomal aberrations than their wild-type counterparts and generate more
breaks when exposed to IR. H2A.X-/- cells are also slower to repair IR-induced
damage (Celeste et al., 2002). Similar phenotypes were observed in yeast
carrying an H2AS129 to alanine (S129A) mutation, which prevents H2AS129
from being phosphorylated in response to damage. Studies examining S.
cerevisiae and S. pombe H2A S129A mutants report increased sensitivity to several
DNA damaging agents, such as MMS, camptothecin, and IR, all of which
generate DSBs (Downs et al., 2000; Nakamura et al., 2004). This sensitivity is far
less than that conferred by checkpoint and repair mutants, suggesting H2A.X
phosphorylation may contribute to but is not essential for both processes.
One of the functions of H2A.X phosphorylation is to provide a unique
binding site for interaction factors. Indeed, Mdc1/Nfbd1 has been shown to
directly interact with phosphorylated H2A.X via its BRCT domain in mammalian
cells (Stewart et al., 2003; Stucki et al., 2005). Their interaction then results in the
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recruitment of 53BP1, Nbs1 and phosphorylated ATM at sites of damaged
chromatin to mediate DNA repair signaling cascade (Stucki et al., 2005) (See
below).

Dephosphorylation of H2A.X
H2A.X phosphorylation can be eliminated by multiple mechanisms including
removal by histone exchange followed by degradation, or, alternatively,
dephosphorylation. Recently, histone H2A phosphoatase complex, HTP-C, has
been found to regulate the phosphorylation status of H2A.X phosphorylation in
vivo and effiecently dephosphrylates H2A.X in vitro (Keogh et al., 2006). Htp-C
contains the phosphatase Pph3 and the deletion of Pph3 leads to increase in
H2A.X phosphorylation in S. cerevisiae (Keogh et al., 2006). In addition, H2A.X
phosphorylation is lost from chromatin surrounding a DSB independently of the
Htp-C, suggesting that the phosphatase targets H2A.X phosphorylation after its
displacement from DNA (Keogh et al., 2006). Morevoer, the DNA checkpoint
recovery defect imparted by the deletion of Pph3 results from the persistent
phosphorylation of H2A.X (Keogh et al., 2006).

Therefore, the

dephosphorylation of H2A.X phosphorylation by the Htp-C may be necessary
for efficient recovery from the DNA damage checkpoint.

H3 serine 10 phosphorylation
Core histone H3S10ph occurs during mitotic and meiotic chromatin
condensation in Tetrahymena, yeast, worm and mammalian cells (Gurley et al.,
1973; Paulson and Taylor, 1982; Wei et al., 1998; Cobb et al., 1999; Hsu et al.,
2000). The link between H3 phosphorylation and chromosome condensation has
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been supported by experiments that induce premature chromosome
condensation (PCC).

Drug-induced phosphorylation correlates with

chromosome condensation, whereas, chromosome decondensation is observed
when dephosphorylation is induced prematurely in mitotic cells (Ajiro et al.,
1996). In addition, inhibition of the putative H3 kinase by staurosporin, a nonspecific kinase inhibitor, resulted in chromosome decondensation as well as
elimination of phosphorylated H3 (Th’ng et al., 1994). Furthermore, the
development of an antibody against histone H3S10ph has allowed in vivo studies
of this event (Hendzel et al., 1997), and further supports the strong correlation
between S10ph and chromosome condensation during mitosis and meiosis
(Hendzel et al., 1997; Van Hooser et al., 1998; Hsu et al., 2000).
Consistent with a role for H3S10ph in chromosome function, a
Tetrahymena mutant strain in which S10 of histone H3 is replaced by an alanine
residue (H3 S10A) exhibits altered chromosome condensation (Wei et al., 1999).
In addition, abnormal chromosome segregation was observed in this strain,
which the authors hypothesize is associated with the perturbation of
chromosome condensation (Wei et al., 1999). However, similar mutational
analysis in yeast showed that the H3S10 to alanine (H3 S10A) mutant does not
have altered generation time or cell cycle progression defects as compared to the
wild-type (WT) strain (Hsu et al, 2000).

In addition, in vitro chromatin

condensation assays using Xenopus extracts indicated that neither H3S10ph nor
the H3 N-terminal tail are required for mitotic chromatin condensation (de la
Barre et al., 2001). Therefore, although H3S10ph may function in chromosome
condensation or segregation in Tetrahymena, the requirement for the modification
in these processes does not appear to be conserved in yeast and Xenopus.
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H3 serine 10 kinase - Aurora B
The kinase responsible for the mitotic and meiotic H3S10ph in eukaryotes is the
Ipl1/aurora B kinase family (Hsu et al., 2000; Zeitlin et al., 2001). The phenotype
of the H3 S10A mutant in Tetrahymena resembles that of the yeast mutant lacking
the only yeast aurora kinase, Ipl1 (Chan and Botstein, 1993; Wei et al., 1999). The
recombinant Ipl1 can phosphorylate H3S10 in vitro and the temperature sensitive
yeast mutant strain Ipl1-2 shows a dramatic reduction of mitotic and meiotic
H3S10ph in vivo. In S. pombe, Ark1, the aurora kinase, is associated with
H3S10ph in mitosis (Petersen et al., 2001). Furthermore, H3S10ph in worms and
mammalian cells require aurora B kinase (Hsu et al., 2000; Giet and Glover, 2001;
Hauf et al., 2003). In agreement with these results, RNAi reduction of aurora B
kinase in these organisms associates with a decrease in H3S10ph (Hsu et al., 2000;
Giet and Glover, 2001; Hauf et al., 2003).

H3 serine 28 phosphorylation
H3S28 phosphorylation (H3S28ph) is increased during mitosis in mammalian
cells (Goto et al., 1999). Although found in the same consensus sequence –ARKSas S10 (see “Histone modification cassette” and the yellow box in Figure 5),
H3S28ph displays a pattern different from that of H3S10ph. H3S28ph initiates in
condensing chromosomes at prophase (Goto et al., 1999), but H3S10ph initiates
in heterochromatin at late G2 (Hendzel et al., 1997). In contrast to H3S10ph,
H3S28ph has never been observed in interphase. Instead it seems to be a mitotic
event strictly related to mitotic chromosome condensation (Goto et al., 1999).
As is the case for H3S10ph, H3S28ph may be stimulus-inducible. The
stimulation of the MAPK pathway by phorbol esters leads to an increase in both
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S10ph and S28ph in ras-transformed fibroblast (Dunn and Davie, 2005),
suggesting that these two modifications might work together. However, acid
urea gel (AU) analysis determined that a significant portion of phosphorylated
S28 and S10 exist on an H3 that has not been otherwise acetylated or
phosphorylated (the mono-modified form), suggesting that the two
modifications do not function in a cooperative manner (Dunn and Davie, 2005).
Furthermore, this mono-modified form was present at the same time when the
H3 phosphorylation is at a maximum (Dunn and Davie, 2005). Thus, H3S28ph is
not dependent upon the phosphorylation of S10 or vice versa.
Despite these differences, H3S28ph and S10ph share a common kinase.
Aurora B was shown to be responsible for the mitosis-specific phosphorylation
of S28 (Goto et al., 2002). Similar to H3S10ph, H3S28ph is sensitive to treatment
with PP1 (protein phosphatase) (Goto et al., 2002). PP1 is a phosphatase that
counteracts aurora B (Murnion et al., 2001).

Dephosphorylation of H3 serine 10 and serine 28
The phosphorylation of S10 and S28 are reversible processes and both are likely
mediated by PP1.

In yeast, Glc7, also known as PP1 is shown to be the

phosphatase that counteracts Ipl1 kinase (Francisco et al., 1994) and catalyzes
dephosphorylation of S10 on H3 (Hsu et al., 2000). In C. elegans, H3S10 is also
dephosphorylated in vivo by a type 1 phosphatase, namely Glc7 (Hsu et al., 2000).
Moreover, as discussed earlier, the level of H3S28ph is diminished to
undetectable levels by PP1 phosphatase (Goto et al., 2002). Therefore, PP1 is
suspected of being responsible for the dephosphorylation of S28 in mammalian
cells as well.
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Although the casual relationship of H3 phosphorylation and chromosome
condensation has not been firmly established in yeast and nematode, much
evidence suggests that PP1 is important for mitotic chromosome transmission.
For example, specific alleles of glc7 in yeast are defective for kinetochore function
(Bloecher and Tatchell, 1999; Sassoon et al., 1999). Defects in chromosome
segregation and condensation have also been noted for PP1 mutants in S. pombe
(Ohkura et al., 1989) and in A. nidulans (Doonan and Morris, 1989). Moreover,
mutation of the Drosophila protein phosphatase gene, Pp1-87B, or inhibition of
protein phosphatase activity in mammalian cells can cause severe mitotic defects
and over-condensed chromosomes (Axton et al., 1990; Guo et al., 1998).
Therefore, these studies suggest that histone H3 is one of the physiologically
relevant substrates for PP1 in variety of organisms including yeast and
nematode, and a possible link between H3 dephosphorylation and mitosis.

H3 threonine phosphorylation
Although H3T3 phosphorylation (H3T3ph) has been identified as mitosisspecific phosphorylation (Preuss et al., 2003; Polioudaki et al., 2004), it has a
different kinetic and localization pattern from H3S10ph. For example, H3T3ph is
absent in anaphase and telophase, while the signal for H3S10ph was clearly
detectable in these stages of mitosis (Polioudake et al., 2004). In addition, the
H3T3ph signal was concentrated in the central region of the metaphase plate and
extending to the chromosome arms, while H3S10ph signal was more dominant
in the periphery of the metaphase plate (Polioudake et al., 2004). Recently,
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Haspin/Gsg2 (haploid germ cell-specific nuclear protein kinase/germ cellspecific gene-2) was identified as a responsible kinase for H3T3 (Dai et al., 2005).
H3T11 phosphorylation (H3T11ph) occurs from prophase to anaphase and
appears to be particularly enriched at mammalian centromeres (Preuss et al.,
2003). Dlk kinase (Death-associated kinase) is a nuclear serine/threonine kinase
that can phosphorylate H3 and H4 in vitro (Preuss et al., 2003). It also colocalizes to the centromeres with H3T11 phosphorylation (H3T11ph; Preuss et
al., 2003), suggesting Dlk as a possible T3 kinase. Recently, H3T11ph was
identified in plant cells during mitosis and meiosis (Houben et al., 2005).
Interestingly, treatment of cells with the phosphatase inhibitor cantharidin
revealed a high level of T11ph in interphase cells (Houben et al., 2005). Taken
together, these results demonstrate the role of H3T11ph in mediating the
progression through mitosis.

H2A serine1 phosphorylation
Phosphorylation on S1 of H2A (H2AS1ph) is found to be involved in
transcription regulation and cell cycle. Recently, it was shown that Msk1, which
is a kinase for active transcription-related H3S10ph (Sassone-Corsi et al., 1999;
Thomson et al., 1999), catalyzes the H2AS1ph, and inhibits transcription in vitro
(Zhang et al., 2004). Therefore, Msk1 seems to regulate transcriptional activation
and repression depending on the histone substrate. It has been postulated that
the acetylated histones suppress a transcriptional repression-related
phosphorylation by Msk1 to induce transcription. Indeed, acetylated H3 inhibits
the phosphorylation of H2A by Msk1 (Zhang et al., 2004). During mitosis, the
phosphorylation at both H2AS1 and H4S1 have similar timing and localization as
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H3 phosphorylation, and closely correlates with the mitotic chromatin
condensation (Barber et al., 2004; see below).

These results suggest that

phosphorylation of H2A may have dual purpose in mitotic chromatin
condensation and transcriptional regulation.

H4 serine 1 phosphorylation
H4S1 phosphorylation (H4S1ph) was first reported to occur in the cytoplasm
prior to being imported into the nucleus. This phosphorylation has been linked
to “new” histone synthesis during S-phase and deposition of H4 onto newly
replicated DNA (Ruiz-Carrillo et al., 1975). Consistent with this result, H4S1ph is
localized in the nucleus of early S-phase cells when histones are synthesized and
assembled into chromatin (Barber et al., 2004). H4S1ph also correlates with
mitotic chromatin condensation and displays kinetics and localization patterns
similar to H3S10ph (Barber et al., 2004). Therefore, H4S1ph may have a dual
purpose in chromatin condensation during mitosis and histone deposition
during S-phase.
H4S1ph has been also linked to DNA damage repair. Upon treatment
within the DNA-damage agent MMS, which introduces single- and doublestrand breaks in DNA, the casein kinase 2 (CK2) phosphorylates histone H4 at S1
in yeast (Cheung et al., 2005; Ultey et al., 2005). CK2 is a DNA damage-regulated
kinase, and null or temperature-sensitive CK2 yeast mutants are defective for
induction of H4S1ph upon DNA damage in vivo (Cheung et al., 2005). CK2
mediated H4S1ph plays a role in non-homologous end joining repair, but yeast
histone H4S1 mutants display no sensitivity to the DNA-damaging agents
(Cheung et al., 2005; Utley et al., 2005), indicating that this modification itself is
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not the DNA damage response. Recently, the increase in H4S1ph during DNA
damage was accompanied with a drop in acetylation of histone H4 (Utley et al.,
2005). In addition, phosphorylation of S1 has a negative effect on acetylation by
NuA4, which is a HAT complex that is recruited to a DSB site, in vitro (Utley et
al. 2005). These data suggest that this modification is a part of the DNA-repair
histone code.

H2B serine 14 phosphorylation
H2BS14 phosphorylation (H2BS14ph) is induced during apoptosis in mammalian
cells. (Ajiro et al., 2000; Cheung et al., 2003). The kinase Mst1 (Mammalian sterile
twenty) was identified as the kinase responsible for S14 apoptotic
phosphorylation (Cheung et al., 2003). The onset of DNA damage marker
H2A.XS139ph precedes H2BS14ph, suggesting a link between DNA damage
repair and apoptosis. Their link is further confirmed by the observation that
showed the phosphorylation of S14 coinciding with the site of DSB induced by
ionizing radiation or laser treatment (Fernandez-Capetillo et al., 2004a). Given
that unrepaired or incorrectly repaired DNA damage triggers apoptosis to
eliminate these deregulated cells (Sancar et al., 2004), H2BS14ph may be the
mechanism to promote apoptosis in these cells. In other words, H2BS14ph
serves as an apoptotic “histone code.”
Given that S14ph is uniquely associated with apoptotic chromatin,
H2BS14ph may function to facilitate the formation of chromatin in species
ranging from frogs to humans (Cheung et al., 2003). So far, the direct link
between H2BS14ph and chromatin condensation has been lacking in vivo,
although the influence of the H2B N-terminal tail on chromatin condensation
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was observed in vitro (de la Barre et al., 2000). In Chapter 2, I have extended this
finding to unicellular eukaryotes by identifying a novel histone H2B
phosphorylation during yeast apoptosis. I have also provided the first in vivo
demonstration that H2B phosphorylation directly mediates chromatin
condensation.

Histone modification “cross-talk”
The nature of the histone code predicts that histone modifications impinge on
each other by acting as molecular switches, enabling or blocking the setting of
other covalent marks that may specify unique downstream functions (Jenuwein
and Allis, 2001; Fischle et al., 2003a; Fischle et al., 2003b). Indeed, this type of
“cross-talk” between different histone modifications has emerged as a paradigm
of chromatin mediated functions/cell biology (Jordan et al., 2000; Pawson and
Nash, 2000). The first level of the complexity of histone modification cross-talk
originates from the modular organization of chromatin itself (Fischle et al.,
2003a). Since each core histone can be post-translationally modified in a large
number of ways, this generates a vast number of possible combinations of marks
for any chromatin domain. The second level of complexity comes from the
modifications on a single histone, which are dependent on each other and
interconnected via various mechanisms (Fischle et al., 2003a). The final level of
complexity is from the fact that cross-talk exists between modifications on
different histones. These effects might be restricted to a single nucleosome or
might affect larger nucleosomal arrays or domains (Fischle et al., 2003a). Thus,
the complexity and diversity that are generated by the modifications add to the
capacity of the genome to store, inherit and release information.
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Figure 4. “Cross-talk” between histone modifications
(A) Potential “choices” of the modification status of different histone residues.
Whereas serine (S) and threonine (T) residues are phospho-acceptor (P) sites,
lysine (K) and arginine (R) residues have multiple choices of post-translational
modification possibilities. Lysine residues can be acetylated (Ac), monoubquitinated (Ub), sumolated (Su), or (mono-, di-, tri-) methylated. Arginine
might be mono- or di-methylated (symmetrical or asymmetrical). This figure
was adapted from Fischle et al., 2003a.
(B) “Cross-talk” at the level of a single histone H3 amino-terminal tail.
H3S10ph promotes acetylation on K14 following epidermal factor treatment.
H3K9 and H3K14 acetylation stimulate H3S10ph during mitosis.
(C) “Cross-talk” between histone H2B and H3. In yeast, only H2B is known to
be ubiquitinated (H2BK120 of the human sequence corresponds to H2BK123
in yeast). This modification is necessary for methylation of H3 on K4 and K79.
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The histone modification choice of a single residue provides the first level
of complexity of chromatin cross-talk (Fischle et al., 2003a). Particularly, lysine
and arginine residues have multiple choices of post-translational modification
possibilities. Lysine residues in histones can be acetylated, mono-ubiquitinated,
or mono- or di-, and tri- methylated (Figure 4A). Similarly, arginine can be
mono- or di-methylated symmetric or asymmetric (Zhang and Reinberg, 2001;
Bannister et al., 2002). It is well documented that H3K9 and H3K14 can be either
acetylated, or mono-, di-, and tri-methylated. Different modifications of a
particular site can have different readouts with distinct biological functions. The
H3K4me2 occurs at both inactive and active euchromatic genes, whereas trimethylation is present exclusively at active genes (Santos-Rosa et al., 2002). The
acetylated state of H3K4, however, correlates with euchromatin, suggesting its
involvement in active transcription (reviewed in Nowak and Corces, 2000). A
similar paradigm also follows for H3K9.

Pericentric heterochromatin is

specifically enriched in H3K9me3 leading to transcriptional repression, but the
K9ac is found in euchromatin leading to transcriptional activation (reviewed in
Lachner and Jenuwein, 2002; Kondo et al., 2003). Conversely, mono- and dimethylated H3K9 is found in silent domains within euchromatin (Rice et al.,
2003), suggesting that K9me3 is functionally distinct from the other H3K9-methyl
modifications. Therefore, the cross-talk choices of single histone residues and the
enzyme system that modifies them provide one level of complexity that impacts
on genomic function and gene activity.
Histone modification cross-talk exists as a chronology in the establishment
of a specific modification pattern. The methylation on H3K9, for example,
appears to trigger sequential events leading ultimately to transcriptional
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repression (Wang et al., 2001b). At least in vitro, this mark can inhibit acetylation
of the H3 tail on K14, K18, and K23 by HAT (e.g. p300) (Wang et al., 2001b), and
methylation on H3K4 by HMT (e.g. Set7) (Wang et al., 2001b). By contrast,
H3K4me2 inhibits K9me2 by Su(var)3-9, but promotes acetylation of H3 by p300
(Wang et al., 2001b). The phosphorylation of histone H3S10 also facilitates
acetylation of K14 and methylation of K4, and leads to gene activation (Lo et al.,
2001; Milne et al., 2002; Cheung et al., 2000; Figure 4B). Thus, this is an example
of a pre-existing modifications close to a site of methylation altering the
recognition motif of protein methyltransferases to regulate gene activation.

Finally, the histone modification cross-talk takes place even between
marks on different histones. For example, ubiqitination of histone H2BK123 is
required for methylation of H3K4 and H3K79, which are both involved in
transcriptional activation (Sun and Allis, 2002; Briggs et al., 2002; Dover et al.,
2002; Ng et al. 2002; Shahbazian et al., 2005; Dehe et al., 2005; Figure 4C).
The diversity of histone modification cross-talk establishes distinct
biological functions. This can be achieved by a “code”, which is set up by
singular as well as combinatorial histone modifications and read by cellular
binding factors bringing about specific responses (e.g. chromodomain and
bromodomain proteins; see “Trans mechanism”). Thus, in contrast to the
straight flow of most signal transduction cascades, where the modification of one
protein impacts directly on downstream effectors, signaling to and from
chromatin appears to be far more complex. In my thesis, I have provided
another example of histone modification cross-talk on the level of a single
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histone, H2B, further supporting the complex nature of chromatin mediated
function.

Histone modification “cassette”
Another mechanism that might govern the biological readout of distinct
modification patterns is the concept of “modification cassettes” (reviewed in
Fischle et al., 2003b). In this hypothesis, the “cassette” refers to a short cluster of
densely modifiable sites in histones with a distinct biological readout (Fischle et
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Figure 5. Putative “cassettes” in histone H3 and H4 N-terminal tails
The sequence of the first 28 residues of human H3 and H4 are denoted and
sites of post-translational modifications are indicated.

The putative

“cassettes” include the stretch between K9 and T11 of H3 that carries four
different covalent marks, whereas the stretch between S1 and K5 of H4 carries
three different marks. An identical stretch of ARKS motif is found on H3 tails,
with modifications on K9 and K27, S10 and S28. The histone modifications
within this short cluster are thought to influence the recognition and binding
of modules to their cognate mark to mediate downstream functions. The
cassettes are denoted by yellow boxes. Note that lysine residues can be mono, di-, tri-methylated and arginine residues can be mono- and di-methylated.
For clarity, these different methylation events are collectively represented as a
single methyl mark for each of the residues. Ac, acetylation; M, methylation;
P, phosphorylation; ® arginine methylation (adapted from Fischle et al.,
2003b).
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al., 2003b). Rather than acting independently, this domain is situated at strategic
locations in the histones and functions as a discrete information unit regulating
and relaying different signals depending on its modification state (Fischle et al.,
2003b). The best examples of short cassettes are readily spotted on the H3 and
H4 N-terminal tail, where there are at least three out of five sites separated by no
more than one residue that can be covalently modified; the stretch between K9
and T11 of H3 or S1 and K5 of H4 (see yellow box in Figure 5). The identical
ARKS motifs are found in H3 tail with modifications on K9 and K27, S10 and S28
(yellow box in Figure 5). The histone modifications within this short cluster are
thought to influence the recognition and binding of modules to their cognate
mark to mediate downstream functions (see “trans mechanism”).

Functional mechanism of histone covalent modifications
Different covalent modification patterns found in the highly basic core histone
tail domains are essential determinants of chromatin fiber dynamics. Two
general types of mechanisms have been proposed to explain the function of
covalent histone modifications: 1) “cis” mechanisms that involve the covalent
modifications inducing the structural alteration in the chromatin fiber by
changing internucleosomal contacts (Figure 6A), 2) “trans” mechanisms that
involve the binding of effectors to engage specific covalent modifications in a
context-dependent fashion (Figure 6B).
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Figure 6. Molecular mechanisms of covalent histone modifications
The function of covalent histone modifications can be mediated by two general
mechanisms that are not mutually exclusive: 1) “trans” mechanisms, operating
through the recruitment of proteins with binding modules (such as
chromodomains (CD) that “read” methyl-lysine marks, bromodomains (BD) that
read acetyl-lysine marks, or phosphate-binding effectors such as BRCT
domains), that, in turn, mediate downstream effects, or 2) “cis” mechanisms that
modulate inter-nucleosomal contacts, leading to structural alterations in the
chromatin fiber. Examples of “cis” mechanisms include acetylation-induced
“charge patches” associated with transcriptional activation and phosphorylationinduced patches that potentially may lead to chromatin condensation. For
histone phosphorylation, details of both mechanisms are largely unknown
(adapted from Wolfgang Fischle).
Cis mechanism
The “cis” mechanism postulates that covalent modifications directly affect the
nucleosomal contacts and histone DNA interactions to alter the chromatin
structure (Figure 6A). In this case, the N-terminal histone tails appear to mediate
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chromatin condensation through multiple mechanisms, only one of which
involves simple DNA charge neutralization. Most of the information available
comes from studies involving “tail-less” nucleosome arrays that have the major
portions of the core histone tails removed by selective proteolysis with trypsin.
Trypsinized arrays are unable to fold into the most compact conformation or to
oligomerize (Fletcher and Hansen, 1995; Garcia-Ramirez et al., 1992; Schwarz et
al., 1996; Tse and Hansen, 1997). In addition, studies of “hybrid” trypsinized
arrays lacking either their H2A/H2B or H3/H4 N-termini demonstrate that the
core histone tail domain, and in particular the H3/H4 tetramer tails, mediate the
solution-state conformational dynamics of the chromatin fiber (Krajewski and
Ausio, 1996; Moore and Ausio, 1997; Tse and Hansen, 1997).

Moreover,

Richmond and colleagues have shown that the chromatin fibers lacking one of
these histone tails with the exception of the H4 N-terminus lead to cationdependent compaction (Dorigo et al., 2003). The detailed experiments revealed
that the basic patch (amino acid residues 14-19) may be integral to the formation
of nucleosome-nucleosome interactions in chromatin higher-order structure
(Dorigo et al., 2003). The electrostatic interactions between the basic residues of
the H4 N-terminal tail and the acidic patch of the H2A/H2B dimer from an
adjacent nucleosome are thought to lead to a chromatin fiber compaction (Davey
et al., 2002; Luger et al., 1997). Apart from the electrostatic component, proteinprotein interactions, for example internucleosomal tail-tail interactions and/or
binding of the tails to exposed protein domains on the surface of other nearby
nucleosomes may also play a role (Hansen, 2002; Luger and Richmond, 1998).
Furthermore, because of the extensive involvement of the tails in chromatin fiber
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folding, it seems likely that at least some core histone tail post-translational
modifications will have significant effects on chromatin fiber dynamics.
Currently, it is widely assumed that particular histone acetylation patterns
lead to altered folding of the nucleosomal fiber that renders chromosomal
domains more accessible. In this case, the reduction of the positive charge due to
the acetylation of lysine and/or arginine residues in this region may contribute
to a less stable, open structure (reviewed in Hansen, 2002). In support, the
acetylated histones disrupted formation of the folded state in vitro (GarciaRamirez et al., 1995). Likewise, the acetylated histones also correlate with
euchromatin in vivo (Vavra et al., 1982; Clarke et al., 1993; Bone et al., 1994;
Hebbes et al., 1992; Hebbes et al., 1994). Recently, the acetylation of H4K16 was
found to directly contribute to the decondensed chromatin in vitro (ShogrenKnaak et al., 2006). Given that H4K16ac has a role in transcriptional activation
and the maintenance of euchromatin in vivo (Hilfiker et al., 1997; Suka et al.,
2002) further reinforces that the functional status of the core histone tail domains
can regulate the higher-order chromatin structure.
To date, the potential cis effects on chromatin structure, produced by
adding or subtracting charge altering phosphates, remains poorly understood.
In Chapter 4, I have provided evidence supporting the phosphorylation-induced
patches leading to chromatin condensation via the cis mechanism.

Trans mechanism
According to the histone code hypothesis, the histone modification marks
provide the binding sites for a series of effector proteins that would affect
chromatin function (Jenuwein and Allis, 2001).
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Interestingly, the histone

modifying enzymes are unable to access their substrates unless targeted there
(Felsenfeld and Groudine, 2003; Johnson et al., 2005). In other words, the same
enzyme will not modify all histones in all genes, at the same time; only that
subset of genes that have recruited the modifying enzyme to the promoter will
be regulated by it. This highlights the relevance of the targeting process, at the
origin of the selectivity of the enzyme action, as an important feature of the
regulation of histone modification. Within this context, it is clear that the protein
domains able to interact with chromatin and/or its modified components (e.g.
bromodomain, chromodomain, BRCT domains) can play a crucial role in the
targeting process (reviewed in de la Cruz et al., 2005; Stucki et al., 2005), and
therefore, induce and direct downstream biological functions, which is referred
to as “trans” mechanism (Figure 6B). Some of the best known histone binding
domains will be discussed below.

Bromodomain
Bromodomains (Brahma organization modifier) are small protein domains that
are found in many chromatin-associated proteins and most HATs (reviewed in
Horn and Peterson, 2001; Zeng and Zhou, 2002). Bromodomains function as
acetylated lysine binding domains (Bottomley, 2004; Hudson et al., 2000; Owen
et al., 2000; Jacobson et al., 2000). A direct interaction between bromodomains
and acetylated lysines was initially suggested by NMR structural studies of
PCAF's bromodomain and confirmed by in vitro peptide binding and
mutagenesis experiments (Dhalluin et al., 1999). Indeed, the acetylation of tail
lysines at the IFN-b promoter by GCN5/PCAF turns out to be highly specific
both in vivo and in vitro and marks three residues: H4K8, and H3K9 and H3K14
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(Agalioti et al., 2002). Using mutated and modified recombinant histones, these
acetylations were found to provide distinct signals for the sequential recruitment
of the bromodomain-containing proteins BRG1, a component of the SWI/SNF
complex, and TAFII250, a component of TFIID (Agalioti et al., 2002; Figure 7A).
Mutating H4K8 to alanine abolished the ability to recruit BRG1, whereas
mutating H3K9 or K14 to alanine abolished the ability to recruit TAFII250
(Agalioti et al., 2002). These studies argue that these interactions are the result of
unique protein-recognition surfaces created by the modifications and thus
represent a histone acetylation code for the IFN-b promoter (Agalioti et al., 2002).
The crystallographic analyses of the double bromodomain of human
TAFII250 showed that these modules have the capacity to bind histones that are
multiply acetylated (Jacobson et al., 2000). Interestingly, the distance between
the two binding pockets ideally suits the interaction with acetylated lysines that
are seven amino acids apart, a configuration that is seen on H4 in vivo (K5, K8,
K12, and K16 of the N-terminal tail are known to be acetylated (Thorne et al.,
1990). Furthermore, in vitro peptide binding assays showed that multiply
acetylated H4 peptides bind to the double bromodomain with much greater
affinity than unacetylated peptides (Dey et al., 2003). Given that TAFII250 is a
component of TFIID (Ruppert et al., 1993; Weinzierl et al., 1993), these findings
immediately suggest a model whereby acetylation of histones, particularly at H4,
may serve to recruit TFIID to relevant promoters and facilitate the assembly of
preinitiation complexes.

Taken together these studies demonstrate that

sequential recruitment and anchoring of bromodomain-containing factors and
complexes to the promoter region are indeed crucial for activation of some genes.
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Examples of “trans” mechanism for the effect of histone

modifications
(A) The pair of acetyl-groups (Ac flags) on H4 functions as an interaction
module and binds to the double-bromodomains (BD) of TAFII250.
(B) By analogy, the methyl-group (M flags) on H3 functions as a unique
epitope that specifically interacts with the chromodomain of HP1.
(C) The phospho-group on H2A.XS139 interacts with the BRCT domain of
MDC1/NFBD1, whereas H3S10ph interacts with 14-3-3 protein.
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Chromodomain
The chromodomain (chromatin organization modifier) was first identified as a
common domain between two distinct regulators of chromatin structure in
Drosophila: heterochromatin protein 1 (HP1) and Polycomb (Pc) (Paro and
Hogness, 1991). Proteins containing chromodomains, have been shown to have
affinity for methylated lysines (Jacobs and Khorasanizadeh, 2002; Fischle et al.,
2003c). The structure of the HP1 chromodomain consists of three-stranded
antiparallel b-sheet supported by an a-helix that runs across the sheet. The
binding pocket consists of three aromatic side chains that become ordered on
binding the methylated histone H3 peptide (Nielsen et al., 2002; Jacobs and
Khorasanizadeh, 2002; Fischle et al., 2003c; Bottomley, 2004). In fact, HP1 binds
to methylated (mono-, di-, tri) H3-K9 (Figure 7B) and silencing protein Pc also
binds tri-methylated H3K9 and all methylated state of H3K27 (Cao et al., 2002;
Czermin et al., 2002; Kuzmichev et al., 2002; Fischle et al., 2003c), thus directing
the binding of other proteins to mediate the formation of heterochromatin and
gene silencing (Bannister et al., 2001; Lachner et al., 2001; Nakayama et al., 2001).

BRCT domains
BRCA1-C-terminal (BRCT) domain contains a pair of tandem repeats that are
essential for the tumor suppressor function (reviewed in Glover et al., 2004).
Similar repeat sequences have been identified in many proteins, such as Nbs1,
the p53 binding protein 53BP1 and MDC1, that mediate cellular mechanisms for
dealing with DNA damage (Celeste et al., 2002; Bassing et al., 2002). The BRCT
domain was recently shown to constitute a module for recognizing
phosphorylated peptides (Williams et al., 2004).
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NBS1, the gene product defective in Nijmegen breakage syndrome (NBS)
(Matsuura et al., 1998; Carney et al., 1998; Varon et al., 1998), physically interacts
with histone, rather than damaged DNA, by direct binding to H2A.XS139ph
(Kobayashi et al., 2002). The N-terminal region of Nbs1 contains both the forkhead associated (FHA) and the BRCT domain (Tauchi et al., 2001). Both FHA
and BRCT domains of Nbs1 are essential for this physical interaction, since NBS1
lacking either domains failed to bind to H2A.XS139ph. In addition, recombinant
FHA or BRCT domains alone can bind to phosphorylated H2A.X (Kobayashi et
al., 2002). Thus, the phosphorylated H2A.XS139 and the FHA and BRCT domain
of Nbs1 may define a signaling/recognition module pair for DNA damage.
Recently, the BRCT domain of mammalian MDC1/NFBD has also been
shown to directly bind to H2A.XS139ph by specifically interacting with the
phospho-epitope at the H2A.X carboxyl terminus following DNA damage
(Stucki et al., 2005; Figure 7C). In addition, MDC1/NFBD1-H2A.X complex
formation regulates H2A.X phosphorylation and is required for normal
radioresistance and efficient accumulation of DNA-damage-response proteins on
damaged chromatin (Stucki et al., 2005). Therefore, binding of MDC1/NFBD1 to
phosphorylated H2A.X plays a central role in the mammalian response to DNA
damage.

14-3-3 domain
The term "14-3-3" denotes a family of dimeric a-helical proteins present in high
abundance in all eukaryotic cells (Fu et al., 2000). 14-3-3 proteins were the first
molecules to be recognized as distinct phosphorylated serine/threonine binding
proteins, forming tight complexes with phosphorylated ligands (Yaffe et al.,
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1997a; Rittinger et al., 1999). In fact, 14-3-3 binds to histone H3 tail in a strictly
S10ph-dependent manner (Macdonald et al., 2005; Figure 7C). In addition, the
acetylation of H3K9 and K14 does not impede 14-3-3 binding to H3S10ph
(Macdonald et al., 2005). In vivo, 14-3-3 is inducibly recruited to c-fos and c-jun
nucleosomes upon gene activation, concomitant with phosphorylation and
acetylation of H3 (Macdonald et al., 2005). 14-3-3 isoforms thus represent a class
of proteins that mediate the effect of histone phosphorylation at inducible genes.

Apoptosis
Since my thesis deals with histone phosphorylation during cell death, in this
section, I will discuss some of the critical pathways that affect apoptosis. As grim
as this term sounds, cell death plays an essential part in development in adult life
of multicellular organisms (Clarke and Clarke, 1996). In general there are two
categories of cell death: passive and active cell death (reviewed in Jin and ElDeiry, 2005). For passive cell death, also known as necrosis, cells die with slow
integration and without features of active cell death. Active cell death is known
as apoptosis or programmed cell death (PCD), which refers to cells that are
“programmed” to die during normal development.
The word apoptosis comes from the Greek word meaning “dropping or
falling off of petals from a flower or leaves from a tree” and it plays a
complementary but opposite role to mitosis in the regulation of animal cell
populations (Kerr et al., 1972). Apoptosis is initially defined by its morphological
and biochemical characteristics such as exposure of phosphatidylserine on the
cell surface, cell shrinkage, membrane “blebbing,” production of reactive oxygen
species (ROS), chromatin condensation and nuclear fragmentation (Kerr et al.,
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1972; Figure 8). The nucleus condenses completely and is segregated into several
fragments, although the other organelles are generally left intact (reviewed in
Hacker, 2000). The entire condensed cell is reorganized into “apoptotic bodies”
which are small membrane-bound vesicles varying in size and composition (Kerr
et al., 1972). The “apoptotic bodies” can contain whole organelles, parts of
condensed nuclei or cytosolic elements, which are phagocytosed by neighboring
cells. Apoptosis is a silent type of cell death, since it does not induce a local
inflammatory response, and has no effects to the surrounding cells (reviewed in
Armstrong, 2006; Jin and El-Deiry, 2005). In this respect, it differs from the

apoptosis activated
by stimuli

cell shrinkage
chromatin condensation

normal cell
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lysis of
apoptotic bodies

nuclear
collapse

apoptotic body
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Figure 8. Apoptosis - the programmed death of a cell
Apoptosis is defined by its morphological and biochemical characteristics.
During apoptosis, the genome of the cell fractures, followed by cell shrinkage
and chromatin condensation. Part of the cell disintegrates into smaller apoptotic
bodies which are phagocytosed by neighboring cells.
(adapted from http://www.bioteach.ubc.ca/CellBiology/Apoptosis/)
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necrotic type of cell death, in which cells die through swelling, influx of calcium
ions and water, followed by cell lysis (Armstrong, 2006; Jin and El-Deiry, 2005).
This process is associated mostly with pathological death and it results in cell
injury and an inflammatory reaction (Leist and Jaattela, 2001). The dying
apoptotic cells simply disappear without leaving any traces (reviewed in Savill
and Fadok, 2000).
Apoptosis is essential in normal development and homeostasis and acts as
a defense mechanism in response to cellular abnormalities in multicellular
organisms including human (reviewed in Fadeel and Orrenius, 2005). Apoptosis
occurs during normal embroyological development and during normal tissue
turnover (Fadeel and Orrenius, 2005). Moreover, dysregulation of this cell death
process has been postulated to play a role in the pathogenesis of a variety of
human diseases (reviewed in Thompson, 1995; Osborne, 1996; Winoto, 1997).
For example, a reduced propensity to die is thought to be important for both the
development of tumors and the acquisition of resistance to chemotherapy
(reviewed in Hanahan and Weinberg, 2000). Diminished apoptosis has been
linked to autoimmune syndromes, whereas excessive apoptosis has been
implicated in neurodegenerative diseases and in part of the tissue destruction
that occurs after vascular occlusions in the brain and heart (reviewed in Fadeel
and Orrenius, 2005). These facets have made apoptotic pathways the objective of
intense interest and as result, enhanced our understanding of the complex
networks of apoptotic signal transduction pathways. In this section, I will
describe some of these pathways that can influence chromatin during apoptosis.
Finally, I will describe an apoptotic mechanism in lower eukaryotes, particularly
in budding yeast.
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Apoptotic pathways
In mammals, a wide array of external signals may trigger tow major apoptotic
pathways, namely the extrinsic pathway (death receptor pathway) or the
intrinsic pathway (the mitochondrial pathway) within a cell (Savill and Fadok,
2000; Green and Kroemer, 2004). The extrinsic pathway is activated by apoptotic
stimuli comprising extrinsic signals such as the binding of death inducing
ligands to cell surface receptors (Jin and El-Deiry, 2005; Green and Kroemer,
2004; Figure 9). In other cases, apoptosis is initiated following intrinsic signals
including DNA damage induced by irradiation or chemicals, growth factor
deprivation or oxidative stress (Jin and El-Deiry, 2005; Green and Kroemer, 2004;
Figure 9). In general intrinsic signals initiate apoptosis via the involvement of
mitochondria (Green and Kroemer, 2004). The induction and execution of
apoptosis require the cooperation of a series of molecules including signal
molecules, receptors, enzymes and gene regulating proteins. Among them, the
caspase-cascade signaling system, regulated by various molecules such as the
inhibitor of apoptosis protein (IAP), Bcl-2 family proteins, and calpain, is vital in
the process of apoptosis (Launay et al., 2005; Figure 9).

Caspases dependent apoptotic pathway
Caspases, the interleukin-1B-converting enzyme family proteases, are highly
homologus to C. elegans cell death gene CED-3 (Cerretti et al., 1992; Zimmermann
et al., 2001; Yuan et al., 1993; Xue et al., 1996). Fourteen caspases have been
identified so far, all of which share some common properties. They are all
aspartate-specific cysteine proteases and contain three domains: N-terminal
prodomain, large domain with the conservative
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The intrinsic and extrinsic pathways leading to mammalian

apoptosis
Apoptosis is triggered in a cell through either the intrinsic pathway or the
extrinsic pathway.

The intrinsic pathway is triggered by cellular stress,

specifically mitochondrial stress caused by factors such as DNA damage and
heat shock. In contrast, the extrinsic pathway is initiated through the stimulation
of the transmembrane death receptors, such as the Fas receptors, located on the
cell membrane.
(adapted from http://www.bioteach.ubc.ca/CellBiology/Apoptosis/)
“QACXG” (X can be R, Q or D), and C-terminal domain (reviewed in Ho and
Hawkins, 2005; Boyce et al., 2004). In addition, their precursors are all zymogens
known as procaspases (Ho and Hawkins, 2005). The activation of caspases
involve cleavage of the C-terminal domain and the N-terminal prodomain
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(Thornberry et al., 1997). The C-terminal domains bind to the large domain to
form a dimer with the catalytically active site between them (Thornberry et al.,
1997). The binding of two dimers then forms an active caspase (reviewed in
Degterev et al., 2003; Ho and Hawkins, 2005). Even though the N-terminal
prodomain is not a part of the active caspase, it contains critical signals such as
caspase-recruitment domain (CARD) or death effector domain (DED) for
interacting with activator molecules (Hofmann et al., 1997; Ashkenazi and Dixit,
1998). Initiator caspases (caspases-2, -8, -9, and –10) can cleave downstream
effector caspases (caspase-3, -6, and –7) also known as “executioners” (Degterev
et al., 2003).
Generally, there are two pathways through which the initiator caspase can
be activated: one is the death signal-induced, death receptor-mediated pathway;
the other is the stress-induced, mitochondria-mediated pathway (Jin and ElDeiry, 2005).

Death receptor-mediated initiator caspase-activation pathway
Cell death signals, such as Fas ligand (FasL) and tumor necrosis factor (TNF)-2,
can be specifically recognized by their corresponding death receptors, such as
Fas or TNF receptor (TNFR)-1, in the plasma membrane (reviewed in Schultz et
al., 2003). Their binding will in turn activate the death receptors. Fas can bind to
the Fas-associated death domain (FADD) or TNFR-associated death domains,
TRADD, and causes FADD aggregation and the emergence of DEDs (Strasser et
al., 2000; Hengartner, 2000; Ashkenazi and Dixit, 1998). These exposed DEDs
interact with the DEDs in the prodomain of procaspase-8, which will induce the
oligomerization of procaspase-8 localized on the cytosolic side of the plasma
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membrane (Chinnaiyan et al., 1995; Schultz et al., 2003). Then a massive
molecular complex known as the death-inducing signal complex (DISC) is
formed (Kischkel et al., 1995; Peter et al., 1998). In DISC, two linear subunits of
procaspase-8 compact to each other followed by procaspase-8 autoactivation to
caspase-8 (reviewed in Walczak and Krammer, 2000). The activation of the
downstream pathways of caspase-8 varies with different cell types. In some
lymphoid cell lines, caspase-8 is vigorously activated and can directly activate
the downstream effector caspases such as caspase-3 (Degterev et al., 2003). In
most cells, caspase-8 activates the mitochondrion-mediated pathway by
truncating Bid (a pro-apoptotic Bcl-2-family member), a kind of proapoptotic
protein in the cytosol, into its active form, tBid (Budihardjo et al., 1999; Ho and
Hawkins, 2005). tBid will trigger the activation of the mitochondria pathway:
cytochrome c, apoptosis-inducing factor (AIF) and other molecules are released
from mitochondria, and apoptosis will be induced (Wang et al., 2005; Arnoult et
al., 2003;).

Mitochondria-mediated initiator caspase-activation pathway
Anti-apoptotic Bcl-2 (B-cell lymphoma) homology domain (BH)-containing
proteins such as Bcl-2 and Bcl-XL reside on the mitochondrial outer membrane
while pro-apoptotic Bcl-2 family member, Bax, Bid, and Bad are in the cytosol
(reviewed in Green and Kroemer, 2004). When cellular stresses such as DNA
damage occurs, Bax, Bid, and Bad are translocated to the mitochondria, and
subsequently these proapoptotic proteins will be activated (reviewed in
Zimmermann et al., 2001). Their activation will in turn induce the opening of
mitochondria permeability transition pores (MPTPs) and as a result, cytochrome
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c localized in mitochondria will be released to the cytosol (Newmeyer et al., 2003;
Green and Kroemer, 2004). With the presence of cytosolic dATP or ATP,
apoptotic protease activation factor-1 (Apaf-1) oligomerizes (Li et al., 1997).
Together with cytosolic procaspase-9, dATP and cytochrome c, oligomerized
Apaf-1 can result in the formation of a massive complex known as apoptosome
(Zou et al., 1997; Zou et al., 1999). The N-terminus of Apaf-1 and the prodomain
of procaspase-9 both have CARDs, with complementary shapes and opposite
charges (Rodriguez and Lazebnik, 1999). They interact with each other by
CARDs and form a complex in the proportion of 1:1 (Arnoult et al., 2003).
Activated caspase-9 can in turn activate effector caspase-3 and caspase-7 (Ho and
Hawkins, 2005).
Once activated, apoptosis effector caspases such as caspase-3, -6, and –7,
then cleave many substrates, such as structural components of the cytoskeleton
and nucleus and signaling molecules, to promote apoptotic features. Membrane
blebbing is most likely mediated through caspase cleavage of the cytoplasmic
structural proteins gelsolin (Kothakota et al., 1997), actin (Mashima et al., 1995;
Kayalar et al., 1996), and spectrin a-fodrin (Cryns et al., 1996; Martin et al., 1995).
Effector caspases also might enhance nuclear condensation through cleaving
nuclear structural proteins lamin A (Lazebnik et al., 1994), lamin B (Kaufmann,
1989), and nuclear mitotic apparatus proteins (NuMA) (Hirata et al., 1998).
DNase responsible for DNA fragmentation during apoptosis are also activated
by caspase-mediated cleavage (Liu et al., 1997; Enari et al., 1998). Finally, many
members of the signaling pathways are substrates of caspases, and they are
believed to be activated or inhibited for the proper progression of apoptosis. For
example, protein kinase c (PKC), p21-activated kinases (PAK2), mammalian
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sterile twenty-like kinase (Mst1), focal adhesion kinase (FAK), NF-KB (nuclear
factor KB), and others are all cleaved by caspases and some of these truncations
have documented roles in apoptosis (Jin and El-Deiry, 2005). For instance, PAK2
is activated by caspase-mediated cleavage, then participates in remodeling the
actin-cytoskeleton for apoptotic cell morphology (Rudel and Bokoch, 1997; Lee et
al., 1997). Cleaving FAK will inactivate it and results in loss of organization of
focal adhesions and hence early detachment of cells from the extracellular matrix
(Wen et al., 1997; Levkau et al., 1998; Bannerman et al., 1998). In addition, the
activation of Mst1 upon cleavage by caspase-3 will in turn phosphorylate histone
H2B at S14 and mediates mammalian apoptotic features including chromatin
condensation (Cheung et al., 2003).

Caspase-independent apoptotic pathway
Apoptosis can be mediated by a caspase-independent mechanism (reviewed in
Kroemer and Martin, 2005). Early cell-death studies in C. elegans hinted that PCD
could occur in the absence of caspases. Characterization of C. elegans ced-3
mutants using light microscopy revealed that the migratory leader cell of the
male gonad, the linker cell, underwent PCD even in the absence of ced-3 (Ellis
and Horvitz, 1986). Subsequent findings are consistent with the existence of ced3-independent PCD; these include reports that, in the anterior pharynx, some
cells die even in animals harboring a deletion of the entire protease-encoding
domain of ced-3 (Shaham et al., 1999). One hint to how a ced-3-independent
pathway might promote PCD came from genetic studies. In a ced-4 loss-offunction mutant of C. elegans, PCD is blocked, suggesting that CED-4, a caspase
activator, is required for PCD (Ellis and Horvitz, 1986). Epistasis experiments
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placed ced-4 activity upstream of ced-3 (Shaham and H.R. Horvitz, 1996). When
CED-4 is overexpressed in the ALM neurons of C. elegans, it is able to kill these
cells (Shaham and H.R. Horvitz, 1996). Surprisingly, killing is reduced but not
completely blocked in a ced-3 mutant background (Shaham and H.R. Horvitz,
1996). This result suggests that ced-4 can kill cells independently of ced-3.
In mammals, there is also evidence for caspase-independent PCD
(reviewed in Kroemer and Martin, 2005). Genetic studies on PCD induced by 3domain-only proteins, such as tBID, BIM and BAD, showed that these proteins,
which have been shown to promote caspase activation and apoptosis, can also
kill cells independently of Apaf-1 and downstream caspases (Mills et al., 2006;
Villunger et al., 2004; Cheng et al., 2001). Specifically, Apaf-1-/- mouse embryonic
fibroblasts (MEFs) could still die in response to the overexpression of BH3domain-only proteins (Cheng et al., 2001). The cell death was reported as
apoptotic, because dying cells displayed apoptotic features including DNA
fragmentation,

chromatin

condensation,

and

externalization

of

phosphatidylserine (Cheng et al., 2001). However, caspase activation was not
detected in the dying cells when assayed with fluorogenic substrates for caspase2, -3, -6 or -7, nor could cell death be blocked by the pan-caspase inhibitor
zVAD.fmk (Cheng et al., 2001), suggesting a caspase-independent cell death.

Apoptotic chromatin condensation
Internucleosomal chromatin fragmentation is a biochemical hallmark of
apoptosis (Jin and El-Deiry, 2005). Apoptotic chromatin condensation has been
attributed to caspase-6 mediated cleavage of nuclear structural proteins such as
A- and B-type lamins (Rao et al., 1996; Neamati et al., 1995; Orth et al., 1996;
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Lazebnik et al., 1995). Lamins are the most abundant peripheral proteins of the
nuclear envelope and are attached to the inner nuclear membranes (reviewed in
Buendia et al., 2001). During apoptosis, lamins are cleaved at the conserved
aspartic residue in a hinge region and this cleavage generates a carboxy-terminal
proteolytic fragment of 46 kDa, disrupting the interior structure of the nucleus
(Takahashi et al., 1996; Orth et al., 1996).
Besides lamin, Acinus was identified as a nuclear factor that induces
apoptotic chromatin condensation after cleavage by caspases (Sahara et al, 1999).
Acinus is predominantly located in the nucleus and expressed in three different
isoforms, termed Acinus-L, Acinus-S and Acinus-S'. They contain 1341, 583 and
568 amino-acid residues, respectively, with apparent molecular weights at 220,
98 and 94 kDa. Acinus is cleaved by caspases on both its N- and C-termini,
producing a p17 active form (amino acid residues 987–1093), which triggers
chromatin condensation in the absence of caspase-3. Full-length acinus-S is
unable to condense chromatin, suggesting that caspase-mediated cleavage is
necessary for this activity. Acinus undergoes several proteolytic cleavages
during apoptosis, and p17 is one of the active forms to induce chromatin
condensation. Although its function is still unclear, Acinus is a direct target of
Akt, a serine/threonine kinase which promotes cell survival by phosphorylation
and inhibiting components of the intrinsic cell death machinery.

The

phosphorylation of Acinus by Akt prevents its proteolytic cleavage mediated by
caspase-3 and inhibits apoptotic chromatin condensation and apoptosis (Hu et
al., 2005). Therefore, these results suggest that the regulation of apoptotic
chromatin condensation is crucial for apoptosis.
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Yeast apoptosis
Often regarded as a phenomenon confined to multicellular organisms, an
apoptotic-like phenotype, characterized by DNA fragmentation and modest
chromatin changes, has been demonstrated in S. cerevisiae (Ludovico et al., 2001;
Madeo et al., 1999; Severin and Hyman, 2002). When the complete genome
sequence of yeast became available in 1997, no relative of the most central
players in apoptosis (e.g. the caspases, members of the Bcl-2/Bax family or Apaf1) were found, supporting the idea of a purely metazoan apoptosis (reviewed in
Madeo et al., 2002a). However, several early studies determined that expression
of pro-apoptotic proteins in yeast can cause cell death. These included human
Bax and Bak and the related C. elegans protein, Ced4/Apaf-1 (Greenhalf et al.,
1996; Ligr et al., 1998; James et al., 1997). In addition to these proteins, expression
of both mammalian caspases-1 and –3 in fission yeast also can lead to cell death
(Kang et al., 1999; Ryser et al., 1999). Both caspases are processed normally, are
fully active when expressed in fission yeast, and are capable of cleaving coexpressed anti-apoptotic Bcl-2 at predicted sites for caspase cleavage (Kang et al.,
1999; Ryser et al., 1999). Therefore, these results suggest that despite the failure
to detect apoptotic components, a single-celled organism such as yeast might
contain an endogenous cell death program that is in part homologous to the
metazoan apoptotic machinery.
Now, it is clear that budding yeast can undergo apoptosis independently
of the expression of mammalian pro-apoptotic proteins (reviewed in Frohlich
and Madeo, 2000). The first clear evidence was obtained in studies of a yeast
strain harboring a point mutation in the CDC48 gene, cdc48S565G (Madeo et al.,
1997), which encodes a protein required for vesicle trafficking (Latterich et al.,
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1995). This mutant displayed a rapid loss in cell viability following a shift to the
restrictive temperature, which was accompanied by the appearance of many of
the same apoptotic markers found in mammalian cells (Madeo et al., 1997).
Granot and colleagues showed that Bax-triggered apoptosis in yeast could be
blocked by enhancing vesicle trafficking (Levine et al., 2001). Moreover, a
downregulation of vesicular transport enhances the susceptibility of yeast cells to
apoptosis (Madeo et al., 1997), providing an explanation for the cdc48S565Gmediated apoptosis. Interestingly, the human CDC48 orthologue VCP/p97
plays a role in mammalian apoptosis. Indeed, a mutated form of VCP, in a
manner similar to the cdc48S565G mutation in yeast, dominantly induce apoptosis
in B-cells (Shirogane et al., 1999; Wu et al., 1999). Cdc48/VCP was also shown to
act as a cell-death effector molecule in the brain, suggesting that its concentration
is critical for neurodegeneration (Higashiyama et al., 2002).
Cell death with apoptosis-like features has also been reported in yeast
after treatment with acetic acid, UV-irradiation, and mating pheromone
(Ludovico et al., 2001; Del Carratore et al., 2002; Severin and Hyman, 2002).
Apoptosis was also observed in yeast exposed to low doses of H2O2, or
accumulation of ROS by depletion of glutathione in wild-type yeast cells,
indicating that as in metazoans, ROS are key regulators of yeast apoptosis
(Madeo et al., 1999). Furthermore, addition of free radical scavengers to yeast
cultures prior to inducing apoptosis led to a significant reduction in lethality, as
did incubation in an anaerobic environment (Madeo et al., 1999), suggesting that
ROS contribute to signaling in pathways leading to PCD. As discussed earlier,
the production and accumulation of ROS are formed as a by-product of
mitochondrial activity during mammalian apoptosis (Fleury et al., 2002) and
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induces cytochrome c release and apoptosis (Shimizu et al., 2001).

Since

cytochrome c release occurs during yeast apoptosis induced by Bax, acetic acid,
mating pheromone and H2O2, the accumulation of ROS in yeast may play a
similar role as in mammals.
The conservation of yeast and mammalian apoptosis was further
confirmed with the recent discovery of a caspase-related protease, Yca1, and its
role in yeast apoptosis (Madeo et al., 2002b). Yca1 is processed in a caspasetypical manner and has proteolytic activity for caspase substrates (Madeo et al.,
2002b). Overexpression of Yca1 in synergy with oxidative stress efficiently
triggers yeast cell death, accompanied by markers of apoptosis (Madeo et al.,
2002b). Conversely, Yca1 disruption increases tolerance against H2O2. Yca1
belongs to the family of metacaspases, which encompass members in fungi,
plants and protists (Uren et al., 2000).

Currently, the yeast metacaspase

substrates are unknown. Recently, an AIF orthologue, Aif1, was identified in
yeast (Wissing et al., 2004). Similar to mammalian AIF, yeast Aif1 is located in
mitochondria and translocates to the nucleus of yeast cells in response to
apoptotic stimuli such as H2O2 (Wissing et al., 2004). While overexpression of
Aif1 strongly stimulates apoptotic cell death induced by H2O2, this effect is
attenuated by disruption of Aif1 along with the yeast caspase Yca1, suggesting
that Aif1 is a caspase dependent cell death effector (Wissing et al., 2004).
Together, these results suggest the common evolutionary origin of yeast and
mammalian apoptosis.
Yeast can also stimulate apoptosis in a caspase-independent mechanism
(Severin and Hyman et al., 2002). It was shown that treatment with pheromone
at high concentrations is toxic to yeast cells and these dying cells displayed
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apoptotic phenotypes including accumulation of ROS (Serverin and Hyman et
al., 2002). Interestingly, deletion of Ste20 kinase, the key component of the MAP
kinase pathway, prevents pheromone-induced cell death and concomitantly
prevents the formation of ROS. Given that Ste20 kinase is the homologue of
Mst1 kinase that plays a role in mammalian apoptosis (Cheung et al., 2003), this
study further reinforces the concept of a conservation of apoptotic machinery
between yeast and mammalian cells.
Why would a single cell organism undergo programmed cell death? One
reason for a unicellular organism to commit altruistic suicide may be to benefit
the cell community (Severin and Hyman, 2002). Such a mechanism would
improve the genetic fund of the community by eliminating the weak individuals.
Yeast shows these aspects of communal behavior when they are damaged or
infected with virus, or during mating. Damaged cells can compromise the
viability of other members of the community by, for example, consuming scarce
nutrients or spreading an infection. Moreover, yeast cells that were unable to
mate after prolonged exposure to the opposite mating type might also be a
detriment to the yeast community (Severin and Hyman, 2002). Therefore, a
cellular suicide program that eliminates these cells would help to ensure the
viability and reproductive success of healthier members of the community.

Histone modification in apoptosis
Given the intimate connection between histones and DNA, the changes in DNA
during apoptosis may be mediated by histone modifications. For example, the
ubiquitination of H2A, which is associated with transcription, is decreased
during apoptosis and this can be due to a decrease in transcription (Marushige
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and Marushige, 1995; Mimnaugh et al., 1997; Mimnaugh et al., 2001; Jason et al.,
2001; Jason et al., 2002). In addition, phosphorylation of a minor histone variant
H2A.X at Ser139 has been shown to increase during DNA double-stranded
breaks and DNA fragmentation in apoptosis (Rogakou et al., 1998; Rogaukou et
al., 2000). However, H2A.X phosphorylation correlates with all double-stranded
DNA breaks rather than with apoptotic chromatin condensation and apoptoticspecific oligonucleosomal DNA fragmentation (Cheung et al., 2003), suggesting it
as a DNA damage marker rather than apoptotic marker. In mammalian cells, the
only core histone modification that has been uniquely associated with apoptosis
is histone H2B phosphorylation in the N-terminal tail as shown by in vivo
labeling of apoptotic cells (Ajiro, 2000). In addition, a cell-free Xenopus chromatin
condensation system shows that the H2B N-terminus, but not other histone tails,
is essential for chromatin condensation (de la Barre et al., 2001). In 2003, Dr.
Wang L. Cheung, a former graduate student, identified that H2B S14
phosphorylation closely associates with apoptosis in multicellular eukaryotes
(Cheung et al., 2003). The onset of this phosphorylation event is mediated and
dependent upon the cleavage of Mst1 by caspase-3 (Cheung et al., 2003).
Although H2BS14ph has been correlated with apoptotic chromatin condensation,
it is still unclear whether phosphorylation of H2B at S14 is required for apoptosis
due to the lack of histone genetics in mammalian cells. Yeast, on the other hand,
is one of the few organisms that provide a powerful combination of genetics and
molecular tools to study biology. Because yeast can undergo mammalian-like
apoptosis, yeast has been emerging as a model system to study the complex
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nature of apoptosis.

Therefore, I started my thesis by identifying and

characterizing a histone modification mark that regulates chromatin
condensation and/or alter chromatin structure during yeast apoptosis (Chapter
2).
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CHAPTER 2

STERILE 20 KINASE PHOSPHORYLATES HISTONE H2B AT
SERINE 10 DURING HYDROGEN PEROXIDE-INDUCED
YEAST APOPTOSIS

Introduction
Apoptosis is the most common form of cell death and plays a central role in
development and cellular homeostasis in higher eukaryotes. In vertebrates,
apoptosis has evolved as a mechanism to remove injured, infected or superfluous
cells via a non-inflammatory pathway. As discussed in Chapter 1, apoptotic cell
death is characterized by distinctive morphological and biochemical changes that
include DNA laddering and chromatin condensation, typically late-stage events
in the apoptotic pathway (reviewed in Kerr et al., 1978; Figure 8). Despite
significant progress in identifying networks of upstream apoptotic regulators
and effectors (reviewed in Kaufmann and Hengartner, 2001), the molecular
details of downstream events, such as large-scale changes in chromatin structure,
are largely unknown.
Often regarded as a phenomenon confined to multicellular organisms,
mounting evidence suggests that some features of apoptosis may extend to
unicellular organisms such as Saccharomyces cerevisiae. An apoptotic-like
phenotype, characterized by DNA fragmentation and modest chromatin
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changes, has been demonstrated in S. cerevisiae when treated with various agents
including acetic acid, osmotin, oxygen radical and pheromone (Ludovico et al.,
2001; Madeo et al., 1999; Severin and Hyman, 2002). While not every identified
mammalian gene involved in apoptosis has a clear counterpart in S. cerevisiae, a
caspase-like protease of unknown function has been reported in S. cerevisiae
(Madeo et al., 2002b).
In eukaryotic cells, DNA is organized into nucleosomes, the fundamental
repeating unit of chromatin (Luger et al., 1997; Richmond and Davey, 2003). One
well-studied mechanism for introducing variation into the chromatin polymer is
the addition of post-translational histone modifications (e.g. acetylation,
phosphorylation, methylation, etc.) whose importance in a wide range of DNAtemplated processes is becoming clear (reviewed in Jenuwein and Allis, 2001;
Felsenfeld and Groudine, 2003). To date, relatively few histone modifications
have been firmly linked to apoptosis-induced chromatin changes.
Phosphorylation of the histone variant H2A.X at S139 acts as a “DNA damage
sensor” during the formation of DNA double-strand breaks (DSBs) induced by
unnatural and natural means, including apoptosis (Rogakou et al., 2000). In
Xenopus, chicken, and human cells, phosphorylation of H2B at S14 (H2BS14ph)
by Mst1 kinase, the mammalian Sterile20-like kinase, is closely associated with
apoptosis (Cheung et al., 2003) and radiation- induced damage foci (FernandezCapetillo et al., 2004a). However, the existence of this phosphorylation mark in
invertebrates and unicellular eukaryotes has remained unclear, in part due to a
lack of strict sequence conservation in H2B amino-terminal (N-terminal) tails.
Thus, as is the case with mitotic (H3S10/H3S28) phosphorylation (Hsu et al.,
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2000), no clear phenotypes, apoptotic or otherwise, have been linked to mutation
of H2B (tail deletion or point mutation) or any other histone protein.
I initiated my thesis studies by surveying yeast cells (four histone
plasmid-shuffle background; Figure 10) lacking specific histone N-terminal tails
for loss of cell death upon H2O2 treatment. In keeping with the H2B N-terminal
tail’s role in mammalian apoptosis, I found that a cell death property exists
uniquely in the N-terminus of yeast H2B. Using both genetic and immunological
LEU2

URA3
5-FOA

WT

Mutants Deletion

H3
H4
H2A
H2B

Figure 10. A four histone plasmid-shuffle strain in budding yeast
Both copies of all four core histones were sequentially deleted and covered with
a shuffle plasmid carrying a single copy of each of the four core histones. Strain
viability is dependent on maintenance of the plasmid-based wild type histone
genes. Any combination of single point mutations or tail truncations can be
tested simultaneously in vivo by “shuffling in” the mutant histones by selection
on LEU deficient growth media and selecting against the URA plasmid with 5FOA media. This strain has proven invaluable for characterizing single point
mutations and tail truncations in yeast. This strain was generated by Jer-Yuan
Hsu and the figure was generated by Judith Recht.
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approaches, I have identified yeast H2B Serine 10 (H2BS10) as a yeast cell death
phosphorylation mark. H2BS10A mutants are resistant to cell death elicited by
H2O2 while H2B S10E phospho-site mimics promote cell death and induce the
“constitutive” formation of condensed chromatin. Finally, I identified Sterile 20
kinase (Ste20) as a bona fide yeast apoptotic H2BS10 kinase.

Upon H2O2

treatment, Ste20 kinase, a yeast homolog of mammalian Mst1 kinase, translocates
into the nucleus in a caspase-independent fashion and directly phosphorylates
H2B at S10.
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Results
Loss of the N-terminus of H2B, but no other histone N-terminal tails, abrogates
hydrogen peroxide-induced cell death
H2B phosphorylation and the H2B, but not other histones, N-terminal tails is
essential for chromatin condensation in Xenopus cell-free systems (de la Barre et
al., 2001). In addition, in vivo labeling studies showed that H2B phosphorylation
occurs specially at the N-terminal tail during mammalian apoptosis (Aijiro et al.,
2000). Because budding yeast may undergo apoptotic-like cell death (Madeo et
al, 1999; Ludovico et al., 2001; Severin and Hyman, 2002), I sought to address
whether the H2B N-terminus was involved. To this end, hydrogen peroxide (1
mM H2O2) was added to wild-type (WT) yeast cells in a four histone plasmidshuffle background that was generated by Dr. Jer-Yuan Hsu. In this strain, both
copies of all four core histones were sequentially deleted and covered with a
shuffle-plasmid carrying a single copy of each of the four core histones. By using
a conventional plasmid-shuffle strategy, any combination of histone mutations
can be tested in vivo (Figure 10). After a 200 minute incubation of H2O2, cell
survival was assayed by plating assay (Madeo et al., 2002) and cell death was
assayed by phloxin B (PB) staining which selectively stains only dead or dying
yeast cells (Severin and Hyman, 2002). Consistent with previous findings
(Madeo et al., 1999), a cell death phenotype was observed in WT cells after
H2O2treatment. WT cells displayed 25-30% cell viability and 70-75% PB stained
cells (Figure 11).

These findings were not a result of cell necrosis, since

protoplasts from cultures treated with H2O2 maintained intact plasma
membranes as illustrated by low yield of propidium iodide staining cells
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Figure 11. N-termini of histone H2B, but no other core histone N-terminal
tails, are required for hydrogen peroxide-induced cell death in yeast
Exponentially-growing WT and mutants lacking specific histone N-terminal
tail (yH2A D1-20, yH2B D1-32, yH3 D1-30, and yH4 D1-27) were treated with 3
mM H2O2 or 200 minutes. Cells were then split into two for cell survival and
cell death analysis.
(A) For cell survival assay, cells were plated onto rich medium (YPD) and
incubated at the room temperature for 2 days. Cell survival percentage was
calculated for each strain by counting number of colonies formed following
H2O2 treatment relative to untreated cells. Data were normalized to the
appropriate wild type control that was set to 100%. High percentage of cell
survival was observed only with H2B amino-terminal tail deletion mutant.
(B) Cell death was examined by phloxin B (PB) staining which stains only
dead or dying yeast cells (Severin and Hyman, 2002). Data were represented
as in (A). H2B amino-terminal tail deletion had a significant reduction in cell
death. For (A) and (B), results were averaged from three independent
experiments.
(Figure 12A). Furthermore, WT cells were stained with Annexin V, which
detects the translocation of phosphatidylserine (PS) from the inner to the outer
leaflet of membrane, an early event of apoptosis. About 80% of cells stained with
Annexin V (Figure 12B), confirming that H2O2 induces an apoptotic phenotype in
yeast.
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Competent with WT result, H2O2 was added to isogenic yeast cells
expressing separate N-terminal truncations of each of the four core histones,
which include yH2A D1-20, yH2B D1-32, yH3 D1-30, and yH4 D1-27, all in
identical histone-shuffle backgrounds that were generated by Dr. Jer-Yuan Hsu.
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Figure 12. Hydrogen peroxide-treated yeast cells display intact membrane
integrity and externalization of phosphatidylserine
WT and mutants lacking a specific histone N-terminal tail (yH2A D1-20, yH2B
D1-32, yH3 D1-30, and yH4 D1-27; see Figure 10 and text for detail) were
treated with 1 mM H2O2 for 200 minutes. Membrane integrity was measured
by propidium iodide staining (A), and externalization of phosphatidylserine
(PS) by Annexin V staining (B). While H2O2 treatment did not affect the
membrane integrity in all the mutants tested, H2O2 treatment caused
translocation of phosphatidylserine in these mutants except for H2B aminoterminal tail.
Interestingly, deletion of the N-terminus of H2B (yH2B D1-32) resulted in a
reproducible resistance to H2O2 (80-85% cell viability; 15-20% phloxin B stained
cells; Figure 11A and 11B) with intact membrane integrity (Figure 12A). In
addition, Annexin V staining was prevented to a larger extent in the H2B tail
corresponding to the abrogation of cell death (Figure 12B). In contrast, levels of
cell death similar to that of WT cells were observed with all other histone tail
truncation mutants (yH2A D1-20, yH3 D1-30, and yH4 D1-27) (Figure 11 and 12).
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These data suggested that a cell death property may exist uniquely in the Nterminus of yeast H2B.

Given the similarities between this pathway and

apoptosis, I will refer to the cell death as apoptosis.

H2B S10A mutant abrogates hydrogen peroxide-induced yeast apoptosis
Histone H2B is specifically phosphorylated at S14 in vertebrates undergoing
programmed cell death (PCD; Cheung et al., 2003). Although H2B S14 and
surrounding sequences are well conserved among vertebrates, they are not
D
1

33

Budding yeast NH2- SAKAEKKPASKAPAEKKPAAKKTSTSTDGKKRSKA…
Fission yeast NH2- SAAEKKPASKAPAGKAPRDTMKSADKKRGKNRKE…
10

P

human

NH2- PEPSKSAPAPKKGSKKAITKAQKKDGKKRKRSRKE…

frog
worm

NH2- PPKTSGKAAKKAGKAQKNITKTDKKKKRKRKESY…
NH2- APPKPSAKGAKKAAKTVTKPKDGKKRRHARKESYS…

14

Figure 13. Sequence alignment of H2B N-terminal tails
Primary sequence alignment of H2B amino-terminal “tails” from a select
group of organisms shows that S. cerevisiae and S. pombe have an identical
sequence surrounding S10 (see downward arrow and underline). Note that
the neighboring sequence around S14ph of human histone H2B (see red dot =
site of apoptotic phosphorylation; see Cheung et al., 2003 for details) is similar
to S10 and S33 of yeast in that both are embedded in basic patches with
nearby alanine and proline residues. The underlined sequences denote yeast
H2B peptides with phosphorylated S10 from residues amino acid 4-14
(hereafter H2BS10ph) and phosphorylated S33 from amino acid 30-37
(hereafter H2BS33ph).
readily apparent in H2B tails of invertebrates and unicellular eukaryotes such as
yeast (see red dot in Figure 13). Thus, it remained unclear whether any of the
serine and/or threonine residues in the yeast H2B N-terminal tail could be
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phosphorylated in an apoptosis-specific manner. As shown in Figure 13,
numerous serine and threonine residues exist in the N-terminal tail of yeast
histone H2B that could potentially serve as phosphate acceptor sites. Although
serine 33 (S33) was embedded in a highly basic motif, similar to that of S14 in
vertebrate H2B, S10 was surrounded in a basic motif that more closely resembled
S14 in vertebrate H2B. This sequence, punctuated by conserved proline and
alanine residues, was identical in S. pombe (see underline in Figure 13) suggestive
of a conserved, but unknown, function for S10.
To analyze if S10 or S33 in yeast H2B serves a functional role in dying
yeast, cells were generated expressing H2B in which S10, and S33 were
separately mutated to alanine (S10A and S33A, respectively) into the four-histone
plasmid-shuffle strain. While S33A H2B mutants were as sensitive to H2O2treatment as WT cells, S10A H2B mutants were de-sensitized to H2O2 treatment
in much the same way as H2B tail truncation mutants (Figure 14). For example,
H2B S10A mutants displayed high cell viability followed by low cell death
judged by PB stained cells and low phosphatidylserine translocation by Annexin
V (Figure 14). On the other hand, H2B S33A mutants conferred typical apoptotic
phenotypes after treatment with H2O2 (Figure 14). These results suggested the
intriguing possibility that S10 in yeast H2B serves a comparable role to
mammalian H2B at S14 by acting as a site of phosphorylation induced during
H2O2-elicited apoptotic pathway.

Histone H2B is specifically phosphorylated at serine 10 in dying yeast cells
To directly test whether H2BS10 serves as a phosphorylation site during yeast
apoptosis, a site-specific H2BS10 phospho-specific antibody (hereafter anti77

B

0

50
25
0

H2B S33A

25

75

H2B S10A

% of FITC labeled cells

50

H2B S33A

H2B S33A

H2B S10A

WT

25

75

H2B S10A

50

100

WT

75

0

C

100

% of PB stained yeast

% of survival

100

WT

A

Figure 14. H2B S10A mutants are resistant to yeast apoptosis elicited by
hydrogen peroxide
Exponentially-growing WT, H2B S10A, and H2B S33A were treated with 1
mM H2O2 for 200 minutes. Cells were then split into three aliquots for cell
survival (A), cell death (B) and externalization of phosphatidylserine analysis
(C).

Briefly, cell survival percentage was calculated for each strain by

counting number of colonies formed on YPD agar and Cell death was
measured by counting number of Phloxin B stained cells following H2O2
treatment relative to untreated cells.

The early marker of apoptosis,

externalization of phosphatidylserine, was measured by counting number of
Annexin V staining cells. H2B S10A mutants displayed a significant increase
in cell viability followed by a significant reduction of Phloxin B and Annexin
V stained cells compared to WT or H2B S33A mutant.
H2BS10ph) was generated. Peptides were synthesized at Baylor College of
Medicine containing histone H2B residues 4-14 with unmodified or singly
phosphorylated at S10 (hereafter H2BS10ph peptide; see underline in Figure 13
for the exact sequence). H2BS10ph peptide was then conjugated to carrier
proteins and injected into rabbits by Covance (Denver, PA). Antisera from these
rabbits were analyzed by enzyme-linked immunosorbent assay (ELISA) as
described in Briggs et al., 2001. Anti- H2BS10ph immunoreacted strongly with
the H2BS10ph peptide, but not the unmodified or H2BS33ph peptide (Figure 15).
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While anti-H2BS10ph did not detect the H2B peptide that is singly acetylated at
lysine 11 (H2BK11ac), but recognized peptide containing dual modifications of
K11ac and S10ph of H2B, indicating that K11ac does not disrupt the epitope for
anti-H2BS10ph (Figure 15). To further ensure that anti-H2BS10ph signal in the
ELISA is specific, a competition was performed with unmodified and H2BS10ph
peptide. As shown in Figure 15, only the H2BS10ph peptide was able to compete
the anti-H2BS10ph signal away, suggesting that the antibody is specific to
H2BS10ph peptide.
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Figure 15. ELISA of anti-H2BS10ph
ELISA assay shows that this antiserum specifically recognizes the H2BS10ph
peptide, but not H2BS33ph or H2BK11ac peptide. This antiserum also reacted
with dually modified H2B peptide containing both S10ph and K11ac.
Substrate specificity is supported by competition assays showing that only
H2BS10ph peptide, and not the unmodified H2B peptide competes for
binding of the antibody. Hereafter this antiserum will be referred to as antiH2BS10ph.
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With confidence in our new phospho-H2B antibody, I decided to test the
hypothesis that yeast apoptotic H2B is phosphorylated at S10. Nuclei were
prepared from logarithmically-growing cells treated with or without H2O2 for
200 minutes and probed by immunoblotting using anti-H2BS10ph. As shown in
Figure 16A, H2B from H2O2-treated WT cells reacted strongly with antiH2BS10ph, suggesting that H2B is phosphorylated at S10 (H2BS10ph) upon H2O2
treatment in yeast. As expected, anti-H2BS10ph antibody did not react with
nuclei prepared from S10A mutant cells that were treated with H2O2 (Figure
16A).

To ensure equal loading, extracts were probed with H4 antibody

generated against H4 residues from 1-20 amino acids (a-H4). In contrast, H2B
from the S33A H2B mutant (H2O2-treated) displayed S10ph pattern similarly to
WT (Figure 16A). To further confirm that anti-H2BS10ph is specific to histone
H2B only, core histones were isolated by acid extraction followed by Western
blotting analysis. H2BS10ph signal was detected from histone H2B isolated from
H2O2-treated WT, and not H2B S10A mutants (Figure 16B). Ponceau staining
ensured the equal loading of histone H2B, proving that lack of signal in H2B
S10A mutant is not due to the absence of histone H2B. Reactivity with antiH2BS10ph antibody was due to phosphorylation since treatment of the histone
preparations with bacterial alkaline phosphatase (AP) resulted in a drastic loss of
anti-H2BS10ph signal for both WT and S33A strains following H2O2 treatment
(Figure 16A).

Thus, genetic and immunological approaches implicate

phosphorylation of H2B at S10 in a cell death pathway brought about by H2O2
treatment.

80

A

WT

AP: -

H2O2:

H2B S10A H2B S33A

-

+
-

-

+
-

+
-

WT

+

H2B S10A

+
+

+

+
+

Anti-H2B
S10ph

Anti-H4

B
H2O2:

-

WT

H2B S10A

+

-

+

Anti-H2B
S10ph
H3
H2B
H2A
H4

Ponceau

Figure 16. Histone H2B is specifically phosphorylated at serine 10 in dying
yeast cells
(A) Total nuclear protein, isolated from cells treated with or without H2O2,
was fractionated by SDS-PAGE before immunoblots were probed with antiH2BS10ph antibody. Except for H2B, no other bands were detected with the
anti-H2BS10ph from H2O2-treated WT or H2B S33A nuclear extracts. In
contrast, anti-H2BS10ph antibody did not react with histones prepared from
S10A mutant cells that were treated with H2O2. Where indicated, samples
were treated with or without bacterial alkaline phosphatase (AP). Anti-H4
was used as a loading control.
(B) Histones were extracted from wild type and H2B S10A mutants treated
with and without H2O2 and analyzed by western blotting using antiH2BS10ph and anti-H4. Equal loading was assessed by Ponceau staining.
H2BS10ph signal was detected from histone H2B isolated from H2O2 treated
WT, and not H2B S10A mutants
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Figure 17. Antibodies to H2B serine 10 phosphorylation selectively stain
TUNEL positive yeast apoptotic cells
WT (A), or mutants lacking either H2B N-terminal tail (yH2B D1-32) and H3 Nterminal tail (yH3 D1-30) (B), or H2B S10A, and S33A (B), treated with or without
H2O2, were stained with TUNEL and anti-H2BS10ph. The same cells were
counterstained with DAPI to detect nuclei. Note the excellent agreement of
TUNEL and anti-H2BS10ph staining in all cells containing a H2B N-terminal tails
or H2BS10.
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Cells exhibiting phosphorylation of histone H2B at serine 10 display apoptotic
DNA fragmentation
I wished to address whether phosphorylation of H2B at S10 has an analogous
function to H2BS14ph during mammalian apoptosis. Yeast cells were doublestained with TUNEL and anti-H2BS10ph antibody and examined by
immunofluorescence (IF) microscopy. In accordance with the loss of cell viability
after treatment with H2O2, about 75-80% of WT cells showed TUNEL staining, a
hallmark of apoptosis (Figure 17A). Strikingly, 100% of the TUNEL-positive cells
were co-stained with the anti-H2BS10ph antibody demonstrating that apoptotic
DNA fragmentation correlates precisely with H2B phosphorylation at S10
(Figure 17A). Similar positive staining patterns were observed with the S33A
and the histone N-tail truncation mutants that included H3 (Figure 17B).
However, in contrast, deletion of the N-terminus of H2B and the S10A mutants
lacked these characteristic markers of apoptosis, even with H2O2 treatment,
further confirming that the H2B histone phosphorylation at S10 is required for
apoptotic DNA fragmentation (Figure 17B).
The onset of mammalian H2BS14ph coincides with the appearance of
apoptotic DNA fragmentation, suggesting that S14ph may play a role in
establishing apoptotic DNA fragmentation (Cheung et al., 2003). Because of the
similarities between yeast and mammalian apoptosis, I sought to determine the
kinetics of apoptotic events and the onset of S10ph. For this purpose, WT cells
induced to undergo apoptosis with H2O2 were harvested at half-hour intervals
for Western blot analyses using anti-H2BS10ph and anti-H2A.XS139ph, and IF.
As discussed earlier, H2A.X phosphorylation at S139 has been correlated with
DSBs (Rogakou et al., 1998; Rogakou et al., 2000) and occurs early in the
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mammalian apoptosis after induction of etoposide such as VP16 (Cheung et al,
2003). Anti-H2A.XS139ph also recognizes serine 129 (S129) phosphorylation
events associated with DSBs in yeast H2A (Figure 18A). Consistent with
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Figure 18. Apoptotic DNA fragmentation via TUNEL precisely coincides
with the phosphorylation of H2B at serine 10
WT yeast cells were harvested after treatment with H2O2 at the indicated times
and split into three fractions.
(A) Yeast cells were harvested in SDS-loading buffer and then subjected to
Western analysis using the indicated antibodies. While anti-H2A.XS139ph,
which recognizes yeast H2A serine 129 phosphorylation events associated
with DNA double strand breaks in yeast H2A, occurred early in H2O2
treatment, H2BS10ph was first detected at 90 minute time point. a-H4 was
used as a loading control.
(B) Yeast cells were stained with TUNEL, anti-H2BS10ph and DAPI and
examined by immunofluorescence microscopy. Initial appearance of TUNEL
and anti-H2BS10ph positive cells at 90 minutes post H2O2 induction.
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mammalian H2BS14ph, yeast H2A phosphorylation preceded H2BS10ph,
suggesting that DSBs occur early during the apoptotic pathway (Figure 18A). In
addition, my time course analyses indicated that the onset of H2B
phosphorylation coincides with the initial appearance of apoptotic DNA
fragmentation evaluated by TUNEL staining (approximately 90 minutes post
induction; Figure 18A and 18B). Taken together, these data suggest that H2B
phosphorylation may play a role in establishing apoptotic DNA fragmentation
and/or chromatin condensation, characteristic of late events in apoptosis.
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Figure 19. H2B is phosphorylated at serine 10 during acetic acid or a-factorinduced cell death
WT and H2B S10A mutants were treated with or without 50 mM acetic acid
for 2 hours, and 30 mg/ml a-factor for 2 hours. These cells were then analyzed
for western blot using anti-H2BS10ph and anti-H4 (A) or stained with
TUNEL, anti-H2BS10ph, and DAPI (B).
phosphorylation of H2BS10.
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Both apoptotic-stimuli led to

Next, I asked whether other yeast apoptotic stimuli could induce the
enhancement of H2BS10ph. Nuclei were extracted from WT and H2B S10A that
were treated with 50 mM acetic acid, or 30 µg/ml a-factor, chemicals reported by
others to induce characteristics of cell death in mammalian cells (Ludovico et al.,
2001; Severin and Hyman, 2002; Madeo et al., 1999). Similar to H2O2 treatment,
these apoptotic-stimuli led to H2BS10ph as demonstrated by immunoblotting
analysis using anti-H2BS10ph . The phosphorylation band is H2BS10ph specific,
since this band was absent in nuclear extracts from the H2B S10A mutant (Figure
19A). In addition, positive TUNEL staining was observed with WT cells treated
with acetic acid or a-factor, but not untreated cells or H2B S10A mutants (Figure
19B). This result demonstrates that this chromatin mark, H2BS10ph, is induced
by a wide range of stimuli that bring about features of apoptotic cell death in
yeast.

H2B S10E mutants induce apoptotic-like features including chromatin
condensation
To determine the role of H2BS10ph during H2O2-induced apoptosis, I separately
mutated S10 and S33 to glutamic acid (S10E and S33E respectively) to mimic
constitutive phosphorylation and to bypass the potential requirement for
induced H2BS10 kinase activity. As shown in Figure 20A, the growth level of
S10E mutations were drastically reduced on YPD agar plates, even in the absence
of H2O2.

Although few S10E H2B mutants grew under these conditions,

surviving cells exhibited cell morphology similar to that of H2O2-treated WT cells
(Figure 20B), indicating that the phosphorylation of this residue is important for
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cell death. In addition, surviving S10E mutant cells were TUNEL-positive
without H2O2 treatment (Figure 20B). Upon the addition of H2O2, fewer S10E
mutant colonies survived and these cells were also stained with TUNEL (Figure
20B). Together, these results suggest that S10E mutation induces apoptotic
characteristics including DNA fragmentation.
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H2B S10A

WT
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Figure 20. Substitution of H2B serine 10 with glutamic acid induces
apoptosis
(A) WT and H2B-mutant yeast strains were grown on YPD agar plates in the
absence of H2O2. H2B S10E mutant, and the double mutant carrying both H2B
S10E and STE20 deletion displayed growth defect even without H2O2.
(B) WT and H2B S10E, treated with or without H2O2, were stained with
TUNEL and DAPI. H2B S10E cells were TUNEL positive.
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Formation of condensed chromatin and fragmentation of DNA into
oligonucleosomal lengths are hallmarks for apoptosis (Savill and Fadok, 2000).
Thus, I asked whether H2BS10ph facilitates apoptotic chromatin condensation.
With the help of Helen Shio from the Rockefeller University microscopy facility,
the yeast nuclei of WT, H2B S10A and H2B S10E treated with or without H2O2
were examined under electron microscopy. In agreement with published data
(Madeo et al., 1999), WT cells incubated with H2O2 revealed reproducible
extensive chromatin condensation typical for apoptosis (Figure 21).

No

condensed chromatin was observed in S10A mutant with or without H2O2. In
contrast, the S10E mutant displayed nuclei with striking patches of condensed
chromatin (see arrows in Figure 21), even in the absence of H2O2. These data
suggest that H2BS10ph and its phospho-mimic, S10E, correlate positively with
“induced” and “constitutive” chromatin compaction in vivo. As far as I am
aware, the H2B S10E point mutant is one of the more striking histone-tail
mutations shown to promote large-scale chromatin compaction.

Ste20 deletion mutants are resistant to hydrogen peroxide and abrogate H2B
serine 10 phosphorylation
During mammalian apoptosis, Mst1 kinase directly phosphorylates H2B at S14
both in vivo and in vitro (Cheung et al., 2003). Mst1 belongs to the PAK (p21activated kinase) family, which also includes the yeast Ste20 kinase, and Mst1
and Ste20 kinase both share considerable sequence similarity throughout their
catalytic domains (Creasy et al, 1996). Moreover, yeast containing a deletion of
Ste20 kinase (ste20D) was resistant to cell death elicited by pheromone treatment
(Severin and Hyman, 2002). Thus, I sought to determine whether Ste20 kinase
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Figure 21. H2B S10E mutant constitutively induces apoptotic chromatin
condensation
Exponentially grown WT, H2B S10A and H2B S10E that were untreated or
treated with 1 mM H2O2 were analyzed by electron microscopy. Arrows denote
chromatin condensation.

N denotes nucleus and V refers to the vacuole.

Condensed chromatin was observed with H2B S10E. These images were taken
by Helen Shio, from the microscopy facility at the Rockefeller University.
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function is necessary for yeast cell death in vivo. For this purpose, I generated a
yeast strain containing a deletion mutation of Ste20 kinase in a four histone
plasmid-shuffle strain background (ste20D) and tested for cell death upon H2O2
induction. Similar to the survival pattern observed with the H2B S10A mutant
cells, ste20D cells had a significant reduction of PB stained cells followed by a
significant increase in cell viability as compared to its isogenic wild-type (Figure
22). In addition, ste20D cells lacked apoptotic DNA fragmentation evaluated by
TUNEL staining (Figure 23A). Hence, these results demonstrate that Ste20
kinase is important for promoting cell death.
To determine whether the H2O2-induced cell death pathway includes both
Ste20 kinase and H2BS10ph, I generated a double mutant carrying both H2B
S10A and STE20 deletion. After H2O2 treatment, I observed no difference
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Figure 22. Ste20 deletion mutants are resistant to hydrogen peroxideinduced yeast apoptosis
H2O2 was added to ste20D, H2B S10A and a double mutant carrying both H2B
S10A and ste20D, and tested for cell survival (A), or cell death via Phloxin B
staining (B) as described in Figure 11. Comparable cell survival pattern was
observed with a single mutant or double mutant carrying ste20D and H2B
S10A.
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between a double mutant of H2B S10A and ste20D, as compared to each
respective single mutant with regard to survival properties (Figure 22). All
mutants conferred similar percentage of cell viability as well as cell death
(Figure 22), suggesting that Ste20 kinase and H2BS10ph are in the same cell
death pathway. Additionally, the double mutant carrying both S10E and ste20D
conferred a growth level similar to S10E, whereas both single and double
mutants carrying either S33E and/or ste20D survived as well as WT (Figure 20A).
Taken together with the previous results reporting the importance of Ste20
during pheromone-elicited yeast death (Severin and Hyman, 2002), my in vivo
results suggest that H2O2 regulates a comparable cell death pathway to other
yeast apoptotic stimuli via Ste20.

Hydrogen peroxide-induced H2B serine 10 phosphorylation is mediated by Ste20
in vivo
To investigate whether Ste20 could trigger the phosphorylation of H2B at S10
during conditions believed to induce yeast apoptosis, the level of H2BS10ph was
assayed by immunoblotting. As shown in Figure 23B, no signal was detected by
anti-H2BS10ph with H2O2-treated yeast lacking Ste20 (ste20D) or double mutant
carrying both H2B S10A and ste20D, suggesting that Ste20 may facilitate the
phosphorylation of H2BS10. Ste20 has a specific kinase activity towards H2B at
S10, since it does not phosphorylate H3 at S10 (Figure 23B). In addition, Ipl1, a
kinase that phosphorylates both H2B and H3 in vitro (Hsu et al., 2000), fails to
phosphorylate H2BS10 (Figure 23B).
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Figure 23. Ste20 mediates hydrogen peroxide-induced H2B serine 10
phosphorylation in vivo
Log phased yeast cells from WT, ste20D, H2B S10A, and double mutant
carrying both H2B S10A and ste20D were treated with 1 mM H2O2 for 200 min.
(A) Half of the cells were stained with TUNEL, anti-H2BS10ph, and DAPI. No
TUNEL or anti-H2BS10ph positive cells were observed with ste20D or H2B
S10A or double mutants carrying both.
(B) The rest of the cells and H2O2-treated or untreated ipl1D were harvested
and nuclear extracts were probed with anti-H2BS10ph and anti-H3S10ph for
Western analysis. Anti-H4 was used as a loading control. Ste20 specifically
phosphorylates H2BS10, whereas Ipl1 phosphorylates H3 at S10.
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An in-gel kinase assay was employed to determine the molecular
weight(s) of potential yeast apoptotic H2B kinases in total nuclear extracts. In
this assay, nuclear extracts, prepared from H2O2-treated and untreated WT or
ste20D cells, were separated by SDS-PAGE gels that were first impregnated with
either unmodified (amino acids 4-14 of yeast H2B) or H2BS10ph peptides (Figure
24). Following renaturation and in-gel kinase assay, numerous bands were in
common between these two peptide gels, likely due to autophosphorylation
(Figure 24). However, a band with a molecular weight of approximately 100 kDa
was consistently detected with H2O2-treated nuclear extracts in kinase activity
gels containing the unmodified H2B peptide (see red arrow in Figure 24). This
100 kDa band was absent in identically treated in-gel kinase assays containing
pre-H2BS10ph peptide or with yeast nuclear extracts prepared from ste20D cells
(Figure 24). As 100 kDa is the predicted molecular mass of Ste20 protein, these
data add further support that Ste20 kinase is an apoptosis-induced H2BS10
kinase.

Ste20 kinase phosphorylates histone H2B at serine 10 in vitro
To further establish a direct role of Ste20 during H2O2 -induced yeast cell death
event, I developed a bacterial expression system which provided a source for
recombinant full-length Ste20 (FL Ste20), and a kinase dead form of Ste20
(Ste20K649R; KD), containing an inactivating single point mutation changing lysine
to arginine, that were N-terminally tagged with GST. Purified FL-Ste20 and KD
were then incubated with yeast histone H2B peptides that contain residues 4-14
with unmodified or singly phosphorylated at S10 at 30 °C in the presence of
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Figure 24. An in-gel kinase assay identifies a 100 kDa H2B phospho-serine
10 kinase as Ste20
Total nuclear extracts prepared from WT and Ste20 deletion mutants were
fractionated by SDS gels that were first impregnated with either an
unmodified histone H2B (amino acids 4-14) peptide or a comparable peptide
that is singly phosphorylated at S10 as substrates. Following denaturation,
renaturation, and in-gel kinase activity procedures (Cheung et al., 2003),
unincorporated

32

P label was removed before the gel was stained with

Coomassie stain to ensure the equal loading, dried and subjected to
autoradiography. An arrow indicates ~100 kDa band that was consistently
detected with H2O2 treated nuclear extracts in the unmodified H2B peptidecontaining gel.

Note that this species is not detected when a pre-

phosphorylated (“blocked”) H2B peptide is used as the substrate or when
extracts are prepared from Ste20 deletion strains suggesting that the apoptotic
induced 100 kDa H2B kinase is Ste20.
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g[32P]ATP. After 1 hr incubation, the kinase activity was assayed by measuring
incorporation of the g[32P] label into peptide substrates using a filter-binding
assay. As shown in Figure 25A, FL Ste20 phosphorylated unmodified H2B
peptide (amino acid residue 4-14), but not H2BS10ph peptide. As expected, no
kinase activity was observed with KD as displayed by a drastic decrease of g[32P]
incorporation into unmodified H2B peptide (Figure 25A), suggesting Ste20 as
H2B kinase.

Next, the specificity of Ste20 kinase was tested using any

unmodified histone peptides that were available in our lab. Both FL Ste20 and
KD were not able to phosphorylate unmodified peptides carrying H2B amino
acids from 30-37, H2A from 1-9, H4 from 1-19 (Figure 25B), suggesting that Ste20
contains a strong histone kinase activity specific for H2B at S10. Interestingly, FL
Ste20 phosphorylated an unmodified H2B peptide containing amino acids 6-16
from mammalian H2B (Figure 25B). In contrast, the phosphorylation level was
significantly reduced with a similar peptide differing by a single phosphate at
S14 (Figure 25B), demonstrating that yeast Ste20 can act similarly in vitro as
mammalian Mst1, a H2BS14 kinase.
Ipl1, a H3S10 kinase, phosphorylates both H3 and H2B in vitro (Hsu et al.,
2000) suggesting that H2B phosphorylation may be functionally redundant with
H3 phosphorylation. Therefore, I sought to address whether Ste20 kinase can
also phosphorylate H3 analyzed by in vitro kinase assay. Unlike Ipl1, FL Ste20
failed to phosphorylate H3 peptides that are either unmodified or singly
phosphorylated at S10, disputing an existence of functional overlap between H2B
and H3 phosphorylation by Ste20 (Figure 25A). As a positive control for
unmodified H3 peptide, His10-Ipl1 was expressed in bacteria and purified for
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Recombinant Ste20 kinase preferentially phosphorylates

unmodified H2B peptide containing amino acid residue 4-14 in vitro
In vitro kinase assays were performed in the presence of GST-tagged fulllength (FL Ste20), or kinase dead form of Ste20K649R (KD). Phosphorylation of
indicated histone peptides was assessed by measuring incorporation of [32P]-gATP using a filter-binding. The indicated kinase activities were obtained from
three independent experiments.
(A) H2B peptides from yeast (amino acids 4-14) or H3 peptides from yeast
(amino acids 1-20) that were unmodified or singly phosphorylated at S10,
were used as substrates for an in vitro kinase assay. FL Ste20, but not KD,
only phosphorylates unmodified yeast H2B peptides. Ipl1 kinase was used as
a positive control with H3 peptides (Hsu et al., 2000).
(B) As in (A), except that in vitro kinase assay was carried out with different
histone peptide substrates including peptides from mammalian H2B (amino
acids 6-16), yeast H2B (amino acids 30-37), yeast H2A (amino acids 1-9), and
yeast H4 (amino acids 1-19). FL Ste20 phosphorylates mammalian H2B
peptides that is unmodified but not singly phosphorylated at S14.
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kinase assay. As expected, Ipl1 displayed a strong preference for unmodified H3
peptide, but not a comparable peptide that is singly phosphorylated at S10 of H3
(Figure 25A). No phosphorylation was observed with both H2B peptides
(unmodified and S10ph containing amino acids 4-14), demonstrating that
H2BS10 is not a suitable substrate for Ipl1.
Purified Ste20 was tested for its substrate preference using a collection of
various composition and origin.

They include recombinant histones,

recombinant nucleosomes, and a mixture of core histones from yeast. The
similar kinase reaction was carried out at 30 °C for 1 hr in the presence of
g[32P]ATP. After stopping the reactions by SDS-loading buffer, proteins were
separated on SDS-PAGE gel and analyzed by autoradiography. Incorporation of
g[32P] label in H2B was detected in the reactions with FL Ste20, and not KD, when
purified H2B, or a mixture of core histones was used as substrates (Figure 26A).
Interestingly, FL Ste20 also phosphorylated nucleosomal H2B in vitro suggesting
that Ste20 kinase has the potential to act on chromatin substrates in vivo (Figure
26A). Finally, parallel kinase reactions were performed with nonradioactive ATP
and analyzed by western blotting. In agreement, only FL Ste20 phosphorylated
H2B as detected by anti-H2BS10ph (Figure 26B). Taken together, these results
demonstrate that Ste20 kinase can directly phosphorylate H2BS10 in vitro under
these assay conditions. Thus, I suggest that Ste20, a bona fide cell death kinase in
yeast, acts to bring about H2BS10ph through a direct enzyme-substrate
interaction in a cascade triggered by H2O2 treatment.
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Figure 26. Nucleosomal H2B is the substrate for Ste20 kinase in vitro
(A) Recombinant Ste20 (FL-Ste20) and the kinase dead form of Ste20K649R (KD)
were incubated with various types of substrates, including recombinant H2B
(H2B), recombinant nucleosomes (nuc), and a mixture core histones from
yeast (histones). The kinase reactions were performed at 30 °C for 1hr in the
presence of g[32P]ATP. After stopping the reactions by SDS-loading buffer,
proteins were separated on SDS-PAGE gel and visualized by Coomassie Blue
staining (lower panel) to ensure the equal loading. Proteins radio-labeled
with 32P were detected by autoradiography (upper panel).
(B) As in (A), except that nonradioactive in vitro kinase assay was carried out
without the g[32P]ATP. Nonradioactive ATP was used as phosphate source.
The phosphorylation of H2B was detected by Western analysis. FL Ste20
phosphorylated H2B as detected by anti-H2BS10ph.
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MAPK cascade signaling during mating or osmotic process and Yca1 are not
required for apoptotic H2B serine 10 phosphorylation
The MEKK Ste20 kinase functions in three Saccharomyces cerevisiae MAPK
cascades including the high osmolarity glycerol (HOG), pheromone response,
and pseudohyphal/invasive growth pathways (Liu et al., 1993; Robers and Fink
1994; Davenport et al., 1995; Kamada et al., 1995; O’Rourke and Herskowitz,
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Figure 27. The MAPK cascade from mating or osmotic pathways are not
required for hydrogen peroxide-induced H2B serine 10 phosphorylation
(A)

Nuclear extracts from mutants lacking various effectors

(ste20D ::HIS3MX6, ste11 D ::HIS3MX6, ste7D ::HIS3MX6, kss1D::HIS3MX6,
ssk2D::HIS3MX6, pbs2D::HIS3MX6, hog1D::HIS3MX6, ssk22D::HIS3MX6, and
cla4D ::HIS3MX6), involved in mating or osmotic pathways treated with or
without H2O2 were analyzed by Western blots using anti-H2BS10ph and antiH4 as a loading control.

Wild type, s t e 2 0D::kanMX6, ste7D::kanMX6,

pbs2D::kanMX6, and hog1D ::kanMX6 were tested for cell survival (B), or cell
death via Phloxin B staining (C) as described in Figure 11. Every effector
tested conferred H2BS10ph and cell survival pattern comparable to WT.
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1998). Therefore, I analyzed a series of strains defective in these pathways to
determine whether they inhibit the enhancement of H2BS10ph. These include
Ste11, Ste7, Kss1 from filamentous growth/pheromone response pathway, Ssk2,
Pbs2, Hog1, Ssk22 from HOG pathway. In my hands, all the downstream
effectors I tested displayed no changes in H2BS10ph (Figure 27A). Furthermore,
yeast strains separately lacking these effectors had normal or increased amount
of cell death as compared to WT (Figure 27B and 27C). Cla4 belong to Ste20 PAK
kinase family and shares some essential function with Ste20 since double
mutation of both kinases result in synthetic lethality (Cvrckova et al., 1995,
Goehring et al., 2003). However, they do not share function in yeast apoptosis
since Cla4 deletion mutant was sensitive to H2O2, accompanied by the
appearance of apoptotic H2BS10ph (Figure 27). Thus, Ste20 kinase is so far the
sole yeast apoptotic mediator that directly phosphorylates the histone H2BS10.
Caspases are integral components of many mammalian apoptotic
pathways. The onset of apoptotic H2BS14ph is dependent upon cleaved of Mst1
by caspase-3 (Cheung et al., 2003) in vertebrates. Hence, I sought to determine
whether H2BS10ph is controlled by Yca1, the only known yeast caspase. Yca1
gets cleaved in a caspase typical way and displays a caspase-like proteolytic
activity which is activated during yeast apoptosis (Uren et al., 2000; Madeo et al.,
2002b). As shown by Madeo et al. 2002, Ycal knockout in yeast decreased cell
death induced by H2O2 suggesting it as an apoptotic mediator (Figure 28A and
28B). However, the immunoblotting analysis showed that the level of H2BS10ph
after H2O2 treatment was normal in the Yca1 mutants (Figure 28C). Taken
together, these results suggest that Yca1 and Ste20/H2BS10ph act in independent
pathways modulating yeast cell death.
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Figure 28. Yca1 and H2B serine 10 phosphorylation act in independent
pathways modulating yeast cell death.
Log phased WT, yca1D and H2B S10A were treated with 1 mM H2O2 for 200
minutes. Cells were then plated onto rich medium, YPD. After 2 days of
growth, cells were counted to determine the cell viability (A), or cell death via
Phloxin B staining (B) as described in Figure 11. As expected Yca1 plays a role in
H2O2-induced cell death in yeast (Madeo et al., 2002b).
(C) Nuclear extracts of indicated yeast strains were separated on SDS-PAGE gel
and immunoblots were probed with anti-H2BS10ph and anti-H4. Anti-H4 was
used as a loading control. The H2BS10ph signal was detected in yca1 deletion
strain even after H2O2 treatment.

Hydrogen peroxide treatment stimulates translocation of Ste20 from cytoplasm
into nucleus
My results indicate that Ste20 directly acts to phosphorylate H2B in vitro and in
vivo. I reasoned then that Ste20 kinase, which is normally present in the
cytoplasm (Leberer et al., 1997), should be able to translocate from the cytoplasm
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Figure 29.

Nuclear localization of GST-Ste20 upon hydrogen peroxide

treatment
(A) Cytoplasmic (C) and nuclear extracts (N) were obtained from GST-Ste20,
GST-Ste12, and GST-Ste7 and analyzed by Western blotting using anti-GST
following treatment with or without H2O2. Anti-H4 reacted with nuclear extracts
while anti-Ste11 reacted with cytoplasmic extracts verifying the quality of the
extracts. In addition, anti-GST reacted with nuclear extracts from GST-Ste12 and
cytoplasmic extract from GST-Ste7.

While GST-Ste20 was found in the

cytoplasmic fraction from the mock-treated samples, 100 kDa full length Ste20
was found in the nuclear fraction from H2O2-treated samples.
(B) As in (A) except that Ste20, Ste7 and Ste12 was visually examined for the
subcellular localization via the GFP tag with or without H2O2 treatment. They
were stained with DAPI for DNA. As expected, GFP-Ste7 localized in the
cytoplasm and GFP-Ste12 localized in the nucleus. On the other hand, GFP-Ste20
and GFP-Ste20K649R translocated from cytoplasm into nucleus upon treatment
with H2O2.
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to the nucleus upon H2O2 treatment, even though an obvious nuclear localization
signal is not apparent in Ste20. To test this hypothesis, a yeast strain was
generated in which the STE20 gene was fused to GST at its N-terminus. This
chimeric protein, under control of its endogenous STE20 promoter, was fully
functional as assessed by survival in H2O2, H2BS10ph, and ability to mate. Since
Ste20 is localized in the growing bud tip and the plasma membrane during
normal growth (Leberer et al., 1997), I predicted that GST-Ste20 would localize
mostly in the cytoplasmic fraction without H2O2 treatment. Hence, nuclei were
extracted from H2O2 treated or untreated GST-Ste20 cells and analyzed GSTSte20’s localization by Western blotting using anti-GST antibody. A high
percentage of GST-Ste20 was found in the cytoplasmic fraction from the mocktreated samples (Figure 29A). Surprisingly, H2O2 treatment facilitated the
translocalization of Ste20 into the nucleus as essentially all of GST-Ste20 was
localized to the nuclear extracts following this treatment (Figure 29A).
Quality of the fractionation procedure was verified by determining the
localization of known nuclear and cytoplasmic proteins. They include histone
H4 and GST-Ste12 as nuclear proteins, and Ste11 and GST-Ste7 as cytoplasmic
proteins.

The localization of histone H4 and Ste11 was determined by

immunoblotting analysis using anti-H4 and anti-Ste11 antibodies. As expected,
all the nuclear extracts contained H4 signal whereas Ste11 was only present in
cytoplasmic fractions (Figure 29A). GST-Ste12 and GST-Ste7 were generated as
described for GST-Ste20, except that GST-Ste12 was under the control of STE12
promoter and GST-Ste7 was under the control of STE7 promoter. As shown in
Figure 29A, GST-Ste12 was found in the nuclear fraction and GST-Ste7 was in
cytoplasmic fractions in both H2O2 untreated and treated conditions. Hence,
106

Ste20 translocated from the cytoplasm into the nucleus during H2O2 -induced
yeast apoptosis. Furthermore, an approximate 130 kDa band was consistently
detected in H2O2-treated nuclear extracts, corroborating that full-length Ste20,
and not a cleaved form of Ste20, is translocated into the nucleus (Figure 29A).
These results are consistent with Yca1 operating in a separate pathway from
Ste20-mediated H2BS10ph (Figure 28). Thus, my data underscore a difference
between yeast and mammalian cells in that Ste20 does not appear to be a
caspase-dependent apoptotic kinase in yeast.
Next, the sequence encoding green fluorescent protein (GFP (S65T)) was
fused to the N-terminal sequence of STE20 in vivo to examine the subcellular
localization of Ste20 in response to H2O2. This chimeric protein displayed H2O2
sensitivity, H2B phosphorylation and mating ability similar to that of WT cells.
As shown in Figure 30B, in the absence of H2O2 treatment, GFP-Ste20 was either
concentrated at the site of bud emergence or appeared as a diffuse signal in
normal growing cells, again correlating with previously documented results (Wu
et al., 1995). However, upon treatment with H2O2, much of the fluorescent signal
concentrated within nuclei, precisely coinciding with DAPI-stained nuclei. Ste20
kinase activity is not required for its nuclear translocation, since GFP-Ste20K649R, a
catalytically-inactive form of Ste20, conferred a localization pattern similar to
GFP-Ste20 (Figure 29B). These results are consistent with nuclear localization
being an upstream event of histone H2B phosphorylation. As control, GFP was
tagged N-terminal of Ste12 and Ste7 promoter to generate GFP-Ste7 and GFPSte12, respectively and their functionality was verified as both displayed H2O2
sensitivity comparable to WT. GFP-Ste7 was concentrated in the cytoplasm,
while GFP-Ste12 was in the nucleus (Figure 29B). Together, these results suggest
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that H2O2 induces a cell death cascade in yeast by translocating Ste20 into the
nucleus in a caspase-independent fashion. I favor the view that Ste20, upon
nuclear uptake, phosphorylates H2B at S10 directly to elicit chromatin
compaction and re-organization that resembles to some extent what typically
occurs during mammalian apoptosis (Figure 30).
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Discussion
Chromatin alterations, induced in part via covalent histone modifications, are
proving to play ever-important roles in a wide range of DNA-templated
processes. Here, I uncover a unique and previously unrecognized “death”
function of the H2B N-terminal tails in S. cerevisiae. This function is unique to the
H2B N-tail, and is not carried by the N-tails of H2A, H3 or H4. In keeping with
results obtained in mammalian cells (Cheung et al., 2003), phosphorylation of S10
in yeast H2B serves a comparable role to phosphorylation of mammalian H2B at
S14 and is catalyzed by Ste20 kinase, a yeast homolog of mammalian Mst1
kinase. I extended our mammalian studies by showing that phosphorylation of
S10 in H2B in yeast is necessary to induce cell death in vivo and exhibit
phenotypic hallmarks of apoptosis including DNA fragmentation and chromatin
condensation.

However, unlike H2BS14, I demonstrated that yeast cells

containing a deletion mutation of Ste20 kinase (ste20D ), as well as mutants
carrying H2B S10A, are resistant to cell death elicited by H2O2. Importantly, a
phospho-mimic of S10, S10E, promotes the constitutive formation of highly
compacted chromatin. Therefore, I favor the view that the Ste20 kinase, a yeast
homolog of mammalian apoptotic Mst1 kinase, directly catalyzes
phosphorylation of H2BS10 during H2O2 induced yeast cell death upon its
translocation into the nucleus in a caspase-independent manner (Figure 30).
Together, these studies begin to define a phosphorylation-based H2B “death
code” and elucidate a mechanism by which H2B phosphorylation regulates
apoptosis, a pathway that appears conserved in significant detail from yeast to
humans.
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Figure 30. Model for the Ste20 mediated H2B serine 10 phosphorylation in
hydrogen peroxide-induced yeast apoptosis
H2O2 induces an apoptotic cascade in yeast by translocating Ste20 kinase into
the nucleus in a caspase-independent fashion. Once in the nucleus, Ste20
kinase directly phosphorylates H2B at S10 (see red circle with P) to elicit
apoptotic chromatin condensation, and ultimately cell death.

Yeast H2B serine 10 phosphorylation versus mammalian H2B serine 14
phosphorylation
Previously, H2BS14 has been shown to serve as a site of phosphorylation
induced during mammalian apoptosis (Cheung et al., 2003).

The studies

reported here suggest that H2BS10 functions as the counterpart of this event in
yeast. In support, my proposed H2O2-induced yeast cell death signaling model is
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similar to the previously described mammalian apoptotic cascade in which
phosphorylation of vertebrate H2B at S14 is mediated by Mst1, a mammalian
homolog of Ste20 (Cheung et al., 2003). My data are consistent with yeast
H2BS10ph serving a role in mediating DNA fragmentation and chromatin
condensation since H2B S10A mutants exhibit a loss of DNA fragmentation and
chromatin condensation (Figures 18 and 20). Therefore, this phosphorylation
event could serve as a mechanism mediating chromatin condensation during
apoptosis in vivo (Cheung et al., 2003).
Interestingly, the Ste20-catalyzed cascade in yeast is distinct from
mammalian Mst1 elicited pathway in that it does not require a proteolytic
processing event. Instead, my data show that the full-length Ste20, and not the
caspase-cleaved form, translocates into the nucleus upon H2O2 treatment (Figure
29). Furthermore, Yca1, the only identified yeast caspase, is not required for
H2BS10ph (Figure 28C), even though it serves as an apoptotic mediator during
H2O2-induced cell death (Madeo et al., 2002b). Therefore, my results suggest that
there may be two independent yeast cell death processes; one which is mediated
by the caspase such as Yca1, and the other mediated by a caspase-independent
mechanism involving H2BS10ph.

Precedent for a non-caspase-mediated

apoptosis has been observed in various human tumor cells after treatment with
specific drugs (Wang et al., 2003). While no link to H2B phosphorylation has
been made in this pathway, I cannot exclude the possibility that similar
downstream effectors from yeast, may be regulating the caspase-independent
apoptosis in vertebrates.
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Ste20 kinase functions in a pathway distinct from known MAP kinase signaling
cascade
Although Ste20 is well known as an activator of MAP kinase pathway (Liu, 1993;
Roberts and Fink, 1994; O’Rourke and Herskowitz, 1998), this role is not required
for H2B phosphorylation induced by H2O2 treatment. Instead, my data support a
view wherein Ste20 facilitates phosphorylation of H2BS10 through a direct
enzyme-substrate interaction without activating the classical MAPK pathway
(Figure 27). In support, I show that Ste20 can translocate into the nucleus in
response to H2O2, even though it lacks an obvious nuclear localization signal
(Figure 29). It remains unclear whether yet unidentified factors interact with
Ste20 to facilitate the nuclear translocation, or whether additional factors are
required for catalytic-activity of Ste20 or its regulation. Interestingly, PAKs, such
as Ste20, are commonly activated by small GTPases of Cdc42/Rac family, and
Ste20 binds to Cdc42, a guanine nucleotide exchange factor (Burbelo et al., 1995).
However, the role of this interaction is controversial since Ste20 lacking its entire
Cdc42-binding domain still retains kinase activity and mating function (Peter et
al., 1996; Leberer, et al., 1997). Thus, it is not surprising that Cdc42 may not be
involved in activating Ste20 during H2O2-induced apoptosis.

Instead, an

autophosphorylation event might represent a crucial step in the activation of
Ste20 since Ste20 exhibits autophosphorylation activity (Wu et al., 1995).
Furthermore, p65PAK, another mammalian homologue of Ste20, has been shown
to be activated in vitro by an authophosphorylation mechanism (Martin et al.,
1995), as has Mst1 (Glantschnig et al., 2002). Thus, it is conceivable that yet
unknown upstream regulators or other kinases may activate Ste20 via
phosphorylation.
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Conserved features of “apoptotic” H2B phosphorylation
The finding of a potential “death code” in organisms as diverse as yeast and
humans, suggests that similar sequences may exist in H2B tails from other
organisms. In S. pombe, for example, the budding yeast S10, as well as its
neighboring sequences, is identically found in its H2B N-terminal tail, suggesting
an intriguing possibility of phosphorylation of S10 participating in apoptotic
function in fission yeast. Interestingly, Pca1, a Yca1 homolog in S. pombe, appears
to play an essential role in S. pombe apoptosis when induced with fatty acid
(lipoapoptosis; Zhang et al., 2003). However, at this time, it is unknown if this
process may be mediated by a mechanism similar to the budding yeast apoptosis
described here.
Although apoptosis has been extensively studied in Drosophila
melanogaster and Caenorhabiditis elegans, it remains unclear whether N-terminal
tail of H2B, or its phosphorylation, plays a significant role during cell death in
these models. As shown in Figure 13, their H2B N-terminal tails are divergent,
but potential phosphorylation acceptor candidates may include serine 5 in
Drosophila and serine 6 in C. elegans as these serines are embedded in basic motifs
near alanine/proline residues similar to that of vertebrate S14 and yeast S10.
Moreover, hippo (Hpo), a Drosophila homolog of mammalian Mst1 and yeast
Ste20 serine/threonine kinase, has been shown to modulate apoptosis in
D r o s o p h i l a (Harvey et al., 2003; Wu et al., 2003) and may facilitate
phosphorylation of H2B during apoptosis. A comparable scenario may exist in
C. elegans as well, since cMst, a C. elegans homolog of mammalian Mst1 (Lee et al.,
2001), has been identified, although it’s role in apoptosis remains to be explored.
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Although many of the major upstream apoptotic regulators described for
mammalian cells have no apparent homolog in S. cerevisiae, a growing list of
properties, including H2B phosphorylation, appear shared between them.
Whether a “true” mammalian-like programmed cell death occurs in yeast is not
answered by my study. Also unclear is whether “surviving” cells carrying the
H2B S10A mutation are “normal” relative to WT cells or are refractory to other
stress-induced insults. What benefits a suicide pathway serves a unicellular
organism are also a matter of debate. It has been suggested that this mechanism
may limit replication of viruses, reduce competition for nutrients during periods
of starvation, or eliminate cells with damaged or mutated DNA to better
maintain genomic integrity of future generations (Severin and Hyman, 2002).
Interestingly, H2BS14ph has recently been correlated with DNA damaged
foci that also stain positively with H2A.X phosphorylation in mammalian cells
(Fernandez-Capetillo et al., 2004a). Together, these data hint at a conserved
pathway wherein histone phosphorylation of core histones (major and variant)
create a specialized compacted chromatin structure that facilitates repair of DSBs
as well as participates in the formation of condensed chromatin characteristic of
dying cells. The precise role of these phosphorylation marks, whether inducing
structural effects on chromatin packaging (“cis” mechanism), or allowing the
binding of “death effectors” that, in turn, bring about downstream effects
(“trans” mechanism), remains an open area of considerable interest. (discussed in
Chapters 4 and 5).
In summary, while important differences in mechanistic details appear to
exist between yeast and mammalian cells, my studies pave the way for a better
understanding of apoptosis by defining the novel role of Ste20 in governing the
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novel H2BS10ph in the yeast. The conservation of the covalent modification, the
choice of the particular core histone tail substrate, and the enzyme system
responsible for bringing about this mark, points to an ancient mechanism of cell
death process conserved from yeast to human.

My findings suggest the

intriguing possibility that yeast can be used as model to provide a better
understanding of the complex network of fundamental mechanisms of apoptosis,
as well as furthering our understanding of link between covalent histone
modifications and cell death. This theme will be further developed in the next
chapter of my thesis.
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Materials and Methods
Reagents and media
Restriction enzymes, T4 DNA ligase (for general cloning) and Vent DNA
polymerase were purchased from New England Biolabs (NEB). The Pfu Turbo
DNA polymerase (for DNA mutagenesis) was purchased from Stratagene.
Hygromycin, G418 and microcystin-LR were purchased from Calbiochem. Yeast
lytic enzyme was purchased from MP Biomedicals. a-factor was purchased from
Zymo research. Yeast extract, peptone, Bacto-Agar, and yeast nitrogen base were
from Fischer Scientific Co. Amino acid drop out mix and 5-FOA were purchased
from Bio101 systems. Reagents and enzymes purchased from Sigma include
common lab chemicals, anti-GST antibody, diamidino-phenylindole (DAPI),
phloxin B, phenylmethylsulfonyl fluoride (PMSF), leupeptin, aprotinin, pepstatin
and salmon sperm DNA.
The commonly used yeast and bacterial media were prepared as
described previously (Sherman et al., 1979). Bacterial cells were grown in LB
medium (1% tryptone, 0.5% yeast extract, and 1% NaCl) or YT medium (6.0%
tryptone, 1.0% yeast extract, 0.5% NaCl, plus antibiotics. These antibiotics
include 100 mg/ml ampicillin, 25 mg/ml chloramphenicol, and 50 mg/ml
kanamycin). For yeast, rich media YPD consists of 1% yeast extract, 2% peptone
and 2% dextrose. The synthetic complete (SC) medium consists of 0.36% yeast
nitrogen base without amino acids, 2% dextrose, 1% ammonium sulfate, and
amino acid drop out mix.
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General DNA manipulation
Escheirchia coli strain DH5a [supE44 DlacU169 (f80 lacZDM15) hsdR17 recA1 endA1
gyrA96 thi-1 relA1] was used for general cloning. Plasmid DNA were purified
using the Qiagen Midi Prep kit (Qiagen). DNA digestions with restriction
enzymes were carried out according to the manufacturer’s instruction. DNA
fragmentions were isolated using QIAquick Gel extraction kit (Qiagen). DNA
ligation was performed using T4 DNA ligase (NEB) and the buffer provided by
the manufacturer in a 30 ml reaction at room temperature (RT) for 3 hr.

Mutation of histone genes
A procedure based on the ‘QuickChange Site-Directed Mutagensis’ protocol by
Stratagene was used for the introduction of point mutations in plasmid-born
histone genes. Plasmid pQQ18 (CEN LEU2, CEN, HTA1-HTB1-HHF2-HHT2),
which contain the genomic fragment of HTA1-HTB1 and HHF2-HHT2 in pRS315
(Sikorski and Hieter), was used as template. Two mutagenic primers with
complementary sequences were designed for each mutation.

The desired

mutation was placed in the middle of the primer with 15 base correct sequences
on both sides. PCR reactions were performed in 0.5 ml Eppendorf tubes in a
total reaction volume of 50 ml, containing 125 ng of the PAGE-purified
oligonucleotide containing the desired base substitution, 1x pFU Turbo DNA
polymerase buffer, 250 mM dNTP, 20 mM oligonucleotides and 1 unit pFU Turbo
polymerase.

The following PCR program was used on the PTC-200

thermocycler: 95°C 30 seconds Æ 16x (95°C 30 seconds, 55°C 1 min, 68°C 10 min)
Æ 75°C 10 min Æ 4°C. After completion of the thermocycling, the products were
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digested with 1 ml of Dpn I restriction enzyme (NEB) at 37°C for 4 hr to digest the
parental (i.e., the nonmutated) supercoiled dsDNA. After heat inactivation at
85°C for 15 min, the digestion products were used to transform E. coli DH5a
competent cells. Desired mutations were confirmed by DNA sequencing and the
minimal DNA fragment containing the mutated region was sub-cloned to the
original parental pQQ18 plasmid to avoid secondary mutations on the plasmid.

Plasmids
pSA17 (HTB1-S10A), pSA18 (HTB1-S33A), pSA65(HTB1-S10E), pSA67 (HTB1S33E), were created by PCR and sub-cloned into pQQ18. pSA51 and pSA52
carrying the STE20 promoter, were created by replacing GAL1 promoter in
pFA6a-His3MX6-pGAL1-GFP and pFA6a-His3MX6-pGAL1-GST (Longtine et al.,
1998), respectively, with the STE20 promoter amplified by PCR using yeast
genomic DNA from wild type yeast cells as template.

Yeast transformation
Yeast transformations were performed by a lithium acetate procedure based on
that of Gietz et al. 1992. Briefly, yeast cells were grown in YPD medium at 30° C
shaker with 200 rpm. When these cells reached 1 x 107 cells/ml, they were
harvested by centrifugation at 3000 g for 5 min, washed cells in 5 ml of 1X
TE/LioAc (made fresh from 10X TE pH 7.5 and 10X LioAc [1M LioAc pH 7.5,
adjusted with diluted acetic acid]) and resuspend in 50 ml of 1X LioAc. The yeast
cell suspension was then mixed with 1 mg transforming DNA, 50 mg of single
stranded salmon sperm carrier DNA that was previously boiled 5 min and
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chilled in ice for 10 min, and 300 ml of sterile 40% PEG 3500 solution (40% PEG
4000, 1X TE, and 1X LioAc made fresh from sterile 50% PEG stock, sterile 10X TE
and 10X LioAc). The yeast cell suspension was incubated at 30° C with agitation
for 30 min, heat shocked in a 42°C water bath for 15 min, then 10 ml YPD was
added and incubated at 30°C with agitation for 1 hr. After centrifugation at 3000
g for 5 min, the supernatant was discarded and cells were resuspended with 300
ml of water. These cells were then plated onto appropriate SC selection plates.

Yeast Strains
Yeast strains are listed in Table 1 and all strains are derived from either S288C
(BY4741; Research Genetics) background. JHY205, the histone shuffle strain with
pJH33 plasmid, was used to generate yeast cells carrying histone mutations.
Briefly, plasmids with histone gene mutations were transformed into JHY311,
grown on SC-LEU medium at 30 C, and then colonies were streaked on a 5-FOA
plate to select for cells that have ‘looped out’ the pJH33 plasmid. Cells having
retained histone mutations were screened by plasmid rescue followed by DNA
sequencing. pSA17 or pSA18 was transformed into JHY205 to replace pJH33 and
generated SAY2 (htb1-S10A) or SAY3 (htb1-S33A), respectively. PSA65 or pSA67
was transformed into JHY205 to replace pJH33 and generated SAY168 (htb1S10E) or SAY170 (htb1-S33E), respectively.
Yeast strains carrying gene deletions (STE20, STE12, STE7, KSS1, STE11,
PBS2, SSK22, SSK2, CLA4, HOG1, and YCA1) were constructed by PCR
amplication of a P TEF promoter-driven bacterial kanamycin-resistance gene as
described by Longtine et al., 1998. PCR products were then transformed into
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JHY311 to create strains that lacked the full ORF (ATG-Stop). Correct integration
of the marker was confirmed by a series of PCR analysis. These strains include
SAY152 (yca1D ::kanMX6), SAY153 (ste11 D ::kanMX6), SAY154(ste7D ::kanMX6),
SAY155 (kss1D::kanMX6), SAY156(ssk22D ::kanMX6), SAY157 (cla4D::kanMX6),
SAY158 (pbs2D ::kanMX6), SAY159 (hog1 D ::kanMX6), SAY160 (ssk2D::kanMX6),
and SAY148 (ste20D::kanMX6). No morphologic or growth phenotype was
apparent between SAY 148 or SAY111 (gift from S.J. Kron). SAY151, a double
mutant carrying both H2B S10A and ste20 D ::kanMX6, was created by
transforming SAY2 (HTB1-S10A) with PCR product as described (Longtine et al.,
1998). The GFP-Ste20 fusion gene under the control of STE20 promoter was
generated by introducing a fragment amplified by PCR, using pSA51 as
template, into JHY311 or BY4741 cells to create SAY144 and SAY145,
respectively. SAY146 and SAY147 carrying the GST-Ste20 fusion gene under the
control of STE20 promoter (from -405 to –1, 5’ to the STE20 ORF) was generated
by introducing a fragment amplified by PCR using pSA52 as template, into
JHY311 or BY4741. The GFP-Ste12 (SAY 161) and GFP-Ste7 (SAY162) were
generated as described for GFP-Ste20, except that GFP-Ste12 was under the
control of STE12 promoter and GFP-Ste7 was under the control of S T E 7
promoter.

The gene disruption and epitope tagging in each strain were

confirmed by PCR. Ste20K649R (SAY150) was constructed using the marker-fusion
PCR method as previously described (Kitazono et al., 2002). Genomic DNA from
SAY149, in which His3MX6 cassette from pFA6a-His3MX6-PSTE20-GFP (Longtine
et al., 1998) was integrated into 100 bp downstream of the STE20 stop codon
(Kitazono et al., 2002), was used as template to generate Ste20K649R.
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Table 1. Genotypes of yeast strains
Strain
BY4741

Genotype
MATa his3∆1 leu2∆0 met15∆0 ura3∆0

JHY205

MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pJH33[CEN URA3
HTA1-HTB1 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pJH53[CEN LEU2
hta1-∆1-20-HTB1 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pJH49[CEN LEU2
HTA1-htb1∆1-32 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pJH57[CEN LEU2
HTA1-HTB1 hht2∆1-30-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pQQ18[C E N
LEU2 HTA1-HTB1 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pJH45[CEN LEU2
HTA1-HTB1 HHT2-hhf2∆1-27]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pSA17[CEN LEU2
HTA1-htb1-S10A HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pSA18[CEN LEU2
HTA1-htb1-S33A HHT2-HHF2]
MATa ura3-52 leu2::hisG ste20∆::kanMX6
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 HIS3MX6::PSTE20-GFPSTE20 hht1-hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2htb2::NAT pQQ18[CEN LEU2 HTA1-HTB1 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 HIS3MX6::PSTE20-GFPSTE20
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 HIS3MX6::PSTE20-GSTSTE20 hht1-hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2htb2::NAT pQQ18[CEN LEU2 HTA1-HTB1 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 HIS3MX6::PSTE20-GSTSTE20
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ste20∆::HIS3MX6 hht1hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT
pQQ18[CEN LEU2 HTA1-HTB1 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 STE20::HIS3MX6
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 HIS3MX6::PSTE20-GFPSte20-K649R hht1-hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH
hta2-htb2::NAT pQQ18[CEN LEU2 HTA1-HTB1 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ste20∆:: HIS3MX6 hht1hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT
pSA17[CEN LEU2 HTA1-htb1-S10A HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 yca1∆:: HIS3MX6 hht1hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT
pQQ18[CEN LEU2 HTA1-HTB1 HHT2-HHF2]

JHY293
JHY297
JHY307
JHY311
JHY315
SAY2
SAY3
SAY111
SAY144
SAY145
SAY146
SAY147
SAY148
SAY149
SAY150
SAY151
SAY152
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Source
Research
Genetics
This study
This study
This study
This study
This study
This study
This study
This study
S. J. Kron
This study
This study
This study
This study
This study
This study
This study
This study
This study

Strain
SAY154
SAY155
SAY156
SAY157
SAY158
SAY159
SAY160
SAY161
SAY162
SAY163
SAY164
SAY165
SAY168
SAY170
SAY172
SAY174
SAY180

Genotype
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ste7∆::HIS3MX6 hht1hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT
pQQ18[CEN LEU2 HTA1-HTB1 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 kss1∆::HIS3MX6 hht1hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT
pQQ18[CEN LEU2 HTA1-HTB1 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ssk22∆::HIS3MX6 hht1hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT
pQQ18[CEN LEU2 HTA1-HTB1 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 cla4∆::HIS3MX6 hht1hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT
pQQ18[CEN LEU2 HTA1-HTB1 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 pbs2∆::HIS3MX6 hht1hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT
pQQ18[CEN LEU2 HTA1-HTB1 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hog1∆::HIS3MX6 hht1hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT
pQQ18[CEN LEU2 HTA1-HTB1 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ssk2∆::HIS3MX6 hht1hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT
pQQ18[CEN LEU2 HTA1-HTB1 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆ HIS3MX6::PSTE12-GFPSTE12 hht1-hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2htb2::NAT pQQ18[CEN LEU2 HTA1-HTB1 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 HIS3MX6:PSTE7-GFPSTE7 hht1-hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2htb2::NAT pQQ18[CEN LEU2 HTA1-HTB1 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 yca1∆::HIS3MX6 hht1hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT
pSA17[CEN LEU2 HTA1-htb1-S10A HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 HIS3MX6::PSTE12-GSTSTE12 hht1-hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2htb2::NAT pQQ18[CEN LEU2 HTA1-HTB1 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 HIS3MX6::PSTE7-GSTSTE7 hht1-hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2htb2::NAT pQQ18[CEN LEU2 HTA1-HTB1 HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pSA65[CEN LEU2
HTA1-htb1-S10E HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pSA67[CEN LEU2
HTA1-htb1-S33E HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ste20∆::HIS3MX6 hht1hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT
pSA65[CEN LEU2 HTA1-htb1-S10E HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ste20∆::HIS3MX6 hht1hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT
pSA67[CEN LEU2 HTA1-htb1-S33E HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pSA17[CEN LEU2
HTA1-htb1-K11R HHT2-HHF2]
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Source
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

Strain
SAY182
SAY183
SAY184
SAY185
SAY186
SAY187

SAY188
SAY190
SAY191
SAY192
SAY193
SAY194
SAY195
SAY196
SAY197
SAY198
SAY199
SAY200
SAY201
SAY205
SAY206

Genotype
Source
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf- This study
2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pSA17[CEN LEU2
HTA1-htb1-S10A K11R HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf- This study
2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pSA18[CEN LEU2
HTA1-htb1-S10A K11Q HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf- This study
2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pSA17[CEN LEU2
HTA1-htb1-S10E K11R HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf- This study
2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pSA18[CEN LEU2
HTA1-htb1-S10E K11Q HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf- This study
2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pSA17[CEN LEU2
HTA1-htb1-K16R HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf- This study
2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pSA18[CEN LEU2
HTA1-htb1-K16Q HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf- This study
2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pSA17[CEN LEU2
HTA1-htb1-S10A K16R HHT2-HHF2]
MATa ura3-52 leu2::hisG hos3∆::kanMX6
Research
Genetics
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ste20∆::HIS3MX6 hht1- This study
hhf1::KAN hhf-2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT
pSA67[CEN LEU2 HTA1-htb1-K11R HHT2-HHF2]
MATa ura3-52 leu2::hisG rpd3∆::kanMX6
Research
Genetics
MATa ura3-52 leu2::hisG hda1∆::kanMX6
Research
Genetics
MATa ura3-52 leu2::hisG hos1∆::kanMX6
Research
Genetics
MATa ura3-52 leu2::hisG hos2∆::kanMX6
Research
Genetics
MATa ura3-52 leu2::hisG hda2∆::kanMX6
Research
Genetics
MATa ura3-52 leu2::hisG hda3∆::kanMX6
Research
Genetics
MATa ura3-52 leu2::hisG gcn5∆::kanMX6
Research
Genetics
MATa ura3-52 leu2::hisG sas32∆::kanMX6
Research
Genetics
MATa ura3-52 leu2::hisG hpa3∆::kanMX6
Research
Genetics
MATa ura3-52 leu2::hisG spt10∆::kanMX6
Research
Genetics
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf- This study
2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pSA81[CEN LEU2
HTA-htb1-P8A-P13A HHT2-HHF2]
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf- This study
2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pSA82[CEN LEU2
HTA+HTB2-16-htb1∆1-32 HHT2-HHF2]
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Strain
SAY208

Genotype
Source
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 hht1-hhf1::KAN hhf- This study
2hht2::NAT hta1-htb1::HPH hta2-htb2::NAT pSA84[CEN LEU2
HTA+HTB2-16-S10E-htb1∆1-32 HHT2-HHF2]

SAY209
SAY210
SAY211
SAY212

MATa ura3-52 leu2::hisG
MATa ura3-52 leu2::hisG sml1∆::URA3
MATa ura3-52 leu2::hisG sml1∆::URA3 rad53::HIS3
MATa ura3-52 leu2::hisG RAD53::TAP::KanMX6

SAY213

MATa ura3-52 leu2::hisG sml1∆::URA3 rad53∆6-66::HIS3

SKY10

MATa/MATa ho::LYS2/ho::LYS2 lys2/lys2
leu2::hisG/leu2::hisG spo11∆::URA3/spo11∆::URA3
MATa/MATa ho::LYS2/ho::LYS2 lys2/lys2
leu2::hisG/leu2::hisG
MATa/MATa ho::LYS2/ho::LYS2 lys2/lys2
leu2::hisG/leu2::hisG ndt80∆::URA3/ndt80∆::URA3

SKY165
SKY169
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S. Elledge
S. Elledge
S. Elledge
Research
Genetics
This study

ura3/ura3 S. Keeney
ura3/ura3 S. Keeney
ura3/ura3 S. Keeney

Yeast culture conditions
The induction of yeast apoptosis by hydrogen peroxide (H2O2) was carried out as
previously described in Madeo et al., 1999. Briefly, 1 mM H2O2 was added to
yeast cells growing exponentially on YPD medium and after a 200-minute
incubation at 30°C with agitation, cells were washed three times with sterilized
distilled water.

Yeast apoptosis was also induced by 50 mM acetic acid

(Ludovico et al., 2001) and 100 mg/ml a-factor (Severin and Hyman, 2002).
Synthetic complete medium (SC) was used for maintaining plasmids and
selecting gene replacements (Rose et al., 1990). G418 (Calbiochem) was added to
YPD agar at 0.2 mg/mL. As for 5-FOA, 0.5 g of 5-FOA was added to 500 ml of
SC medium with 15 g of Bacto-agar.

Test for Apoptosis and Immunofluorescence Staining
The survival rate was carried out as previously described (Madeo et al., 2002).
An aliquot of the cultures was counted, diluted in distilled water, and about 1000
cells were plated on YPD plates. After two days of growth at 28°C, colonies were
counted.
The cell death analysis was carried out as previously described (Severin
and Hyman, 2002). An aliquot of the cultures were incubated with 0.4 mg/ml
phloxin B for 5 min, and visualized under 63x objective lens.
For TUNEL staining, yeast cells were fixed with 3.7% formaldehyde and
prepared as described (Madeo et al., 1999), except that TUNEL staining kits were
purchased from Promega and used as recommended by the manufacturer. For
immunofluorescence, cells were fixed with 3.7% formaldehyde, digested with
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yeast lytic enzyme and applied to a poly-lysine coated slide. After washing the
slide three times with PBS, cells were blocked in 2% goat serum PBS (block) for 1
hour and then incubated with anti-H2BS10ph in block at 37°C. After more
washes, cells were incubated for 1 hr in the goat anti-rabbit Cy3-conjugated
secondary antibody (Jackson), washed three times, and mounted in Vectashield
mounting media containing DAPI. For double staining with TUNEL and antiH2BS10ph, cells were stained with TUNEL first and then with a-H2BS10ph.
Annexin V staining assay to detect the exposed phosphatidylserine was
carried out as previously described (Madeo et al., 1997).

Yeast Nuclei and Histone Extraction
Half a liter of yeast cells were grown to log phase (<5 x 107 cells/ml) in YPD and
collected by centrifugation with 3000 rpm at room temperature for 5 min. Cell
pellets were washed with 100 ml of water then resuspended in 100 ml of SP (1.1
M sorbitol, 0.02 M PIPES, pH 6.3) plus 0.5 ml of b-mercaptoethanol. Cells were
subjected to spheroplasting by adding 2-4 mg of lytic enzyme (ICN) and
incubated at 30°C with slow shaking (<120 rpm). Efficiency of spheroplasting
was monitored by percentage of decrease in OD600 reading of minute amount of
cells (10-20 ml) suspended in 1 ml of 1% SDS. When 80-90% of the cells were
spheroplasted (usually 30 min to 1 hr), the spheroplasts were spun down,
washed with 10 ml SPI (SP plus inhibitors for protease and phosphatases
including 1 mg/ml of aprotinin, leupeptin, and peptstatin A, 1 mM PMSF, 1 mM
microcystin-LR, and 0.2 mM p-chloromercuriphenylsulfonic acid). All the
procedures hereafter were processed on ice or at 4° C unless noted otherwise.
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The spheroplasts were collected by centrifugation and the pellets were
resuspended in 20 ml of FPMI (18% Ficoll, 20 mM PIPES, 1 mM MgCl2, pH 6.3
plus protease and phosphatase inhibitors) and transferred to a Dounce
homogenizer. Speroplasts were lysed by <200 strikes with B pestle and then
transferred to a centrifuge tube and chilled on ice for 10 min. The release nuclei
were separated from the debris and unbroken cells by centrifugation at 3000g for
10 min. The supernatants were carefully transferred to an ultracentrifuge tube
(14 x 95 mm, Beckman) and then centrifuged at 50,000g for 30 min (SW-40 rotor,
Beckman L7-65). The pellets containing nuclei were resuspended in 10 ml of NP
(0.34 M sucrose, 20 mM Tris-HCl, 50 mM KCl, 5 mM MgCl2, pH 7.4 plus protease
and phosphatase inhibitors) and centrifuged through a 2 ml sucrose cushion
buffer (1.7 M sucrose, 20 mM Tris-HCl, 50 mM KCl, and 5 mM MgCl2, pH 7.4) at
30,000g for 30 min. The resulting nuclei pellets were resuspended 1 ml of NP
buffer and spilt to 1.5 ml centrifuge tubes before frozen at –80°C.
To extract histones, nuclei in 1 ml of NP were washed with 1 ml of buffer
A (10 mM Tris-HCl, 0.5% NP-40, 75 mM NaCl, pH 8.0 plus protease and
phosphatatse inhibitors) extensively by pipetting the pellets up and down. Each
washing solution was discarded after 5 min spinning in a benchtop minicentrifuge. After the final wash, pellets were resuspended in 500 ml of buffer B
(10 mM Tris-HCl, 0.4 M NaCl, pH 8.0) and then added gradually with 50 ml of 4
N H2SO4 and were gently agitated on a rotator for >30 min. The suspendsion
was centrifuged and the histones in the solution were precipitated by adding
TCA to 25% final concentration and incubated on ice for >1 hr. Precipitated
histones were centrifuged and washed with acetone containing 0.1% HCl
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followed by another wash with acetone. The protein pellets are dissolved in 200
ml of water and the protein concentration was estimated by measuring OD218
(0.15 mg/ml/OD) or Coomassie Blue staining after SDS-PAGE.

Peptide synthesis and ELISA assay
Unmodified H2B peptide was synthesized corresponding to residues 4-14 of
yeast histone H2B (AEKKPASKAPA). Phosphorylated yeast H2B peptide was
synthesized with a single phosphorylated serine residue at position 10
(AEKKPAS[p]KAPA). [p] denotes phosphate. Both peptides contain an artificial
cysteine residue at position 15 for coupling to Keyhole limpet hemocyanin for the
antibody generation.
ELISA procedures were performed as described (Muller et al., 1987). All
antisera were diluted 1:1000. For peptide competition experiments, 100 ml of
antiserum was incubated with 100 mg of peptide for 1 hr at room temperature
prior to ELISA. The bound enzyme conjugate was quantified by turnover of pnitrophenyl phosphate substrate (Sigma), as described by absorbance at 492 nm.

Western Blot
Approximately 1.5 mg of yeast histone proteins were analyzed by SDS-PAGE on
8% or 15% gels and then transferred to a piece of PVDF membrane (Immobilon-P
Millipore) with Towin buffer (192 mM glycine, 25 mM Tris-Cl, 0.1% SDS, and
20% methanol, pH 8.0) by a Semi-dry system (Hoefer). The proteins transferred
were examined by Ponceau S staining (0.4% w/v Ponceau S in 2% acetic acid and
8% TCA). The membrane was blocked with 5% non-fat dry milk dissolved in
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TBS (20 mM Tris-Cl, pH 7.6, and 137 mM NaCl) at 4°C for overnight or at room
temperature for 1 hr. After blocking, the membrane was immersed in 5 %
milk/TBS-T buffer (TBS plus 0.1% Tween-20) containing appropriate dilution of
desired antibody in a heat-sealable plastic bag and incubated at room
temperature for 2hr on a horizontal shaker. Antibodies were diluted as follows:
anti-H2BS10ph: 1:5,000, anti-H4: 1:5,000, anti-GST: 1:10,000 (Sigma). Following
the primary antibody incubation, the membrane was washed with TBS-T for 10
min three times. The membrane was then incubated with appropriate secondary
antibody diluted in 5% milk/TBS-T and incubated for 2 hr at room temperature.
A HRP-conjugated rabbit secondary antibody (Amersham Pharmacia) was used
as the secondary antibody for the primary rabbit polyclonal antibodies. The
membrane was finally washed three times with TBS-T for 10 min and then
subjected to chemiluminescence detection by ECL plus kit (Amersham
Pharmacia).

For an alkaline phosphatase (AP) treatment, histones were

incubated with 1 ml of shrimp alkaline phosphatase (Promega) at 37°C for 2 hr,
boosted with another 1 ml of enzyme, and then the incubation continued for
another 1-2 hr. Six times concentrated Laemmli sample buffer was added to stop
the reaction.

Protein Kinase
GST-Ste20 and GST-Ste20K649R were constructed by PCR using yeast genomic
DNA from wild type yeast cells and SAY149 (GST- Ste20K649R) and then ligating
into pENTRY and then into pDEST15 (GST). The GST fusion proteins were
expressed in E. Coli strain BL21-Codon Plus (DE3)-RIL(Stratagene) at 30°C for
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2hr, bound to glutathione-Sepharose beads, and eluted with glutathione
according to the manufacturer’s instructions (Amersham).
Kinase assays were performed in 40 mL of 20 mM Tris-HCl (pH 7.0), 5 mM
MgCl2, 1 mM EGTA, 90m M ATP, 0.75 m Ci of [32P]-g-ATP, and 1 m g of
recombinant Ste20 or Ste20K649R, in the presence of 5 mg of the indicated H2B or
H3 peptides. After 1 hr incubation at 30°C, 10 mL of the reaction mixture was
removed and spotted onto P81 filter paper. The filter paper was then washed,
dried and subjected to scintillation counting. Alternatively, Ste20 or Ste20K649R
was incubated as above with either recombinant yeast H2B (2 mg), a mixture of
acid-extracted yeast free histone (2.5 mg) or yeast nucleosomes (0.5 mg). Assay
mixtures were resolved by SDS-PAGE (15% gels) and processed for
autoradiography. For nonradioactive (cold) reactions, no [32P]-g-ATP was used
and the reactions were run in an SDS-PAGE gel for Western blot analysis.

In-Gel Kinase Assay
The in-gel kinase assay was done as described (Cheung et al., 2003), except that 5
mg/ml unmodified (amino acids 4-14 of yeast H2B) or S10-phosphorylated H2B
peptides were added to 10% SDS-PAGE gels. In-gel assays were performed as
essentially described in Sassone-Corsi et al., 1999). Following electrophoresis,
gels were washed in 30 mM Tris-HCl pH 7.4, 1 mM DTT, 0.1 mM EDTA, 20%
(v/v) isopropanol for 20 min and this was repeated three times. Gels were then
incubated in 8 M urea, 30 mM Tris-HCl pH 7.4, 1 mM DTT, 0.1 mM EDTA for 1
hr. The gel was then immersed in 30 mM Tris-HCl, pH 7.4, 5 mM MgCl2, 2 mM
MnCl2, 1 mM DTT, 100 mM NaCl, 0.05% Tween 40 at 4°C overnight to renature
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the proteins. After renaturation, the in vitro kinase reaction was performed using
50 mCi of g-ATP in 30 mM Tris-HCl pH 7.4, 5 mM MgCl2, 2 mM MnCl2, 1 mM
DTT at 30°C for 2 hr. Gels were then stained with Coomassie Blue, destained,
and dried for autoradiography.
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CHAPTER 3

HISTONE MODIFICATION “CROSS-TALK” BETWEEN
YEAST H2B SERINE 10 PHOSPHORYLATION AND
LYSINE 11 ACETYLATION

Introduction
Histone proteins are well-known substrates for numerous covalent posttranslational modifications. Combinations of post-translational marks on single
histones, single nucleosomes and nucleosomal domains can be altered by
multiple extracellular and intracellular stimuli, and they in turn convey
information that regulates the dynamics of the genome over the lifespan of a
cell/organism (Strahl and Allis, 2000; Turner, 2000; Fischle et al., 2003a). In
contrast to the straightforward flow of most signal transduction cascades, where
the modification of one protein impacts directly on downstream effectors,
signaling to and from chromatin appears to be far more complex. Indeed, each
core histone, notably H3 and H4, can be post-translationally modified in a
remarkably large number of ways, thus generating the potential for histone
modification ”cross-talk’, defined as positive or negative “communication”
between different covalent modifications on one or more histone tails.
As discussed in Chapter 1, the “cross-talk” between post-translationally
modified histones occurs at the level of single histone tails (Figure 4).
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Phosphorylation of histone H3 at serine 10 (H3S10ph) has been linked, for
example, to the acetylation of lysine 14 (H3K14ac) resulting in an open chromatin
conformation and gene activation (Cheung et al., 2000; Lo et al., 2001; Figure 4B).
Indeed, Snf1 and Gcn5, the enzymes that phosphorylate H3S10and acetylate
H3K14, respectively, appear to work synergistically to mediate these events (Lo
et al., 2001; Clements et al., 2003). Serving as an example of cross-talk at the level
of the nucleosome, the ubiquitination of yeast H2B K123 by Rad6 has been
shown to be a prerequisite for the methylation of H3 on K4 and K79 (Sun and
Allis., 2002; Dover et al., 2002; Figure 4C).

This specific “cross-talk” is

unidirectional since abolishment of H3 K4 methylation has no effect on H2B
ubquitination (Sun and Allis, 2002). As shown in Figure 4A, individual residues
such as lysine have many potential states of modification. It is well documented
that H3 K9 can be either acetylated or (mono-, di-, tri-) methylated (Zhang and
Reinberg, 2000; Bannister et al., 2002). Since different marks on the same site
cannot co-exist, they therefore exclude each other and perhaps then influence
subsequent modifications made on that histone tail and/or nucleosome.
Previous studies have documented that H2B lysine11 is acetylated
(H2BK11ac) in logarithmically-growing yeast (Suka et al., 2001). Since K11 is
located adjacent to S10 in H2B, a site that correlates with the yeast cell death, I
sought to address whether a potential interplay exists between these tow histone
modifications in the yeast H2Btail. In this chapter, I show that acetylation of
histone H2B at K11 inhibits the phosphorylation of an adjacent site S10, catalyzed
by Ste20 kinase, pointing to a mutually exclusive existence of the K11ac and
S10ph marks in the tail of H2B. In support, yeast undergoing apoptosis lacked
K11 acetylation, but displayed high levels of Ste20-mediated H2BS10ph. In
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addition, K11Q, an acetyl-mimic mutant in H2B, failed to activate the apoptotic
pathway; in contrast, K11R, a mutant mimicking deacetylation, displayed
apoptotic features including H2BS10ph upon induction of H2O2.

Finally, I

identified Hos3 as the HDAC responsible for removing the acetyl mark on K11.
Together, these findings lend strong support to the general view that a
regulatory network of phos/acetyl cross-talk serves to integrate input signals to
the tail of yeast H2B controlling a switch from cell proliferation to cell death.
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Results
H2B K11R mutants are resistant to hydrogen peroxide-induced yeast apoptosis
As discussed in Chapter 2, the histone H2B is specifically phosphorylated at S10
in a hydrogen peroxide (H2O2)-induced cell death pathway in S. cerevisiae (Ahn et
al., 2005). As shown in Figure 31A, S10 is located adjacent to K11 in H2B, a site
known to be acetylated in growing yeast (Suka et al., 2001). As phoshorylation of
the adjacent S10 correlates precisely with the cell death, I sought to address
whether a potential interplay (cross-talk) exists between these two histone
modifications in the yeast H2B tail. To this end, yeast cells were generated
expressing H2B in which K11 was mutated to either glutamine to mimic
constitutive acetylation (K11Q), or arginine, to mimic constitutive deacetylation
(K11R), in a four-histone plasmid shuffle strain. No growth difference was
apparent between these H2BK11 point mutants compared to wild type (WT), as
indicated by their growth rate, suggesting that other acetylation events may
compensate for lack of H2BK11ac during cell growth.
Upon treatment with 1 mM H2O2 for 200 minutes, no difference was
observed between WT and the H2B K11R mutant with regard to survival
properties (Figure 31B). Both strains displayed 20-30% cell viability measured by
a plating assay (Figure 31B), followed by 70-80% cell death measured by phloxin
B-stained cells (Figure 31C).

Interestingly, however, K11Q resulted in a

reproducible resistance to H2O2 with 70-80% cell viability and 20-30% phloxin Bstained cells, comparable to the S10A mutant (Figure 31B and 31C; also see
Figure 14). Furthermore, H2BK16, another known acetylation site in yeast H2B
(Suka et al., 2001; see Figure 31A), displayed a phenotype similar to WT in both

135

A

B

C

Figure 31. Histone H2B is specifically deacetylated at lysine 11 in dying yeast
cells
(A) Primary sequence alignment of the amino-terminal tails of yeast and human
H2B. In yeast, lysine 11 (K11) is located adjacent to serine 10 (S10), an apoptotic
phosphorylation site (Chapter 2).

Both K11 and K16 are acetylated in

logarithmically-growing yeast (Suka et al., 2001). Note that K15, also known to
be acetylated in mammalian cells (Thorne et al. 1990), is also adjacent to a
mammalian apoptotic H2BS14ph site (Cheung et al., 2003). Other known
acetylation marks are highlighted with blue “Ks”.
(B & C) Exponentially-growing WT, H2B S10A, H2B K11R, H2B K11Q, H2B
K16R, and H2B K16Q stains were treated with 1 mM H2O2 for 200 minutes. Cells
were then split into two aliquots for cell survival (B), and cell death assays (C).
Briefly, cell survival percentage was calculated for each strain by counting
number of colonies formed on YPD agar; cell death was measured by counting
the number of phloxin B stained cells following H2O2 treatment relative to
untreated cells, as described in Figure 11.

Note that, while the H2B K11R

mutant was as sensitive to H2O2 as WT cells, the H2B K11Q mutant was resistant
to H2O2 treatment in either assay.
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assays when K16 was mutated to R or Q. (Figure 31B and 31C). These data
suggest that K11 in the yeast H2B tail, but not other H2B acetylation sites, needs
to be deacetylated as part of a pathway leading to yeast cell death.

Characterization of anti-H2BK11ac antibody
To directly test whether the deacetylation at H2B K11 correlates with cell death, a
site-specific H2BK11 acetyl-specific antibody (hereafter anti-H2BK11ac) was used
to evaluate the acetylation state of K11 during H2O2-induced yeast apoptosis.
Anti-H2BK11ac antibody was a gift from Dr. Michael Grunstein (University of
California; Los Angeles, CA). This antibody was generated against the peptide
containing amino acids 8-17 with singly acetylated at K11 (hereafter H2BK11ac
peptide; see Figure 31A for the sequence). The specificity of anti-H2BK11ac was
analyzed by ELISA as described earlier for anti-H2BS10ph antiserum (see Figure
15 for anti-H2BS10ph). Anti-H2BK11ac reacted strongly with the H2BK11ac
peptide, but not the unmodified counterpart (Figure 32A). This reaction was
shown to be specific because only the H2BK11ac peptide and not the unmodified
peptide competed this signal away (Figure 32A). Anti-H2BK11ac did not
recognize the H2BS10ph peptide, but recognized peptide containing dual
modification of both S10ph and K11ac (Figure 32A). Further, anti-H2BK11ac
failed to react with the histone H2B peptide containing amino acids 12-21 with a
single acetyl mark at K16 (H2BK16ac peptide) or a yeast H4 peptide (amino acids
1-22) with a single acetyl mark at K5 (H4K4ac peptide). These data suggest that
anti-H2BK11ac specifically recognizes H2BK11ac and not just any acetyl-histone
epitope.
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Next, I decided to test the hypothesis that yeast H2B is deacetylated at K11
during yeast apoptosis. Nuclei were isolated from logarithmically-growing cells
treated with or without H2O2 before histones were extracted and probed by
immunoblotting using anti-H2BS10ph and anti-H2BK11ac antibodies (Figure
32B). H2B from logarithmically-grown WT yeast nuclei was recognized by antiH2BK11ac, but not by anti-H2BS10ph, demonstrating that H2BK11 acetylation is
found in growing yeast cells, as expected (Suka et al., 2001). In contrast, H2B
from H2O2-treated WT reacted strongly with anti-H2BS10ph, but not with antiH2BK11ac (Figure 32B). S10ph was only detected in H2O2-treated K11R, but not
in K11Q (Figure 32B), suggesting that H2BK11ac mark might interfere with the
onset of S10ph. Anti-H2BK11ac did not recognize either the K11R or K11Q
mutant (Figure 32B), likely due to the lost epitope. However, the H2B K16R
mutant displayed H2BS10ph and K11ac behavior (reactivity to both antibodies)
similar to WT cells (Figure 32B), suggesting that the induction of H2BS10ph is
not affected by acetylation/deacetylation at other known H2Bac sites.

In

addition, the global acetylation pattern of H3 and H4 appeared to remain the
same with or without H2O2 treatment, as judged by anti-H4ac and anti-H3K14ac
(Figure 32B), demonstrating that the H2O2-induced cell death may be specific for
H2BK11. These results provided us with an early hint that the changes in yeast
histone H2BK11ac and S10ph may be linked in a signaling pathway leading to
chromatin compaction during yeast apoptosis.
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Figure 32. Characterization of anti-H2BK11ac antibody
(A) ELISAs were performed using the H2BK11ac - specific antibody raised
against H2BK11ac peptide residues 8-17 (see Figure 31 for the sequence; Suka et
al., 2001). For indicated peptide competitions, antibody was incubated with 1
mg/ml competing peptide prior to dilution. Note that the anti-H2BK11ac
immunoreacted strongly with the H2BK11ac peptide (amino acids 1-20) or a H2B
peptide containing both S10ph and K11ac (amino acids 1-20).

Substrate

specificity is supported by competition assays showing that only H2BK11ac
peptide, and not the unmodified H2B peptide, competes for binding of the
antibody.
(B) Exponentially growing WT, H2B K11R, H2B K11Q and H2B K16R strains
were treated with 1 mM H2O2 for 200 min. Total nuclear protein was then
prepared from these cells before being resolved on SDS-PAGE gel for Western
analysis; blots were then probed with anti-H2BK11ac, anti-H2BS10ph, anti-H4ac,
anti-H3K14ac, and anti-H3. As expected, anti-H2BS10ph reacted strongly with
WT cells following oxidative stress. Note, in contrast, that anti-H2BK11ac only
reacted with nuclear extracts from untreated cultures, but did not react with
extracts from H2O2-treated cells. Characterization of this antibody suggests that
this failure of antibody reactivity is not due to “epitope disruption” (see above).
The level of anti-H4ac and anti-H3K14ac stayed constant in all the nuclear
extracts tested. Anti-H3 was used as a loading control.
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Figure 33. Cells exhibiting “deacetylation” of histone H2B at K11 display
TUNEL-positive DNA fragmentation
(A) Exponentially-growing WT, H2B K11R, and H2B K11Q strains were treated
with 1 mM H2O2 for 200 minutes. Half of the cells were double-stained with
TUNEL and anti-H2BS10ph after which cells were counterstained with DAPI for
DNA. Cells carrying the H2B K11R mutant displayed immunostaining patterns
similar to WT, while the K11Q mutant did not, suggesting that histone H2B K11
is deacetylated during H2O2-induced yeast apoptosis.
(B) Remaining cells from (A) were stained with Annexin V to measure the
externalization of phosphatidylserine (PS), an early marker of yeast apoptosis
(Koopman et al., 1994). 75% of WT cells and the K11R mutants displayed
externalization of PS, further confirming deacetylation of H2BK11 is required for
apoptosis.
(C) Nuclei were prepared from logarithmically-grown WT, H2B K11R, H2B
K11Q, and H2B K16R strains that were treated with or without acetic acid, and
resolved on SDS-PAGE for Western analysis using anti-H2BK11ac, antiH2BS10ph, anti-H4ac, and anti-H3. Identical patterns of H2BS10ph and K11ac
upon H2O2 treatment (see Figure 32B) were observed with acetic acid. Anti-H3
was used as a loading control.
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Cells exhibiting deacetylation of histone H2B at lysine 11 display apoptotic
phenotypes
To confirm that deacetylation of H2B at K11 occurs specifically in apoptotic cells,
H2O2-treated yeast cells were double-stained with TUNEL and anti-H2BS10ph
antibody, and examined by immunofluorescence (IF). In accordance with the
loss of cell viability after treatment with H2O2, about 75% of WT cells showed
TUNEL staining, a hallmark of apoptosis (Figure 33A). Consistent with my
previous findings in Chapter 2, 100% of the TUNEL-positive cells were costained with anti-H2BS10ph, indicating that apoptotic DNA fragmentation
correlates precisely with H2B phosphorylation at S10 (Figure 33A). Similar
positive staining patterns were observed with the K11R (70% TUNEL staining
and anti-H2BS10ph staining; Figure 33A). However, K11Q mutants lacked both
apoptotic DNA fragmentation and S10ph, even following H2O2 treatment (20%
TUNEL staining and anti-H2BS10ph staining; Figure 33A), suggesting that
histone H2B must be deacetylated at K11 in a pathway linked to the formation of
condensed

apoptotic

chromatin.

Furthermore,

translocation

of

phosphatidylserine (PS) from the inner to the outer leaflet of membrane, an early
event of apoptosis detected by Annexin V staining (Koopman et al., 1994), was
prevented in the H2B K11Q mutants (Figure 33B). In contrast, 80% of WT cells
and the K11R mutants displayed externalization of PS. These results further
confirm that deacetylation at H2BK11 is required for these apoptosis-like
properties in yeast.
Because acetic acid can also induce yeast apoptosis (Ludovico et al., 2001;
Madeo et al., 1999; Figure 19), I asked whether this apoptotic stimulus could
induce the deacetylation of H2BK11. Exponentially-growing WT cells were
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incubated with acetic acid, and nuclear extracts were prepared and subjected to
SDS-PAGE for Western analysis. As shown in Figure 33C, acetic acid treatment
lead to deacetylation at K11 and phosphorylation at S10, demonstrating that the
“off/on” behavior of these chromatin marks is induced by a wide range of
apoptotic stimuli.

H2B lysine 11 deacetylation is upstream of serine 10 phosphorylation during
yeast cell death
To determine if an ordered hierarchy existed between H2BK11ac and S10ph, WT
cells, induced to undergo apoptosis with H2O2, were harvested at various
intervals for Western blot analysis. As shown in Figure 34, logarithmically
growing yeast cells contained acetylated H2B at K11 and this mark was present
through 60 minutes of H2O2 treatment. However, after 90 minutes post H2O2
H2O2
min:
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Figure 34.

Deacetylation of H2B lysine 11 precedes H2B serine 10

phosphorylation
Logarithmically-growing WT cells were harvested after treatment with H2O2
at the indicated times and their nuclear extracts were assayed by Western
analysis using anti-H2BS10ph or anti-H2BK11ac.

After H2O2 treatment,

progressive deacetylation of K11 coincides with the progressive increase in
S10ph. Anti-H3 was used as a loading control.
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Figure 35.

H2B lysine 11 deacetylation is upstream of H2B serine 10

phosphorylation during yeast apoptosis
A, B, and C) Exponentially-growing yeast strains were treated with 1 mM H2O2
for 200 minutes and tested for cell survival (A), cell death (B) and histone
modifications as probed by modification-selective antibodies (C).

Double

mutants, carrying either H2B S10A or ste20∆ with K11R or K11Q, displayed
comparable cell viability and cell death similar to single mutants containing H2B
S10A or ste20∆. Together, these results suggest that K11 deacetylation and S10ph
act in the same pathway leading to cell death. (C) Immunoblots containing
indicated nuclear extracts were probed with anti-H2BS10ph, anti-H2BK11ac, and
anti-H3. H2BK11ac was present in logarithmically-growing cells, but not in
H2O2-treated single mutants carrying H2B S10A or ste20∆. None of the double
mutants carrying either H2B S10A and K11R or K11R and ste20∆, reacted with
anti-H2BS10ph or anti-H2BK11ac.
(D) WT and H2B-mutant yeast strains were grown on YPD agar plates in the
absence of H2O2. H2B S10E mutant, and the double mutant carrying both H2B
S10E and K11R or K11Q displayed growth defects, even without H2O2.
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induction, the disappearance of K11ac coincided with the onset of S10ph in H2B
(Figure 34).

Thus, it seems likely that H2B phosphorylation occurs after

deacetylation of H2BK11 in yeast apoptotic pathway.
Yeast strains carrying mutations that either lack the S10ph site (S10A) or
catalytic enzyme (ste20∆) were combined with K11R or K11Q mutations to
further assess the sequence of these covalent histone modifications during yeast
apoptosis. Cells were treated with 1 mM H2O2 for 200 minutes before cell
survival was measured by a plating assay and cell death by phloxin B staining.
Although low cell viability was observed with K11R, the double mutants
carrying either S10A or ste20∆ in combination with K11R displayed similar
resistance to H2O2 as single mutants with S10A or ste20∆ (Figure 35A and 35B).
Moreover, no difference was observed between double mutants carrying both
K11Q and S10A or K11Q and ste20∆, as compared to each respective single
mutant with regard to survival properties (Figure 35A and 35B). Next, the level
of H2B phosphorylation and acetylation were assayed by immunoblotting. As
expected, no signal was detected by anti-H2BS10ph with H2O2-treated yeast
double mutant carrying both H2B S10A or ste20∆ and each respective single
mutant (Figure 35C). Consistent with the acetylation pattern of WT cells,
untreated nuclear extracts of H2B S10A or ste20∆ or the double mutant carrying
both mutations reacted strongly with anti-H2BK11ac (Figure 35C), suggesting
that K11ac is not dependent on S10ph by Ste20. Upon H2O2 treatment, only WT
nuclear extracts displayed S10ph. K11ac was lost in all the mutants as well as
WT (Figure 35C).

This result further demonstrates that the inability to

phosphorylate S10 does not interfere with the deacetylation of H2BK11, hence
hinting that K11 deacetylation is upstream of S10ph during yeast apoptosis.
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If the deacetylation of K11 is upstream of S10ph, one would expect that
the slow growth of the phospho-mimic of H2BS10 (S10E), would be unaffected
by a K11R mutation. As expected from cell viability assays and Western blots
(Figure 35A and 35C), double mutants carrying either K11R or K11Q combined
with S10E grew poorly on YPD agar plates even without H2O2 treatment, and
displayed growth levels similar to a S10E mutant (Figure 35D). Thus, these data
indicate that deacetylation of K11 is upstream of S10ph.

Hos3 is the HDAC for acetylated histone H2B lysine 11 during yeast apoptosis
To identify the HDAC responsible for deacetylation of H2BK11 during yeast cell
death, I surveyed HDAC knockout yeast strains and measured their cell viability
after H2O2 treatment. Yeast strains lacking Rpd3 (rpd3∆), Hda1 (hda1∆), or Hos3
(hos3∆) were resistant to H2O2 (Figure 36A and 36B), implicating them as possible
H2BK11 HDAC candidates. For further analysis, nuclear extracts were prepared
from rpd3∆, hda1∆, or hos3∆ and tested by immunoblotting with anti-H2BK11ac
and anti-H2BS10ph. As shown in Figure 36C, Hos3 was identified as the HDAC
for K11, since only the HOS3 deletion strain failed to remove the K11ac mark
after H2O2 treatment. Moreover, the death-related H2BS10ph signal was lost in
hos3∆, further supporting that the deacetylation of K11 by Hos3 is upstream of
S10ph during yeast apoptosis.

Hos3 deacetylates H2B lysine 11 in vitro
To further establish a direct role for Hos3 during H2O2-induced yeast cell death,
full-length Hos3 (Hos3), full-length Ste20 (Ste20) and a kinase-dead form of Ste20
(KD; catalytically inactive point mutation K646R), were expressed in bacteria as
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Figure 36. Hos3 deacetylates H2B lysine 11 during hydrogen peroxide-induced
yeast apoptosis
Yeast HDAC knockout strains were treated with H2O2 and tested for cell survival
(A) and cell death (B). Possible HDAC candidates included: Rpd3, Hda1, and
Hos3 since their knockout mutants displayed cell viability similar to H2B S10A.
(C) Yeast nuclear extracts from H2O2-treated or untreated WT, rpd3∆, hda1∆, and
hos3∆ were probed with anti-H2BS10ph and anti-H2BK11ac. Only the HOS3
deletion strain fails to remove the acetyl mark on K11 upon H2O2 treatment.
Moreover, the death-related H2BS10ph signal was not detected, suggesting that
deacetylation of K11 is upstream of S10ph during H2O2-induced yeast apoptosis.
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GST-fusions and purified for both HDAC and kinase assays. The HDAC assay
was carried out with recombinant Hos3 and various combinations of H2B
peptides at 37°C for 1 hour (Figure 37A). An ordered series of H2B peptide
(amino acids 1-20) substrates for these reactions included: unmodified, S10ph,
K11ac, or dual-modified at S10ph and K11ac. After quenching the reaction, the
peptide substrate was extracted and the recombinant Ste20 was added for the
kinase reaction. An identical in vitro kinase reaction was performed as described
in Chapter 2. The kinase activity was assayed by measuring the incorporation of
the g[32P] label into peptide substrates (Figure 37A). In the absence of Hos3, Ste20
alone phosphorylated unmodified H2B peptide, but not H2B peptides containing
either S10ph, K11ac or both modifications (Figure 37B). In contrast, g[32P]
incorporation with the K11ac peptide was significantly increased after the
addition of both Hos3 and Ste20, supporting the idea that deacetylation of K11
by Hos3 is necessary for Ste20 mediated S10ph. (Figure 37B). Ste20 was not able
to phosphorylate S10 in the K11ac peptide when inactive Hos3 was used in the
HDAC reaction (Figure 37B). Therefore, these data support that Hos3 is an
HDAC responsible for the dephosphorylation of H2B at K11.
The status of deacetylation and the phosphorylation on H2B peptides after
the HDAC and kinase reaction were further verified by MALDI-TOF mass
spectrometry with the help of Robert Diaz (Figure 37A). Initially, each H2B
peptide tested displayed a sharp peak at the position corresponding to their
expected molecular mass. For example, unmodified H2B peptide displayed a
mass peak at 2721 Da (H2BS10K11 in Figure 37C), H2BS10ph peptide at 2801 Da
(H2BS10ph in Figure 37C), H2BK11qc peptide at 2762 Da (H2BK11ac in Figure
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Figure 37. Hos3 deacetylates H2B lysine 11 and promotes H2B serine 10
phosphorylation by Ste20 in vitro
(A) Schematic delineation of an in vitro HDAC and Kinase reactions. First, a
HDAC reaction was carried out by incubating recombinant active (Hos3) or
inactive Hos3 (Dead) with indicated H2B peptides as substrates. The peptides
were then extracted and incubated with the recombinant active (Ste20) or
inactive Ste20 (KD; Ste20K646R) for a kinase reaction. When g[32P]ATP was used as
phosphate source, the kinase activity was assayed by measuring incorporation of
the g[32P]ATP label into peptide substrates by scintillation counting (cpm). For
non-radioactive reactions, unlabeled ATP was used instead, and the status of
peptide was verified by MALDI-TOF mass spectrometry. As controls, the
HDAC and kinase reactions were performed with Hos3 or Ste20 enzyme alone.
(B) In vitro HDAC reactions were followed by kinase reactions and carried out
using indicated H2B peptides as substrates. For the HDAC reaction, peptides
were incubated with recombinant Hos3, or Hos3 inactivated by boiling. After
quenching the HDAC reaction, a kinase reaction was performed with
recombinant Ste20 at 30 °C for 1 hour in the presence of g[32P]ATP. The kinase
reaction was stopped with the addition of phosphoric acid and spotted onto the
filter paper; incorporation of [32P] on the substrate peptide was measured by
scintillation counting. When H2BK11ac peptide was used as the substrate,
incubation with both Hos3 and Ste20 yielded a significant increase in [32P] count
compared to its incubation with Ste20 alone.
(C) Assays were performed as in (B), except that the in vitro kinase assay was
carried out using a non-radioactive ATP as phosphate source. After HDAC and
kinase reactions, the substrate peptides were analyzed by MALDI-TOF mass
spectrometry. The appearance of a peak at 2721 Da corresponds to unmodified
H2B peptide (H2BS10K11), at 2762 Da corresponds to acetylated K11
(H2BK11ac), at 2801 Da corresponds to phosphorylated S10 (H2BS10ph), and at
2843 Da corresponds H2B peptide containing dual modification of S10ph and
K11ac (H2BS10phK11ac). All peptides tested contain amino acids 1-20 from
yeast H2B.

The addition of both Hos3 and Ste20 caused loss of peaks

corresponding to unmodified and K11ac, but an increase of S10ph when H2B
K11ac was used as a peptide substrate.
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37C) and H2B peptide containing dual modification of S10ph and K11ac at
2843 Da (H2BS10phK11ac in Figure 37C). While Ste20 kinase was able to
phosphorylate S10 in the unmodified peptide, it was unable to phosphorylate
the same peptide acetylated at K11 (Figure 37C), further confirming that the
acetyl mark on K11 inhibits H2BS10ph.

As expected from my in vivo

experiments (Figure 36C), Hos3 can deacetylate K11ac peptide, but not the
unmodified or S10ph peptides (Figure 37C). In addition, I observed a loss of
peaks corresponding to the unmodified and K11ac, and the emergence of a
new peak at the expected mass for the H2BS10ph after sequential addition of
Hos3 and Ste20 to the K11ac peptide (Figure 37C). Interestingly, with the
H2B peptide containing both modifications of S10ph and K11ac, its mass
profile remained the same even after incubation with Hos3, Ste20, or both
enzymes (Figure 37C). These results are consistent with the notion that that
K11ac and S10ph do not co-exist on the same H2B as part of signaling
pathway leading to chromatin compaction during yeast apoptosis. Instead,
my in vivo and in vitro data are most consistent with the idea that H2BK11ac
mark is removed by Hos3 and effectively creates a substrate for Ste20 kinase
to mediate H2BS10ph during yeast apoptosis (see Discussion and Figure 38).
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Discussion
“Cross-talk” between histone modifications postulates that covalent
modifications can “communicate” between each other to specify unique
downstream functions (Fischle et al., 2003a).

Indeed, emerging evidence

documents that histone modifications, often adjacent or nearby one another
within a single histone tail, serve to regulate important signaling events that
ultimately govern downstream chromatin and chromosome function (Fischle et
al., 2003a). Perhaps the best documented cross-talk events are those that occur
on a short stretch of the histone H3 tail, including various combinations of
acetylation, methylation and phosphorylation marks on residues K9, S10 and
K14 (Barratt et al., 1994; Cheung et al., 2000; Fischle et al., 2005).
Here, I extend this phenomenon by uncovering a cross-talk relationship
between two neighboring residues within H2B that play an essential role in
regulating yeast apoptosis, K11ac and S10ph. In keeping with earlier findings
(Suka et al., 2001), H2BK11ac is found in asynchronously-growing yeast cells.
However, I demonstrate that this mark blocks Ste20’s ability to phosphorylate its
adjacent site, S10 (Figures 35 and 37). I further demonstrate that deacetylation of
K11 occurs upon oxidative stress (H2O2), mediated by the HDAC Hos3, an event
upstream of H2BS10ph in yeast’s apoptotic cascade (Figure 36). In addition,
K11Q, an acetyl-site mimic mutant, failed to activate the apoptotic pathway even
in the addition of H2O2, whereas K11R, a mutant that can not be acetylated,
displayed pronounced apoptotic features and induced H2BS10ph upon H2O2
treatment (Figures 31 and 33). Based upon these findings, I propose a model for
regulated cross-talk in H2B wherein Hos3 directly catalyzes the deacetylation of
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H2BK11 that, in turn, mediates H2BS10ph by Ste20 kinase during H2O2-induced
yeast cell death (see Figure 38).

AC

1. NH2-…AEKKPASKAPA…
10

+ H2O2

Hos3
AC

2. NH2- …AEKKPASKAPA…
10

Ste20

P

3. NH2-…AEKKPASKAPA…
10

Figure 38. Model for histone H2B “phos/acetyl cross-talk” (S10/K11) during
hydrogen peroxide-induced yeast apoptosis
K11 in H2B is acetylated in exponentially-growing yeast cells. Upon H2O2
treatment, Hos3 HDAC directly catalyzes the deacetylation of H2BK11. This in
turn, mediates H2BS10 phosphorylation by Ste20 kinase, which then leads to the
activation of the yeast apoptotic cascade. We envision that deacetylation of K11
is required for H2BS10 phosphorylation (see text and discussion for details).
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Hos3 is the HDAC for lysine 11 during H2O2-induced yeast apoptosis
HDACs, such as Rpd3, Hda1 and Hos3, are members of large, multi-protein
complexes, which require specialized subunits within each complex for activity
of the catalytic subunit (Rundlett et al., 1996; Kasten et al., 1997; Suka et al., 1998).
Unlike Rpd3 and Hda1, Hos3 has intrinsic catalytic activity as a homodimer
when expressed in Escherichia coli in the absence of other deacetylase complex
components (Carmen et al., 1999). Early in vitro studies have suggested that
Hos3 has specificity for various sites in each of the core histones, including H2B
site at K11. Here, I demonstrate that Hos3 has histone deacetylase activity
specifically on H2BK11 during H2O2-induced yeast apoptosis in vivo (Figures 36
and 37).
Interestingly, Rpd3 and Hda1 are also involved in H2O2-induced yeast
apoptosis according to the cell survival assay (Figure 36). Although these
HDACs have been shown to deacetylate H2BK11, as well as other acetylation
sites in H3 and H4, during transcriptional repression (Suka et al., 2001; Wu et al.,
2001), they do not seem to exhibit HDAC activity towards histone H2BK11
during yeast apoptosis. Rpd3 and Hda1 may deacetylate other histone or nonhistone substrates that play an indirect role in yeast apoptosis. Since both Rpd3
and Hda1 regulate transcriptional silencing (Rundlett et al., 1996; Rundlett et al.,
1998; Wu et al., 2001), they may, for example, repress transcription of an
apoptotic regulator(s) that, in turn, acts in the apoptotic pathway.

The existence of “cross-talk” between H2B serine 10 and lysine 11
In this chapter, I provide in vivo and in vitro evidence for cross-talk between two
histone neighboring residues (S10 and K11 of H2B) acting in a poorly
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appreciated pathway leading to chromatin condensation in dying yeast cells as
result of oxidative stress stimuli. My combined kinetic, biochemical and genetic
experiments suggest that a pre-existing K11ac mark antagonizes Ste20-mediated
phosphorylation at S10 in H2B. Moreover, I have identified Hos3 as a H2B K11
deacetylase that is induced upon oxidative stress and functions to remove this
antagonistic acetyl mark from the H2B tail.
As shown in Figure 31A, numerous lysines are found around the
mammalian H2BS14, a previously-characterized apoptotic phosphorylation site
mediated by Mst1 kinase (Cheung et al., 2003) that in many ways acts similarly
to S10 in yeast H2B. In particular, K15, located adjacent to S14, is acetylated in
asynchronously-growing HeLa cells (Thorne et al., 1990) reminiscent of
H2BK11ac in growing yeast (Suka et al., 2001).

I suggest the intriguing

possibility that phos/acetyl cross-talk also exists in mammalian cell H2B
between S14 and K15.

Role of H2BK11 acetylation/deacetylation
Previously, H2BK11 has been identified as one of the acetylation sites that
correlate closely with euchromatin formation during transcriptional activation
(Suka et al., 2001). Here, I have shown that deacetylation of H2BK11 correlates
with the activation of the yeast apoptotic pathway including DNA fragmentation
and chromatin compaction. Interestingly, H2B K11R, which is generally believed
to mimic the deacetylated state of K11, did not display any growth defect (data
not shown).

One potential explanation for this observation is that other

potentially-redundant acetylation sites may compensate for the loss of
H2BK11ac. In growing yeast, at least six lysines is reported to be acetylated in
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yeast core histones (Waterborg, 2000), and many of these sites of acetylation have
been mapped using site-specific antibodies (Suka et al., 2001). Other studies
have suggested that more flexible acetylation “charge patches” may govern
chromatin function, which are not tied to specific residues (Dion et al., 2005; Ren
and Gorovsky, 2001). My studies, however, provide a suggestion that H2BK11ac
may serve a negative role governing H2BS10ph that is not provided by other
acetylation sites such as H2BK16ac.

The recent evidence of methyl/phos

“switches” on H3K9me and H3S10ph (Fischle et al., 2005) lend support to the
general concept that adjacent modification, or those that are extremely close
within a short stretch, may be more attractive candidates for potential histone
cross-talk regulation.
In summary, my studies provide in vivo evidence for histone modification
cross-talk between H2BS10ph and K11ac. Not only do my results further
elucidate the budding yeast apoptotic signaling mechanism by defining a novel
role of Hos3 and deacetylation of H2BK11, but also underscore a critical
interplay between different histone modifications on multiple structural and
functional levels.
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Materials and Methods
Plasmids, Yeast strains and Culture Conditions
Plasmid pQQ18 (CEN LEU2, CEN, HTA1-HTB1-HHF2-HHT2) was used to
generate histone mutant plasmids; pSA70 (htb1-K11R), pSA71 (htb1-K11Q),
pSA72 (htb1-S10A K11R), pSA73 (htb1-S10A K11Q), pSA74 (htb1-S10E K11R),
pSA75 (htb1-S10E K11Q), pSA76 (htb1-K16Q), pSA77 (htb1-K16R), pSA78 (htb1S10A K16R). These mutants were created by PCR and sub-cloned into pQQ18 as
previously described in Mutations in histone genes (Chapter 2; Materials and
Methods).
Yeast strains are listed in Table 1 and all strains are derived from S288C
(BY4741; Research Genetics) background. Strain JHY205 was used to shuffle in
plasmids containing histone H2B K11 or H2B K16 mutations (pSA60 through
pSA68) using 5-FOA as a counterselecting agent for the URA3 plasmid. SAY191,
a double mutant carrying both H2B K11R and ste20D::kanMX6, was created by
transforming pSA60 plasmid into SAY148 (ste20D::kanMX6). Transformation of
yeast cells was performed by the lithium acetate procedure, as described in Yeast
transformation (Chapter 2; Materials and Methods).

Test for Apoptosis
Yeast apoptotic induction by H2O2 and acetic acids were carried out as described
in Yeast culture conditions (Chapter 2; Materials and Methods).

The cell

survival, cell death analysis, TUNEL staining and immunofluorescense were
done as described (Chapter 2; Materials and Methods).

159

Yeast Nuclei and Histone Extraction, and Western Blot
Yeast nuclei were prepared before histones were extracted as described in
Chapter 2. Approximately 1.5 mg of yeast histone proteins were analyzed by
SDS-PAGE on 8% or 15% gels followed by Western blot analysis.

HRP-

conjugated rabbit secondary antibody (Amersham Pharmacia) was used. For
chemiluminescence, the ECL plus kit (Amersham Pharmacia) was used for
detection. For alkaline phosphatase (AP) treatments, histones were incubated
with 1 mL of shrimp alkaline phosphatase (Promega) at 37°C for 2 hr, boosted
with another 1 mL of enzyme, and then the incubation continued for another 1-2
hr. Six times concentrated Laemmli sample buffer was added to stop the
reaction.

Peptides Synthesis
H2B peptides (amino acids 1-20 from yeast; SAKAEKKPASKAPAEKKPAA)
were synthesized at the Rockefeller University Proteomics Resource Center.
These peptides include; unmodified, phosphorylated at S10, acetylated at K11, or
dual-modified at S10ph and K11ac.

These peptides contain an artificial

biotinylated residues at position 21 for linking to streptavidin beads or
fluorescent dye.

HDAC and Kinase Assays and MALDI-TOF
GST-Ste20 and GST-Ste20K649R were purified as previously described in Chapter 2.
The full-length Hos3 gene was cloned as described in Carmen et al., 1999. First,
Hos3 was amplified by PCR, using oligonucleotide primers that added Bam HI
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and Sma I sites then cloned into the Stratagene E. coli expression vector pCALn.
The resulting plasmid was transformed and expressed in the E. coli strain
BL21(DE3)pLysS. Cells with the HOS3 enzyme or vector alone were grown at
37° C in 2 liters of LB liquid medium plus ampicilin to OD600 0.4 and then
induced with 1 mM isopropyl b-D-thiogalactoside for 2 hr at 30° C. Cells were
harvested and resuspended in lysis buffer (50 mM Tris-HCl, pH 8, 250 mM NaCl,
2.5 mM DTT, 1.0 mM magnesium acetate, 1.0 mM imidazole, 2.0 mM PMSF) at
4°C. Cells were lysed by sonication and then centrifuged in a Beckman 45Ti
rotor at 40,000 rpm for 45 min. The fusion protein was affinity-purified on
calmodulin affinity resin (Stratagene) according to the manufacturer’s
instructions except that the wash and elution buffers contained 400 mM NaCl.
This material was concentrated in vacuum dialysis in buffer DBHS (50 mM Tris,
pH 8.0, 500 mM NaCl, 10 mM ZnCl2, 2.5 mM DTT). The concentrated enzyme
was purified further on a Superdex-200 column in the DBHS buffer. Hos3 was
boiled for 30 min to inactive the enzyme.
HDAC reaction was carried out before the kinase reaction. HDAC assay
was carried out as described in Carmen et al., 1999. 2 mg of recombinant active or
inactive HOS3 enzyme was incubated with various histone substrates (5 mg) in a
40 ml reaction containing: 75 mM Tris-HCl, pH 7.0, 275 mM NaCl, 2.0 mM 2mercaptoethanol, and 0.1 mM EDTA. The reactions were incubated at 30°C for 2
hr before adding 1 M HCl and 0.16 M acetic acid (50 ml). The peptide substrate
was extracted and the recombinant Ste20, Ste20K649R (KD), or no enzyme was
added for the kinase reaction as indicated. Kinase assays were performed as
described in Chapter 2. The reaction mixture was removed and spotted onto P81
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filter paper.

The filter paper was then washed, dried and subjected to

scintillation counting.
Analysis of histone peptides was performed after the HDAC and kinase
reactions as described above, except this time, unlabeled ATP was used instead
of [32P]-g-ATP for the kinase reaction. 0.5 ml alpha cyano-4-hydroxycinnamic acid
(HCCA) was spotted on a Maldi plate followed by 2 ml of each reaction, and
analyzed on a Voyager DE-STR (Applied Biosystem) on reflector mode.
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CHAPTER 4

THE ROLE OF THE H2B SERINE 10 PHOSPHORYLATION
IN CHROMATIN FIBER FOLDING

Introduction
The chromatin fiber is a dynamic macromolecular entity that is intimately
involved in nuclear functions. Chromatin fiber allows the compression of meters
of DNA molecules into a few micrometers of a cell’s nucleus.

This is

accomplished by the folding of nucleosomes in 10 nm “bead-on-a-string”
conformation into the 30-nm or condensed chromatin fiber (Figure 1). Once
thought of solely in terms of chromosomal DNA packaging in the nucleus,
chromatin fiber condensation is now recognized as having widespread biological
functions, such as DNA replication, mitosis, meiosis, DNA repair and apoptosis
(Fletcher and Hansen, 1996; Annunziato and Hansen, 2000). For example, the
conformational dynamics of the chromatin fiber yields heterochromatin and
euchromatin, which serve as a platform for transcriptional repression and
activation in dividing cells (Rusche et al., 2003; Alvarez et al., 2003). Unique
chromatin changes reminiscent of chromatin fiber compaction are also observed
during apoptosis (Chapter 2), but the molecular determinants and mechanisms
responsible for chromatin fiber dynamics remain elusive.

163

In order to understand the mechanism of chromatin condensation, the in
vitro self-assembly system for nucleosome array is commonly used; recombinant,
histone proteins that lack post-translational modification are combined with
DNA of defined-sequence and undergo a reversible cation-dependent
compaction in response to change in solution conditions (Hansen et al., 1989;
Garcia-Ramirez et al., 1992; Schwarz and Hansen, 1994). Since the degree of
chromatin fiber compaction depends strongly on the valency (mono or divalent
cations) and concentration of salt present in the buffer (Ris and Kubai, 1970), it
may be measured by a sedimentation velocity experiment using analytical
ultracentrifugation following changes in the sedimentation coefficient upon
addition of salt (Hansen et al., 1989). For divalent cations, concentrations in the
1-2 mM range are sufficient to induce compaction equivalent to that of the
compacted 30-nm chromatin fiber, whereas monovalent ions compact the
chromatin fiber at a 100 mM concentration (Hansen et al., 1989; Garcia-Ramirez
et al., 1992; Schwarz and Hansen, 1994). As removal of salt re-establishes a single
10-nm diameter decondensed chromatin fiber (Hansen, 2002), all the transitions
in the folding and self-association pathway are apparently reversible. Thus, the
mechanisms and determinants of chromatin fiber dynamics characterized in this
in vitro system have some relevance to in vivo events.
The consequences of histone modification on chromatin fiber are likely to
be of key importance in regulating the folding of chromatin. In the case of
hyperacetylation, it has been suggested that charge neutralization in structurally
important regions of the histone tail offers a direct link to euchromatin structure
(Tse et al., 1998; “cis” mechanism; Figure 6A).

Although, most other

modifications still lack a complete mechanistic explanation, it is generally
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assumed that they serve as recognition modules for chromatin modification
factors such as remodeler complexes, heterochromatin propagating proteins or
the transcription machinery (Fischle et al., 2003b; “trans” mechanism; Figure 6B).
In support of the cis mechanism of histone tail function, Dr. Timothy Richmond’s
group (ETH Zurich, Switzerland) has shown that a “basic patch” of the H4 tail
(residues 14-19) is sufficient to induce condensed chromatin structures (Dorigo et
al., 2003). This result suggests that histone tails can directly establish the
internucleosomal contacts and histone/DNA interactions that mediate chromatin
condensation. This study elegantly demonstrated for the first time that histone
tails are critically required for full fiber folding using the in vitro nucleosome
array system, however, the influence of covalent histone modification within this
basic stretch was not addressed. Recently, the acetylation of H4K16 was found to
directly contribute to the decondensed chromatin in vitro (Shogren-Knaak et al.,
2006). Taken together, these results reinforce that the covalent modification
status of the core histone tail domains can regulate the higher-order chromatin
structure.
As discussed in Chapter 2, yeast cells carrying a phospho-mimic H2BS10
mutation (S10E), but not a non-phospho mimic H2B S10A mutation, induced
“constitutive” formation of condensed chromatin, suggesting that H2BS10ph
mediates the chromatin condensation, a hallmark of apoptosis. In this chapter, I
sought to gain a mechanistic insight into chromatin compaction mediated by
H2BS10ph. I have found that peptides corresponding to the phosphorylated
form of yeast H2B and human H2B (phosphorylated at S10 and S14, respectively)
have the intrinsic mobility retardation in SDS-PAGE gel in accordance with cis
mechanism (Cheung et al., 2003; Figure 39). This peptide mobility retardation
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and cell death/apoptotic chromatin condensation function of H2BS10ph is
dependent on the close proximity of proline residues (P8 and P13 in yeast H2B).
In addition, in vitro nucleosome arrays carrying yeast H2B S10E or human H2B
S14E affect nucleosomes to form the compacted chromatin fiber, as measured by
analytical ultracentrifugation. This compaction is not dependent on linker
histone H1, which was previously shown to influence the formation of chromatin
fiber. Interestingly, the H2B N-terminus (amino acids 2-16) appears to function
as a modular signaling “cassette,” since S10A and S10E H2B point mutations
function in the context of a new histone tail as well as they do in the natural H2B
tail. Together, these results support the idea that H2BS10ph plays a role in
mediating chromatin condensation.
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Results
H2BS10ph peptide displays an intrinsic “aggregation” property in vitro
Mammalian H2BS14ph peptide has been reported to migrate slower than its
unmodified counterpart on a standard SDS-PAGE gel (Cheung et al., 2003).
Since both yeast and mammalian H2B phosphorylation (S10 and S14,
respectively) correlate with apoptosis in each respective organism, I decided to
test whether this unusual migration property in H2BS14ph peptide extends to
yeast H2B peptide. To this end, the unmodified and the H2BS10ph (amino acids
4-14) peptides were resolved on a 12% SDS-PAGE gel followed by coomassie
staining. Similar to H2BS14ph peptide, H2BS10ph peptide showed slower
migration compared to its unmodified counterpart (Figure 39B). The unmodified
peptide migrated to a band corresponding to the expected molecular weight of
the peptide (Figure 39B). To determine whether the high mobility bands are
strictly due to the phosphate group, I treated yeast H2BS10ph and mammalian
H2BS14ph (amino acids 6-16) peptides with shrimp alkaline phosphatase (AP)
for 3 hours at 37°C, and re-electrophoresed them on a SDS-PAGE gel. As shown
in Figure 39B, all of the high mobility bands in S10ph and S14ph peptides
collapsed back to the expected size of the peptide, suggesting that the
phosphorylation of the target serine contributes to these shifts. However, this
shift was not common in all phosphorylated histone peptides as demonstrated
by the absence of higher mobility bands in H2BS32ph, H2BS33ph, or Htz1S132ph
peptides (Figure 39A). Therefore, this unique migration property exists only in
our “apoptotic” phospho-serine H2B peptides.
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Figure 39. “Death”-inducing phospho-peptides contain an intrinsic selfaggregation property in vitro
(A) List of peptide sequences and the status of their aggregation property.
Apoptotic-inducing phospho-peptides, such as human H2BS14ph and yeast
H2BS10ph, migrate anomalously in SDS-PAGE gels, a phenomenon we refer to
as self-aggregation. This property is also observed with peptides containing
glutamic acid in place of S10 (H2B S10E), or H3S28ph, a site followed by alanine
and proline residues (labeled “YES” under “Aggregation.”) No other phospho
histone peptide tested in this manner displayed this aggregation property,
including a similar phospho-peptide from the C-tail of yeast Htz1 and the
H3S10ph, which lacks an AP sequence (labeled “NO” under “Aggregation.”)
When all prolines in the phospho-yeast H2B peptides were re-synthesized as
alanine, aggregation is not observed.

There, both phosphorylation and

proximity to AP residues contribute to peptide aggregation. Note the strict
correlation between peptide aggregation in this assay and in vivo chromatin
condensation in yeast H2B S10A and S10E mutants.
(B) Various phosphorylated histone peptides listed above were incubated with
0.1 M DTT, then separated in standard SDS-PAGE gels following boiling in the
sample buffer containing reducing agents. The aggregation effect, as indicated
by higher molecular weight bands, (see red stars) is sensitive to alkaline
phosphatase (AP) treatment.
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Interestingly, yeast H3S28ph peptide displayed this unusual migration
property, whereas it was absent in H3S10ph peptide in the same SDS-PAGE gel
assay (Figure 39A). Although both H3 peptides contain identical –ARKS- motif,
the serine phosphorylation site followed by alanine and proline residues (“AP”
motif) are present in both H3S28ph and phospho-H2B peptides (see the yellow
box in Figure 39A). Other phosphorylated peptides, which failed to yield high
mobility bands, also lacked “AP” motif (H2BS32ph, H2BS33ph, or Htz1S132ph
peptides; Figure 39A), suggest that prolines may be crucial in this in vitro peptide
migration property. To test this hypothesis, a peptide with proline residues at 8th
and 13th surrounding yeast H2BS10ph with replaced alanine (P8A, H2BS10ph,
P13A H2B peptide) was subjected to same gel analysis. The unique migration
property was not observed with this peptide even though a single phosphate
was present at S10 (P8A, S10ph, P13A H2B peptide; Figure 39B). Therefore, the
phosphorylation serine site and the proximity to AP sequence contribute to in
vitro migration shift.
Next, I was curious whether the peptide containing glutamic acid in place
of S10, S10E, would yield as dramatic a shift as H2BS10ph. As expected, the high
mobility band was also observed with H2B S10E containing amino acids 4-14 of
yeast histone H2B (Figure 39B). In contrast, the peptide containing the alanine in
place of S10, S10A, displayed the band corresponding to the expected size of the
peptide (Figure 39B). These in vitro result correlates well with my in vivo results
(Figure 21). For example, H2B S10E displayed high mobility band in vitro, and
condensed chromatin in vivo. In contrast, H2B S10A lacked this mobility shift in
a peptide gel and conferred decondensed chromatin in vivo. Therefore, I
hypothesize that the high mobility bands are “aggregation” of potential
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secondary structure of H2BS10 or S14 that is dependent on the phosphate moiety
and prolines. The proposed secondary structure could be a helix and the multimer of helices formed by self-interaction of H2B tails, which then yields the high
mobility bands. In keeping with the cis mechanism, this direct interaction
between phospho-H2B tails in the nucleosome may be the mechanism to form
highly condensed chromatin as seen during apoptosis.

H2B proline mutants are resistant to hydrogen peroxide treatment
Phosphate-induced proline isomerization induces conformational changes in
protein/peptide structure to mediate biological functions in vivo (Lim and Ping,
2005; Smet et al., 2004; Schutkowski et al., 1998; Yaffe et al., 1997b). Given that
the occurrence of phospho-serine in conjunction with proline (H2BS14, H2BS10
and H3S28) can induce conformational changes in peptide structure (Figure 39), I
hypothesized that the prolines may be important for altering chromatin structure
as seen during apoptosis. For this purpose, two prolines, at amino acid position
8 and 13, surrounding yeast H2BS10 were separately mutated to alanine (H2B
P8A P13A; Figure 40A) and tested for cell survival/death upon H2O2 treatment
as described in Chapter 2 (cell survival was tested by plating assay, cell death by
phloxin B staining). This double mutant showed some resistance to H2O2
compared to WT or H2B S10A mutants (Figure 40B and 40C). While WT and
H2B S10A displayed 25% and 80% survival as judged by plating assays,
respectively, the proline mutants showed 70% cell viability (Figure 40B). The
proline mutants displayed 30% phloxin B stained cells compared with 70% for
WT and 20% for H2B S10A mutants (Figure 40C). In accordance with the cell
viability/death analysis, about 25-35% of H2B P8A P13A double mutants were
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Figure 40. Prolines in the yeast H2B “death motif”
Prolines in close proximity to S10 in H2B have an aggregation property in vitro
and a cell survival/death function in vivo.
(A) Two prolines, at amino acid position 8 and 13, found in the yeast H2B
“death motif” were separately mutated to alanine (H2B P8A P13A).
(B and C) H2B P8A P13A double mutants were tested for cell survival/death
upon H2O2 treatment (cell survival was tested by a plating assay; cell death by
phloxin B staining; See Figure 11 for detail). This double mutant shows some
resistance to H2O2 (60% survival, 30% death; see red arrows) compared to WT
(25% survival, 75% death) or H2B S10A mutants (80% survival, 20% death).
(D) H2O2 treated or untreated yeast cells were stained with TUNEL. In
accordance with the cell viability/death analysis, about 35% of H2B P8A P13A
double mutants were stained with TUNEL (compare 80% TUNEL for WT;
15% for H2B S10A mutant). The same cells were counterstained with DAPI.
for DNA.
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stained with TUNEL (compare 80% TUNEL for WT; 15% for H2B S10A mutant;
Figure 40D). Taken together, these results underscore the importance of proline
residues surrounding H2BS10ph during H2O2-induced yeast apoptosis. Since
proline-mediated isomerization leads to the alteration of protein/peptide
structure, prolines along with H2BS10ph may serve as a “facilitator” of
chromatin condensation.

Nucleosome arrays of yeast H2B S10E
To better understand the function(s) of histone H2B phosphorylation as it relates
to apoptotic-chromosome compaction, I used the self-assembly system of the
nucleosome array and in vitro chromatin-fiber folding assay. Dr. Timothy
Richmond’s laboratory at ETH Zurich, Switzerland had previously identified
that the basic path of H4 tails can induce condensed chromatin structures by
using these in vitro assays (Dorigo et al., 2003). I spent two and half months at
Dr. Richmond’s laboratory to learn these methods and to test whether yeast
H2BS10ph directly effects chromatin compaction in collaboration with Dr.
Richmond’s post-doc fellow, Dr. Thomas Schalch. Since the in vitro nucleosome
array constitutes recombinant, post-translationally unmodified histone proteins,
we decided to create nucleosome arrays containing yeast H2B S10E or H2B S10A.
We expressed yeast histone H2B protein containing glutamic acid or alanine as
the replacement of S10, and mixed them with the rest of yeast’s core histone
proteins to form functionally refolded histone octamers (Figure 41). Nucleosome
array reconstitution was achieved by mixing histone octamers containing
different H2BS10 mutations with the DNA array in high-salt buffer (2M KCl) and
slowly lowering the concentration of
173

KCl to 10 mM by dialysis against

Recombinant histones
Histone expression plasmids
Histone expression

H3

H4

H2B

H2A
Gel filtration
Ion exchange
(denaturing)

H3

H4

H2B

H2A

Refolding
Gel filtration

Histone octamer

Histone octamer

+

DNA array
Salt gradient
Reconstitution
HOS gel

Nucleosome array
Figure 41. Outline of the in vitro nucleosome array system
Recombinant, post-translationally unmodified, core histone proteins were
separately expressed in E.coli and mixed in equimolar amounts. These histone
mixtures were folded into histone octamer and combined with a DNA array
of defined sequence. The nucleosome array is reconstituted by series of salt
gradient dialyses, which brings the 2 M overall salt concentrations to 0.01 M.
The quality of nucleosome array is assessed by higher-order structure gel
(HOS gel). (modified from Dyer et al., 2004).
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decreasing levels of salt (Figure 41). This step-wise salt dialysis allowed the
deposition of one histone octamer per DNA repeat in an array by changing the
ionic strength of the reconstitution reaction. For my studies, I used 36 tandem
177 bp repeats of the 601 DNA array (36_177_601 DNA array). The 601 DNA
sequence which binds to histone octamers, contains repeats of alpha satellite
sequence used for the nuclear core particle crystallization (Lowary and Widom,
1998). This DNA array was found to be the ideal choice for the chromatin fiber
model because of its exceptional stability (Lowary and Widom, 1998). The repeat
length of 177 bp was chosen from a list of preferentially quantized linker DNA
lengths determined from a statistical analysis of nucleosome repeat lengths
(Widom, 1992). Hence, the nucleosome array reconstituted with this particular
DNA array yielded 36-nucleosome repeats of 601 DNA sequence with a repeat
length of 177 bp (Figure 42).
Tandem DNA array of a defined sequence
Histone octamers
Nucleosome

ScaI

Salt

Higher Order Structure (HOS)

Figure 42. Schematic delineation of chromatin higher-order structure
system
An array with tandem repeats of defined DNA sequence are combined with
histone octamers to yield higher-order structure or nucleosome array with
one histone octamer per DNA repeat.

A red arrow indicates the ScaI

endonuclease digest site found in a linker DNA. (adapted from Thomas
Schalch thesis, 2004).
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The biophysical properties of nucleosome array depend on the histone
octamer to DNA stoichiometry (Dorigo et al., 2003). Therefore, it is crucial to
find the ratio of histone octamers to DNA that would yield the homogeneous
nucleosome array with one histone octamer occupying each DNA repeat (see “an
ideal array” in Figure 43A). Histone octamer to DNA template stoichiometry
was evaluated by ScaI endonuclease digestion
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1
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0.8 0.8

Purification and stoichiometry of the in vitro assembled

nucleosome arrays
(A) Schematic delineation of nucleosome array after ScaI endonuclease
digestion. In an ideal case, after ScaI digest, the saturated array with the
correct

histone

octamer

to

DNA

template

stoichiometry

left

mononucleosomes and little or no free DNA. If lower amounts of histone
octamers are used for the nucleosome assembly compared to DNA template,
then a mixture of free DNA and mononucleosomes are observed after ScaI
digest, which is a non-ideal array.
(B) A native agarose-polyacrylamide composite gel of a 36_177_601
nucleosome array reconstitution with different octamer/DNA ratios and
following ScaI digestion. Purified 601 nucleosome arrays yield a band above
23 Kb (higher-order structure; HOS). Upon ScaI digest, an ideal array
displayed mononucleosomes (390 bp,), whereas nonideal array displayed
mixtures of mononucleosome and a visible band of free DNA (190 bp).
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polyacrylamide gel electrophoresis (APAGE). The nucleosome arrays contain a
ScaI restriction digest site in a linker DNA.

After ScaI digest, the full-length

arrays carrying one histone octamer per DNA repeat (occupied site) will be
release as mononucleosomes and the arrays lacking histone octamers in the DNA
repeat (unoccupied sites) as free DNA after ScaI digest (Figure 43A). The large
full-length arrays as well as mononucleosome and single, free DNA repeats are
visualized in APAGE. Run under denaturing conditions, the saturated array
with the correct histone to DNA stoichiometry leaves mononucleosomes and no
free DNA after ScaI digest (see left panel in Figure 43A). In contrast, free DNA is
dominantly present in the nucleosome array with mis-positioned histone
octamers after ScaI digest (see right panel in Figure 43A). Figure 43B shows the
assembly products generated with increasing ratios of the WT histone octamer to
DNA as well as corresponding ScaI digestion products. The undigested, large,
full-length nucleosome array, also known as a higher-order structure (HOS), was
displayed as a band above 23 Kb. Upon ScaI digest, I observed mixtures of bands
corresponding to mononucleosomes (390 bp) and free DNA (190 bp) with the
array prepared from a WT histone octamer to DNA repeat-stoichiometry of 0.8:1
(Figure 43B).

On the other hand, the ratio of 1:1 yielded a single band

representing mononucleosomes and left no free DNA (Figure 43B), indicative of
the ideal array with a single, well-positioned octamer per DNA repeat. By using
this analysis of ScaI digestion, the ratio of histone octamer to DNA was
determined for each of the H2B nucleosome arrays.
The sedimentation velocity by analytical ultracentrifugation was used to
measure the influence on chromatin compaction by H2BS10ph. The degree of
chromatin compaction depends strongly on the valency and concentration of salt
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in the buffer; concentrations in the 1-2 mM of MgCl2 divalent ion range are
sufficient to induce compaction whereas monovalent ions (KCl) partially
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Figure 44. Folding of nucleosome arrays containing yeast H2B mutants
(A) Sequence of yeast H2B WT, H2B S10A, and H2B S10E to be used in the
nucleosome array.
(B) Magnesium induced compaction of 36_177_601 was measured by
sedimentation velocity experiments. Each data point represents the mean
and standard deviation of 3 separate determinations of the sedimentation
coefficient. 40 S corresponds to decondensed chromatin state and 80 S for the
condensed conformation equivalent to a 30 nm diameter chromatin fiber.
While the nucleosome array containing H2B S10A displayed a similar
sedimentation pattern to WT, H2B S10E chromatin fiber reached 105 S,
indicating a highly condensed structure more compacted than the 30-nm
chromatin fiber.
(C) Potassium-induced compaction of 36_177_601 was measured by
sedimentation velocity experiments.

While the overall sedimentation

coefficient level was lower than those obtained with magnesium, the H2B
S10E chromatin fiber yielded the highest S20,w higher than WT or the H2B
S10A fiber, suggesting that H2BS10ph can directly mediate chromatin
structure and allow the formation of higher-order structures.
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compact the chromatin fiber at 100 mM concentrations (Hansen, 2002). For the
sedimentation velocity experiments, each of the nucleosome samples combined
with varying concentration of salt were centrifuged at 12,000 rpm at 20°C
collecting scans at 259 nm. We analyzed these data with the program, “Sedfit”
(Schuk, 2000), and the sedimentation coefficient (S20,w or S) was determined. This
coefficient reflects the status of the chromatin fiber; a low coefficient corresponds
to the decondesnsed state of chromatin fiber, with a high sedimentation
coefficient corresponds to the compacted state. The compact 30-nm chromatin
fibers observed in mitosis were correlated with a 80 S sedimentation coefficient.
In WT array, such structure was only formed when MgCl2 concentration was
raised to 1.2 mM (Figure 44A). Strikingly, H2B S10E mutant array formed a
structure equivalent to 30-nm even at the lowest MgCl2 concentration (0.2 mM).
When MgCl2 reached 1.2 mM, S10E array yielded a sedimentation coefficient
above 100 s, indicating a highly compacted structure (Figure 44A). In contrast,
the H2B S10A nucleosome array, the nonphospho-mimic of yeast H2BS10,
produced the same sedimentation coefficient as a WT nucleosome array (Figure
44A).

Previously, aggregation of chromatin was observed when the

concentration of salt is raised above the level required for compaction (Ris and
Mirsky, 1949; Olins and Olins, 1972; Schwarz et al., 1996). We found that
aggregation was consistently observed after 1.2 mM MgCl2 for all the arrays we
tested, suggesting that 1.2 mM is the solubility boundary. These results indicate
that the phospho-mimic S10E mutation causes a significant chromatin
compaction in vitro. Since S10E S 20,w is much higher than WT, the H2B S10E
nucleosome array could be more compacted than the 30-nm chromatin fiber seen
during prophase of mitosis.
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In our hands, the recombinant nucleosome arrays displayed compaction
behavior without aggregation between 0 and 100 mM KCl, the monovalent
cation salt (Figure 44B). The overall compaction levels achieved with KCl were
20 S lower than those obtained for the WT or H2B S10A array with MgCl2. As
shown in Figure 45B, the S20,w for the WT and H2B S10A array was lower than 80,
further supporting that arrays with KCl do not reach the fully compacted 30-nm
chromatin fiber state. In contrast, H2B S10E array formed highly compacted
chromatin fibers in the presence of monovalent cations, as demonstrated by 90 S,
before reaching the solubility boundary at 100 mM KCl (Figure 44B). Taken
together, these results further support that the nucleosome array containing
H2BS10ph can directly mediate internucleosomal contact to form highly
compacted chromatin in vitro.

Nucleosome array of Xenopus H2B S14E
Since yeast H2BS10ph can directly mediate chromatin compaction in vitro, we
decided to determine whether mammalian H2BS14ph would display similar
level of chromatin compaction in vitro. With help from Dr. Thomas Schalch and
Sywia Duda at Dr. Richmond’s laboratory, we expressed all four Xenopus histone
proteins along with the phospho-mimic H2B S14E. Then we combined these
histone proteins with 36_177_601 DNA array to reconstitute the nucleosome
array as described earlier. The first 3 amino acid residues (PEP) were missing
from the Xenopus H2B construct, so H2B S14E was referred to as H2B S11E
(Figure 45A). Both the WT and H2B S11E arrays reached the same extent of
compaction as yeast WT and yeast H2B S10E, respectively (compare Figures 44
and 45). Similar to the yeast WT nucleosome, the Xenopus WT nucleosome array
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reached a compacted state equivalent to 30-nm in 1.2 mM MgCl2, and a partially
compacted state in 100 mM KCl (Figure 45B and 45C). The S11E array reached a
maximum of 105 S and 90 S before reaching the solubility boundary of MgCl2
and KCl (Figure 45B and 45C), respectively. Moreover, the addition of first 3
amino acids did not change the sedimentation coefficient; both full length WT
H2B and H2B S14E arrays compacted in a similar level as WT and H2B S11E,
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Figure 45. Folding of nucleosome arrays containing Xenopus H2B mutants
(A) Sequence of H2B S14E and H2B S11E nucleosome array. The top panel
denotes the sequence of first 20 amino acids of full length Xenopus H2B with
S14 mutated to glutamic acid. The bottom panel denotes Xenopus H2B
lacking the first 3 amino acid residues (PEP) with serine 11 mutated to
glutamic acid. Therefore, H2B S14E was referred to as H2B S11E.
The mean S20,w of the sedimentation coefficient distribution as measured in
Figure 44 are shown for the nucleosome array containing Xenopus H2B, H2B
S11E, WT H2B, and H2B S14E in the MgCl2 (B)Figure
or in the
45KCl(C). Both WT
H2B and H2B S14E contain full length Xenopus H2B protein, whereas first
three amino acids are absent in both H2B and H2B S11E.

Similar

sedimentation velocity patterns were observed between the H2B and WT
H2B, or H2B S11E and H2B S14E array.
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respectively (Figures 45C and 45C).

These results further confirms that

phosphorylation of H2B is critical for the chromatin condensation.

Compaction of Xenopus H2B S11E and yeast H2B S10E are not dependent on
linker histone H1
Linker histones, such as H1, comprise a large family of chromatin associated
proteins that bind to nucleosomes and influence chromatin fiber dynamics
(Hansen, 2002). Because linker histones are considered to be necessary to induce
folding of the chromatin fiber (Hansen, 2002), I investigated the influence of the
H1 on compaction of the Xenopus H2B S11E chromatin fiber, which lacks the first
3 amino acids (PEP) of H2B. I reconstituted nucleosomes with full length H1
(gift of Dr. Chrysolula Leontinue at Dr. Richmond’s laboratory) using input H1
to nucleosome ratio of 1:1 mimicking the in vivo nucleosome structure. The
resulting nucleosome array contained 1 H1 per nucleosome and was verified by
coomassie stained SDS gels. The quality of the nucleosome arrays was validated
by observing histone octamers along with a 30 kDa band representing full length
H1 (Figure 46A).

The compaction was measured by analytical

ultracentrifugation under several divalent or monovalent cation concentrations
for each reconstitution. Compared arrays devoid of H1, arrays containing H1
compacted in less divalent or monovalent salt (Figure 46B and 46C). In the
presence of divalent cation such as MgCl2, concentrations in the range of 0.1-0.5
mM were sufficient to induce compaction whereas the monovalent ion, KCl,
compacted the chromatin fiber at a 50 mM concentration and exceeding 0.5 mM
MgCl2 or 50 mM KCl induces precipitation (Figure 46B and 46C). With an
increasing MgCl2 concentration, we observed a comparable sedimentation
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pattern for both arrays with or without H1; S 20,w value increased linearly and
reached maximum of 80 S for array containing Xenopus WT with H1, or 110 S for
Xenopus H2B S11E with H1 (Figure 46B). Similar to the compaction under a
divalent cation, KCl also caused compaction between arrays with or without H1
(compare 60 S for Xenopus WT or 90 S for H2B S11E with or without H1; Figure
46C). Consistently, yeast nucleosome arrays of both WT and H2B S10E with H1
displayed comparable sedimentation coefficient as each respective H1-less
nucleosome array. Together, these results suggest that Xenopus H2B S11E and
yeast H2B S10E compaction are not enhanced by linker histone H1.
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Figure 46. The influence of H1 on folding of Xenopus nucleosome array
(A) 18% SDS-PAGE showing 36_177_601 nucleosome arrays reconstituted
with H1. Numbers above the lanes indicate the corresponding input ratios of
H1:nucleosome. Arrow indicates purified, full-length H1.
(B and C) Plot of S20,w values obtained for Xenopus nucleosome arrays with H1
in MgCl2 (B) or in KCl (C). 0.1–0.5 mM MgCl2, or 10–50 mM KCl are sufficient
to induce compaction. Similar levels of sedimentation coefficients were
observed between yeast nucleosome arrays with and without H1 (refer to
Figure 44, and Figure 45). xH2B, Xenopus H2B; yH2B, yeast H2B.
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Yeast H2B+H2A chimera mutants display hydrogen peroxide-induced yeast
apoptosis
Can the H2B “death function” be moved from the H2B tail to another core
histone tail such as H2A, H3 or H4, where no H2BS10ph motif currently exists?
Previously, domain-swap experiments have been executed between H3 and H4
N-terminal tail or H2A.Bbd domain and H2A C-terminal tail (Ling et al., 1996;
Bao et al., 2004) to determine whether histones tail functions are limited to its
native context. Having established that the C-terminal end of the H2B is not
involved in yeast apoptosis, I next sought to address whether H2BS10ph motif
serves as a modular histone modification “cassette.” In pilot experiments, I took
a short stretch of the H2B N-terminal tail, corresponding to amino acids 2-16, and
inserted it into the H2A N-terminal tail at amino acid position 2 in a plasmid
shuffle strain lacking H2B N-terminal tail, yH2B ∆1-32 (Figure 47A). Hereafter,
this chimera strain will be referred to as H2A+B. Given that H2B N-terminal tail
is missing in the H2A+B chimera strain, the H2BS10ph motif was only present at
H2A N-terminal tail (Figure 47A). The growth rate and the sensitivity to H2O2
were comparable between the chimera strain and WT (Figure 47B and 47C,
respectively). Unlike the H2B N-terminal tail deletion mutant, the H2A+B
chimera was sensitive to H2O2 treatment in a manner similar to WT; both
displayed 30% cell viability and 70% cell death (Figure 47B and 47C). Next,
H2BS10 was separately mutated to alanine or glutamic acid in H2A+B chimera
mutant background and they were referred to as H2A+B S10A or H2A+B S10E,
respectively. These chimera mutants displayed similar levels of cell viability and
cell death as the H2BS10 mutants in their natural H2B N-terminus (Figure 47B
and 47C); both S10A mutants in H2A+B or in native H2B N-terminus displayed
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70% cell viability followed by 30% phloxin B staining, whereas S10E mutants in
chimera or in native context conferred growth defect (Figure 47D). To determine
whether H2A+B restores apoptotic phosphorylation in a H2B N-terminal tail
deletion background, nuclear extracts purified from H2O2-treated or untreated
chimera yeast cells were subjected to Western analysis. While H2B from H2O2treated WT cells reacted strongly with anti-H2BS10ph antibody, the H2BS10ph
signal was shifted to histone H2A in H2O2-treated chimera strains. In addition,
the H2BS10ph signal was lost in H2A+B S10A mutant (Figure 47E). These results
suggest that apoptotic H2BS10ph is re-established even in the absence of a wildtype copy of H2B N-terminal tail (Figure 47E). Given that H2A+B chimera
mutants restore the cell death phenotype and apoptotic S10ph abolished by H2B
N-terminal tail deletion, the H2B N-terminus (amino acids 2-16) appears to
function as a modular signaling “cassette”, further supporting the existence of
histone modification “cassettes” that are functionally modular.

Chromatin compaction of yeast H2A+B chimera mutant
Given that chromatin condensation correlates with yeast apoptosis, I sought to
address whether phospho-H2B’s role in chromatin compaction is still conserved
in this H2A+B chimera mutant.

The exact replica of the yeast H2A+B

nucleosome was reconstituted in vitro using a 36_177_601 DNA array. In short,
this nucleosome array contained a short stretch of the H2B N-terminal tail
(amino acids 2-16) in the H2A at residue 2 and lacked the H2B N-terminus
(H2A+B). I also generated identical nucleosome arrays that carry S10A or S10E
H2B mutants (H2A+B S10A or H2A+B S10E, respectively; Figure 47). The degree
of compaction was assessed by analytical ultracentrifugation in the presence of
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Figure 47. Movable “death-cassette” in H2B
(A) Sequence of yeast H2A+B chimera mutants. A short stretch of the yeast H2B
N-terminal tail at amino acid position 2-16 (see blue underline) was inserted into
the H2A N-terminal tail at amino acid position 2 in a plasmid shuffle strain
lacking H2B N-terminal tail (yH2B ∆1-32). The H2BS10ph (denoted in red) was
mutated to alanine or glutamic acid in the H2A+B chimera mutant background
and hence forth referred to as H2A+B S10A or H2A+B S10E, respectively.
(B and C) yH2A+B chimera mutants were tested for cell survival/death upon
H2O2 treatment (cell survival was tested by plating assay; cell death by phloxin B
staining; See Figure 11 for detail). Similar levels of sensitivity towards H2O2 were
observed between yH2A+B chimera (yH2A+B, yH2A+B S10A) and non-chimera
mutants (WT, H2B S10A).
(D) WT, H2B S10E, yH2A+B, and yH2A+B S10E yeast strains were grown on
YPD agar plates in the absence of H2O2. H2B S10E and yH2A+B S10E mutants
displayed a growth defect even without H2O2.
(E) Nuclear extracts purified from H2O2 treated or untreated WT, yH2A+B, and
yH2A+B S10A were subjected to Western analysis using anti-H2BS10ph, antiH2BK11ac and anti-H3 antibodies.

Except for H2B, no other bands were

detected with the anti-H2BS10ph or anti-H2BK11ac antibodies. Anti-H3 antibody
was used as a loading control.
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different divalent or monovalent cation concentrations.

The overall

sedimentation velocity pattern for nucleosome arrays with H2A+B chimera
mutants was similar to yeast H2B mutant arrays (compare Figures 44 and 48).
For example, the S 20,w value for the H2A+B chimera array starts at 40 S and
reaches 80 S in 1.2 mM MgCl2, or 70 S in 100 mM KCl, similar to the yeast WT
nucleosome array (Figure 48A and 48B). S10A or S10E in H2A+B chimera also
obtained the similar sedimentation coefficient values as arrays containing H2B
S10A or S10E in a non-chimera background (Figure 48A and 48B). These results
give credence to the idea that the H2B tail (amino acids 2-16) functions as a
modular signaling platform to mediate yeast chromatin condensation further
supporting the concept of a “death-cassette” in histone H2B.
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Figure 48. Folding of nucleosome arrays containing yeast H2A+B mutants
The mean S20,w of the sedimentation coefficient distribution are shown for
nucleosome array containing the H2A+B mutant in MgCl2 (A) or in KCl (B).
As described in Figure 47, the H2A+B nucleosome arrays contain a short
stretch of the H2B N-terminal tail, corresponding to amino acids 2-16, in the
H2A N-terminal tail at amino acid residue 2, and lacked H2B N-terminal tail.
Either the S10A or S10E mutations were introduced into H2A+B background.
Similar sedimentation velocity patterns were observed between the
nucleosome array containing chimera yeast H2A+B mutants or non-chimera
yeast mutants.
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Discussion
Chromatin is a complex of DNA and proteins, primarily histones that organize
the genetic material in the eukaryotic nucleus. The dynamics and structure of
chromatin are directly involved in nuclear processes like apoptosis. In this
chapter, I have described the role of H2BS10ph in mediating the dynamics of
chromatin fiber folding. H2B peptides carrying S10ph or phospho-mimic of S10
(S10E) in the proper sequence context (i.e. close proximity to proline residues)
induce an intrinsic aggregation property under reasonably harsh denaturing
conditions (Figure 39). We observed that S10E mutants activate the yeast
apoptotic pathway and chromatin condensation constitutively, whereas S10A
mutants fail to activate it at all even upon cell-death stimuli (Chapter 2). Because
this unusual in vitro property is mirrored by the in vivo phenotypes of the
corresponding mutants, this property may be a mechanism for aggregating
nucleosomes to form highly condensed apoptotic chromatin.

To test this

hypothesis, I have utilized in vitro homogeneous nucleosome array system and
assessed the degree of compaction of chromatin fiber by analytical
ultracentrifugation with help from Dr. Richmond’s group. I determined that
apoptotic markers in yeast and Xenopus, H2B S10E and H2B S14E respectively,
are critical for condensation of chromatin fibers that are more compacted than
the 30-nm chromatin fibers seen during mitosis (Figures 44 and 45). In addition,
the H2BS10 motif serves as a modular signaling platform which functions in
mediating yeast apoptotic chromatin condensation and apoptosis, which I refer
to as “death-cassette”. These results support that the yeast H2BS10ph can
directly mediate the chromatin compaction (cis mechanism; see Figure 6).
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In vitro peptide aggregation and in vivo chromatin status
As shown in Figure 39, yeast H2BS10ph and mammalian H2BS14ph peptides
migrated anomalously in the SDS-PAGE gel, however, most of the phosphohistone peptides migrated “normally” in this assay. I have found that two
properties contribute to “aggregation” behavior in test peptides: 1)
phosphorylation of the target serine residue and 2) the presence of nearby, often
repeating, “AP” residues. In accordance with the above criteria, no aggregation
was observed when the peptides were treated with alkaline phosphatase or
when proline was replaced with alanine in the “aggregating” yeast H2BS10ph
peptide (Figure 39B).
Without exception, phospho-peptides that displayed this unusual
“aggregation” property, notably apoptotic phospho-peptides (yeast H2BS10ph
and mammalian H2BS14ph), coincide precisely with condensed chromatin in
vivo (Figures 39 and 21). These peptide data also correlate precisely with the in
vitro chromatin compaction assay. Indeed, the H2B S10E phospho-mimic mutant
displayed peptide “aggregation” in the simple gel assay (Figure 39), highly
compacted chromatin fiber as measured by sedimentation velocity (Figure 44),
and condensed chromatin in vivo (Figure 21).

In contrast, the H2B S10A

nonphospho-mimic mutant failed to aggregate in a peptide gel (Figure 39), and
conferred decondensed chromatin fibers in vitro and in vivo (Figures 44 and 21).
Thus, the peptide “aggregation assay” arises as one indicator for compacted
chromatin fiber in vitro and in vivo.
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The role of proline during yeast apoptosis
Proline isomerization causes conformation changes in protein/peptide structure
in vivo and controls important biological functions including apoptosis
(Schutkowski et al., 1998; Lim and Ping 2004; Smet et al., 2004; Wulf et al., 2005;
Berger et al., 2005). It was previously shown that the function of the tumor
suppressor gene, p53, is regulated in its conformational changes by the proline
isomerase, Pin1. For example, the mutation in the polyproline region (PPR) of
p53 leads to the inhibition of Pin1-mediated conformational changes in p53, and
in turn, impairs its apoptotic function (Berger, et al., 2005). A similar paradigm
may be applied during yeast apoptosis. In this case, the proline residues found
in histone H2B serves as a target for a proline isomerase, which induces
conformational changes in H2B, and ultimately chromatin. In support, the
importance of proline residues in yeast apoptosis was observed since the
apoptotic phenotype is abrogated in the absence of prolines near the S10
phosphorylation site in H2B (Figure 40). It is implied that structural change in
chromatin is dependent on both prolines and phosphorylated S10, but the
proline isomerases that are responsible for facilitating these events are unclear at
this time. Therefore, surveying the proyl-isomerase knockout yeast strains upon
H2O2 treatment should identify the responsible enzyme.

Moreover,

reconstituting the yeast nucleosome array containing proline mutants and
measuring its sedimentation coefficient should determine whether S10
phosphate-induced proline isomerization plays a direct role in chromatin
compaction (cis mechanism).
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H2B “death-cassette”
In this chapter, I have described the existence of a “cassette,” a short cluster of
densely modifiable sites in histones with a distinct biological readout (Fischle et
al., 2003b; see Figure 4). Rather than acting independently, this domain is
situated at strategic locations in the histones and functions as a discrete
information unit regulating and relaying different signals depending on its
modification state (Fischle et al., 2003b). Already, several clusters of adjacent or
closely-spaced modifiable residues are observed in all core histones and well
studied hot spots of clustered marks punctuate the tails of H3 and H4 (Figure 5).
Given that a cassette is a modular information domain, an intriguing possibility
surfaces of a movable cassette in which its functions are not confined to its
natural location. Although, this mobility has not been observed with cassettes
from H3 or H4, I have found that the stretch consisting of yeast H2BS10ph does
not need to be attached to its native H2B N-terminal tail (Figures 47 and 48). In
support, it re-establishes both the cell-death phenotype upon in yeast H2O2
treatment and the compaction of the nucleosome array when inserted into the
H2A N-terminus (Figures 47 and 48). The post-translational modification
patterns of H2BK11 and H2BS10 are also re-established on the H2A tail in
H2A+B chimera strain (Figure 47), suggesting that this motif maintains its ability
to serve as a target substrate of Ste20 kinase and Hos3 HDAC, even in the
unnatural setting.
This “death-cassette” consists of 2 proline residues at the 8th and 13th
residues as well as K11 and S10. Shortening the cassette may provide further
insights into the influence of histone modifications facilitating yeast cell death. I
hypothesize that the combination of K11 influencing S10ph and phosphate192

induced proline isomerization comprises the functional unit that relays an
apoptotic signal. Since H2B and H2A form a dimer (Klug et al., 1980; Richmond
et al., 1984), moving the H2B death-cassette into H2A might not alter the
structure of nucleosome and disrupt its normal biological function. Therefore,
moving this cassette to additional histone tails should determine how movable
this histone modification cassette is. Nevertheless, my preliminary results
identified a death-cassette in the histone H2B N-terminus that functions as a
modular and movable histone covalent modification domain to recruit and
facilitate yeast’s apoptotic signaling cascade.

Influence of linker histone H1
For many years it was thought that the formation of the 30-nm chromatin fibers
depend on the presence of H1, but the sedimentation analysis of defined
nucleosome arrays in MgCl2 has shown that compact fibers can form in the
absence of linker histone H1 (Carruthers et al., 1998). I have observed that
compaction of chromatin fibers in phospho-mimic H2B serine mutants are
independent of H1 (Figure 46). In yeast, linker histones are nonessential (Ausio,
2000), further supporting that H1 does not mediate yeast chromatin
condensation. H1 is essential in vertebrates (Georgel and Hansen, 2001), but the
in vitro chromatin sedimentation analysis and the endogenous chromatin from
Xenopus egg extracts suggest otherwise. In both cases, chromatin can fold into
the highest levels of compaction similar to the metaphase chromosome even in
the absence of H1 (Carruthers et al., 1998; Dasso et al., 1994; see Figure 46 for our
in vitro chromatin sedimentation analysis). Therefore, we hypothesize that the
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formation of higher-order chromatin structure is directed by core histones rather
than H1.
In support of our hypothesis, studies of endogenous nucleosome arrays
reassembled with linker histone indicate that the highly basic C-terminus of H1
is responsible for fiber stabilization, not condensation (Allan et al., 1986). In vitro,
H1 has been shown to stabilize the folded and oligomeric states of chromatin
fibers; less MgCl2 when compared to H1-less nucleosome arrays is required to
induce folding (Carruthers et al., 1998). We have also observed that arrays
containing H1 compact in less divalent salt compared to arrays devoid of H1
(Figure 46B). Taken together, our studies demonstrate that H2B phosphorylation
can induce chromatin compaction directly without linker H1.

In vitro nucleosome array and in vivo chromatin compaction status
Perhaps the most obvious question when considering functional ramifications of
chromatin fiber dynamics is whether the solution behavior of chromatin fibers in
vitro is relevant in vivo. Short stretches of 10-nm and 30-nm chromatin fibers can
exist in extensively coiled 100-200 nm diameter chromosomal domains without
causing widespread chromosomal fiber decondensation (Belmont and Bruce,
1994).

This suggests that local chromatin fiber dynamics and long-range

chromosomal domain structures are uncoupled in vivo, a conclusion that also is
consistent with the physical uncoupling of folding and oligomerization in
nucleosomal arrays and chromatin fibers in vitro (Schwarz et al., 1996). Thus, the
mechanisms and determinants of chromatin fiber dynamics characterized in vitro
should have direct relevance to those regions of the genome that are assembled
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into some type of stable, higher-order structure domains, such as those seen
during apoptosis.
The yeast H2B S10E mutant, which mimics the phosphorylated state of
S10, induces a highly-compacted chromatin state in vivo and in vitro in fibers that
were previously uncondensed, suggesting that H2BS10ph regulates chromatin
fiber condensation. Therefore, the compacted chromatin should be absent in a
mutant lacking S10ph in vitro and in vivo. Indeed, both WT and H2B S10A
nucleosome arrays, where S10ph was absent, displayed a sedimentation
coefficient value much lower than that of the S10E array (Figure 44). These
results not only validate the in vitro nucleosome array to the in vivo chromatin
status, it also reinforces the idea that H2BS10ph are critical for condensation of
chromatin fibers.

“Cis” mechanism
By using phospho-mimic mutants of yeast and Xenopus H2B, I have shown that
H2B phosphorylation can directly cause internucleosomal contact and
histone/DNA interaction in order to mediate chromatin condensation. It is
remarkable that nucleosome arrays with one amino acid replacement, yeast H2B
S10E or Xenopus H2B S14E, can cause a dramatic change in chromatin fiber
folding (Figures 44 and 45). Yeast H2B motifs consisting of amino acid residues
2-16 appear to function as a modular signaling platform (Figures 47 and 48), so it
can be argued that conformation change is solely dependent on the negative
charge in the H2B motif and not necessarily on serine. In other words, chromatin
fibers would form a compacted conformation as long as a negative charge is
present within this motif. Dr. Grunstein’s group has shown that amino acid
195

residues 21-29 of the H4 N-tail is critical for the repression of silent mating loci
and changing the charge of this motif by a single amino acid insertion or deletion
are extremely detrimental (Johnson et al., 1992). This suggests that overall
charge is crucial to the function of the H4 motif and a similar paradigm may exist
in H2B as well. To test this hypothesis, replacing residues near phospho-targeted
serine with glutamic acid in vitro (peptide or nucleosome array) or in vivo (yeast
mutant) should elucidate the importance of the negative charge on serine or on
any residues in the H2B histone tail for mediating chromatin compaction.
In vitro nucleosome array system allows one to examine the influence of
histone in its proper and native context, although one shortcoming is that
influence of covalent histone modifications cannot be addressed. Histone
modifications play important roles in modulating nearly all DNA-associated
processes.

Therefore, it is essential to understand how post-translational

modification of histones influence chromatin structure and the binding and
function of chromatin-associated proteins. For this purpose, a native chemicalligation strategy can be used to generate “designed” histones, which consist of
covalently modified histone peptides linked to recombinant histone proteins
(Shogren-Knaak et al., 2003; Blaschke et al., 2000).

Unlike enzymatically-

modified histones or those purified from cellular lysates, ligation provides
homogeneously modified histones making it possible to study the effect of
histone modification on chromatin structure and function where recognition or
interaction between histone domains, octamer subunits, nucleosomes, or
nucleosomal DNA is important. Yeast histone H2B could be “designed” by
linking a peptide containing the N-terminus of H2B featuring single phosphate
on S10 with recombinantly-expressed, C-terminal H2B protein. Then, this
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“designed” H2B will be incorporated into histone octamers and reconstituted
into nucleosome arrays to study the effects of H2BS10ph on chromatin structure.
In 1.2 mM MgCl2, the sedimentation coefficient for yeast H2B S10E and
Xenopus H2B S14E were higher than the WT nucleosome array that is equivalent
to compacted 30-nm chromatin fiber (Figures 44 and 45). These results abet our
finding that both phospho-mimic H2B mutants may display chromatin fibers
that are more compacted than the 30-nm chromatin fiber. Elucidating the higherorder structure of compact nucleosome arrays should provide further insights
into the role of H2B phosphorylation in apoptotic chromatin condensation.
Recently, Dr. Richmond’s group had great success in visualizing chromatin fiber
compaction by electron microscopy (Dorigo et al., 2004). Nucleosome arrays
were stabilized by crosslinking with glutaraldehyde and were prepared under
different salt conditions. At very low ionic strength, they observed the “bead-ona-string” conformation (decondensed state) and in higher ionic strength, a round
particle with a diameter 30-nm (condensed state). Employing a similar method
of stabilization and visualization of the nucleosome array should determine the
chromatin structure influenced by the phosphorylation of H2B.
In conclusion, I have illustrated the possible existence of cis mechanism as
the function of H2BS10ph in mediating the yeast apoptotic cascade. The in vitro
peptide and the nucleosome array containing phospho-mimic H2B S10E gives
strength to the idea that H2BS10ph may serve as a “facilitator” during apoptotic
chromatin condensation. It is still unclear whether this type of cis mechanism
exists in vivo, but these results point to a potentially novel mode of histone
phosphorylation directly affecting the chromatin structure.
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Materials and Methods
Histone Expression Plasmids
The pET-3a plasmid containing the individual yeast or Xenopus Laevis histone
were generated as previously described in Luger et al., 1997. For histone
mutagenesis, a procedure based on the ‘QuickChange Site-Directed Mutagensis’
protocol by Stratagene was used. For creating mutations in yeast histone H2B,
pET-3a plasmid containing full-length yeast histone H2B gene was used as
template.

Two mutagenic primers with complementary sequences were

designed for each mutation. The desired mutation was placed in the middle of
the primer with 15 base correct sequences on both sides.
The pET-3a plasmid containing Xenopus Laevis histone H2B lacks
sequences encoding first three amino acids (PEP). The expression plasmid with
the full-length Xenopus Laevis histone H2B was generated by PCR. Xenopus H2B
S14A or H2B S11A mutation was generated by PCR using pET-3a plasmid
containing H2B gene with or without first 3 amino acids, respectively. Desired
mutations were confirmed by DNA sequencing.

Histone Expression
The pET-3a plasmid with histone genes was transformed into competent E. coli
BL21 (DE3)pLysS cells as described in Bacterial transformation (Chapter 2;
Materials and Methods) The cells were plated and incubated at 37°C for 10-18 hr
on TYE plates (1.0% tryptone, 0.5% yeast extract, 0.8% NaCl, 1.5% agar, 100
mg/ml ampicillin and 25 mg/ml chloramphenicol) containing ampicillin and
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chloramphenicol to select not only for the presence of the pET-3a plasmid, but
also maintain the pLysS plasmid.
For the large scale expression, a 100 ml 2X TY (100 mg/ml ampicillin and
25 mg/ml chloramphenicol) starter culture was inoculated with six colonies from
a transformation plate and grown at 37°C until the OD600 reached 0.4.
Subsequently 12x 1 liter 2X TY with ampicillin and chloramphenicol was
inoculated with 5 ml of the starter culture for 1 liter of medium and grown until
the OD600 reached 0.6. Addition of 0.4 mM IPTG induced the expression of the
lacUV5 dependent T7 RNA polymerase and therefore also the expression of the
T7-promoter controlled histone gene. The cells were harvested after 2 hr by
centrifugating at room temperature for 6 min at 6,000g in 500 ml containers. The
pellet was resuspended in 200 ml wash buffer (50 mM Tris-HCl pH 7.5, 100 mM
NaCl, 1 mM benzamidine, 1 mM b-mercaptoethanol), and frozen in liquid
nitrogen.

Histone purification
The purification protocol involves three steps: preparation of inclusion bodies,
gel filtration under denaturing conditions, and HPLC-ion exchange
chromatography under denaturing conditions.

Inclusion body preparation
The frozen cells were lysed by thawing in a 37°C waterbath. The freeze-thawing
disrupts the inner cell membrane and liberates T7 lysozyme, which can then
digest the outer cell membrane. For homogenization, the viscous cell suspension
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was mixed in the Ultra Turrax twice for 20 seconds. Inclusion bodies were
collected by spinning at 4° C for 30 min at 17,000g. The pellet was resuspended
in 50 ml 1% Triton X-100 in wash buffer and dounced, then spun at room
temperature for 10 min at 17,000g. The washing of the pellet was repeated once
with 1% Triton in wash buffer and twice with wash buffer only. The pellet was
redissolved in 40 ml unfolding buffer and stirred at room temperature for 1 hr.
The undissolved matter was spun down at room temperature for 60 min at
17,000g and the supernatant loaded onto the Sephacryl S-200 column.

Gel filtration chromatography
The Sephacryl S-200 column was equilibrated with 2 liters SAUDE 200 (7 M
deionized urea, 20 mM NaAc pH 5.2, 200 mM NaCl, 1 mM b-mercaptoethanol, 1
mM EDTA). The fractions of the histone peak were run on a SDS-PAGE gel and
the fractions containing the relatively pure histone were pooled, dialyzed in 68000 MWCO bags against 3 changes of 5 liters 5 mM b-mercaptoethanol, frozen
in liquid nitrogen, lyophilized and stored at -20°C.

Cation ion exchange chromatogrphy
The lyophilized S-200 histone was dissolved in SAUDE 200 and spun for 10 min
at 20,000g. The 6 ml Resource S column was equilibrated with SAUDE 200 and a
maximum of 50 mg per run was injected into the column. Using a flow rate of 2
ml/min, proteins were eluted with the following gradient with buffer A=
SAUDE 200 and buffer B= SAUDE 600 (7 M deionized urea, 20 mM NaAc pH 5.2,
600 mM NaCl, 1 mM b-mercaptoethanol, 1 mM EDTA).
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Histone octamer refolding and purification
Purified, lyophilized histone H2A, H2B, H3 and H4 were dissolved individually
in unfolding buffer (7 M guanidine hydrochloride, 20 mM NaAc pH 5.2, 10 mM
DTT) to a concentration of approximately 2 mg/ml. After at least 30 min at room
temperature, the histone concentration was determined by measuring the OD276
of the undiluted sample against unfolding buffer. The four histones were mixed
in equimolar amounts and adjusted to a final protein concentration of 1 mg/ml
with unfolding buffer and then dialized in 6-8000 MWCO dialysis bags against
three changes of 2 liter refolding buffer at 4°C for at least 3 hr. The sample was
spun for 20 min at 4,000g to remove the precipitate. The supernatant was
concentrated in a Micropore Ultra 15 at 4°C to a final volume of 1-1.5 ml. The
sample was spun twice at 4°C for 15 min at 20,000g and then loaded onto the
Superose 6 column, which was pre-equilibrated with refolding buffer (2 M NaCl,
10 mM Tris-Cl pH 7.5, 1 mM EDTA, 5 mM b-mercaptoethanol, 1 mM EDTA) at
4°C. The first eluted peak contained aggregates, followed by a peak containing
the octamer and finally a small peak of dimer. The fractions containing the
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octamer were determined by SDS-PAGE, pooled and concentrated in a
Micropore Ultrafree 4, then stored on ice.
The H2A/H2B dimer were reconstituted separately using the same
protocol as used for the histone octamer.

Reconsitution of nucleosomes on 36-mer DNA fragment
DNA, 5 mM measured in nucleosome repeat, was mixed with 4 M KCl and water
to yield a final concentration of 2 M KCl in a total volume of 100 ml. The histone
octamer was added such that the desired molar ratio of octamer/DNA was
obtained (see Determination of octamer/DNA ratio). For reconstitutions with
601 based arrays 147 bp MMTV A DNA was added as a histone octamer buffer.
The 100 ml reconstitution reaction mixture was placed in a small dialysis bag
(Spectra/Por 6-8000 MWCO membrane) and the dialysis protocol automatically
executed overnight by a specially designed reconstitution apparatus. The
reconstitution started in 200 ml of 1.4 mM KCl, 10 mM Tris pH 7.5, 0.1 mM
EDTA. By stepwise dilution with End buffer (10 mM Tris pH 7.5, 10 mM KCl, 0.1
mM EDTA) the dialysis was brought to 0.6 M KCl. The step (in time and KCl
concentration) were 70 min 1.4 M, 70 min 1.2 M, 420 min 1.0 M, 70 min 0.8 M, 70
min 0.6 M, following which the dialysis container was emptied and refilled with
200 ml of End buffer. After 180 min, the End buffer was exchanged again and
the sample was dialyzed for another 180 min. The reconstituted arrays were
recovered from the dialysis bag and centrifuged for 10 min with 20,000g at 4°C to
remove precipitated material.
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Determination of octamer/DNA ratio by ScaI digestion
The stoichiometry of soluble material was assessed by digesting the assembled
arrays with ScaI in 100 mM KCl, 10 mM Tris-Cl pH 7.5, 0.5 mM MgCl2 for 4 hr at
22°C. Each repeat is separated by a ScaI restriction site. The ratio of free DNA to
nucleosomal DNA was analyzed on an APAGE gel. A single well positioned
octamer per DNA repeat yields a pattern showing no bands corresponding to
free DNA and uncleaved DNA repeats.

Native agarose-polyacrylamid composite gels (APAGE)
An aliquots of 60 ml MilliQ water containing 1% agarose was heated until the
agarose was dissolved, following which 50x TAE was added to give 0.25x TAE.
While the solution was still hot 2 ml acrylamide (40%, 20:1), 100 ml of 25% AMPS
and 30 ml of TEMED were added. The solution was poured between assembled
and preheated (60°C) glass plates (20 cm x 20 cm, 1.5 mm spacers, comb was
inserted only few millimeters). The agarose was let harden for 20 min at room
temperature, and the comb was removed very carefully and gel was mounted in
the vertical gel box. The gel was prerun for 3 hr at 200 V in 0.25 x TAE with
buffer recirculation. Approximately, 1-3 pmol of reconstituted material was
loaded in native 5% sucrose and run under the same conditions for 3 hr. After
electrophoresis, the gel was stained for 10 min in a 1 mg/ml ethidium bromide
solution and photographed on a MultiImage Light Cabinet.
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Sedimentation velocity
Sedimentation velocity experiments were performed using a Beckman XL-1
analytical ultracentrifuge and an AN-50 Ti rotor. The initial sample absorbance
at 259 nm was between 0.6 and 0.8. Sampes (350 to 400 ml for sedimentation
velocity) were equibrated in their respective buffer solutions in the analytical
ultracentrifuge chamber under vacuum for 30 min at 20°C prior to sedimetaiton
at 12,000 rpm in 12 mm double sector cells and an 8 hole rotor. Scans were
collected at 259 nm in continous scan mode using 1 0.003 cm radial step size.
Boundaries were analyzed by sedimentation boundary fitting using the c(s)
distribution method provided by the program Sedfit (Schuck, 2000).

Plasmids, Yeast strains and Culture Conditions
Plasmid pQQ18 (CEN LEU2, CEN, HTA1-HTB1-HHF2-HHT2) was used to
generate histone mutant plasmids; pSA81 (htb1-P8A P13A) and pSA82. Plasmid
pSA82 contains a short stretch of the H2B N-terminal tail, corresponding to
amino acids 2-16, and inserted it into the H2A N-terminal tail at amino acid
position 2 in a plasmid shuffle strain lacking H2B N-terminal tail, htb1 ∆1-32.
These mutants were created by PCR and sub-cloned into pQQ18 as previously
described in Mutations in histone genes (Chapter 2; Materials and Methods).
Yeast strains are listed in Table 1 and all strains are derived from S288C
(BY4741; Research Genetics) background. Strain JHY205 was used to shuffle in
plasmids containing histone mutations using 5-FOA as a counterselecting agent
for the URA3 plasmid. SAY206, a chimera mutant strain containing pSA82 is
referred to as H2A+B. Transformation of yeast cells was performed by the
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lithium acetate procedure, as described in Yeast transformation (Chapter 2;
Materials and Methods).

Test for Apoptosis and Western Blot
Yeast apoptotic induction by H2O2, the cell survival, cell death analysis, TUNEL
staining, immunofluorescense, yeast nuclei preparation and Western analysis
were carried out as described in Chapter 2; Materials and Methods.

In vitro peptide aggregation assay
15 mg of peptides were mixed with 6X Lammeli buffer with 1 M DTT, boiled for
10 min and put in ice for 10 min. These peptides were run on 15% SDS-PAGE gel
for 20 min at 220 V and stained with fresh filtered Coomassie for 1 hr. The gel
was then destained for 10 min.
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CHAPTER 5

RAD53 ASSOCIATES WITH H2B SERINE10
PHOSPHORYLATION DURING YEAST APOPTOSIS

Introduction
Understanding the biological roles of post-translational histone modifications
requires understanding the mechanisms by which these marks are selectively
recognized by protein modules (reviewed in Seet et al., 2006). One of the best
illustrations of a histone modification in mediating protein-protein interactions is
the recognition of methylated lysine residues by a structure known as the
chromodomain (de la Cruz et al., 2005). The amino-terminal chromodomain
found in heterochromatin protein 1 (HP1) has been shown to bind to the
methylated H3K9, particularly in its di- and tri-methylated states (Bannister et
al., 2001; Jacobs et al., 2001; Lachner et al., 2001; Figure 7B). It is thought that this
interaction is crucial for establishing and maintaining regions of heterochromatin
(Sims et al., 2003; Schotta et al., 2004). As for acetyl-lysines in histones, a motif
known as the bromodomain, which is found in a number of nuclear histone
acetyltransferases and transcription regulators, binds to acetylated histone H3
and H4 (Jeanmougin et al., 1997; Winston and Allis, 1999). The interaction
between the double bromodomains of hTAFII250 and acetylated K5 and K8, or
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K12 and K16 of H4 leads to the assembly of preinitiation complexes for
transcription activation (Mizzen et al., 1996; Rossignol et al., 1999; Figure 7B).
A docking module for a phosphorylated serine residue in the histone
variant, H2A.X, has also been identified. The phosphorylation of this relatively
minor histone variant, H2A.X S139 in mammalian cells and H2A S129 in yeast,
correlates with double-stranded DNA breaks (DSB) induced by numerous
stimuli, suggesting that this mark acts as a DNA-damage sensor (Rogakou et al.,
1998, Rogakou et al., 2000). In mammalian cells, Mdc1/Nfbd1 directly interacts
with H2A.XS139ph via its BRCT domain (Stucki et al., 2005). Their interaction
then results in the recruitment of 53BP1, Nbs1 and phosphorylated ATM at sites
of damaged chromatin, and is thought to mediate the DNA repair signaling
cascade (Stucki et al., 2005; Figure 7C). The 14-3-3 protein has also been
identified as a binding protein for H3S10ph (Macdonald et al., 2005; Figure 7C).
Although H3 phosphorylation at S10 occurs during mitotic and meiotic
chromatin condensation, a causal relationship between this phosphorylation
event and chromosome dynamics has not yet been demonstrated; yeast mutants
lacking S10 (H3 S10A) have generation times and cell cycle progression identical
to those of the wild-type strain (Hsu et al., 2000). To date, the binding modules
that “read” the covalent histone modifications associated with the chromatin
compaction (e.g. H2BS14ph in mammalian cells and H2BS10ph in yeast) still
remain elusive.
As discussed in Chapter 2, H2AS129ph occurs early and precedes
apoptotic H2BS10ph in yeast (Figure 18); this suggests an intricate interplay
between DNA damage/repair and apoptosis. If DSBs are unrepaired or repaired
incorrectly, they can cause cell death (Sancar et al., 2004; Zhou and Elledge, 2000;
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Modrich, 1997). Thus, cells react to DSBs by rapidly deploying a host of proteins
to the damaged-chromatin regions. Some of these proteins engage in DNA
repair, while others trigger a signaling pathway (DNA-damage checkpoint). In
yeast, the central proteins involved in this DNA damage response are the
checkpoint kinases Mec1, Rad53, Rad9, and Chk1. Mec1 and Rad53 are the
central transducers of DNA damage response signals and they activate another
kinase such as Dun1 to delay cell-cycle progression and coordinate repair
processes (Zhou and Elledge, 2000; Paciotti et al., 2000; reviewed in Rouse and
Jackson, 2002; Bashkirov et al., 2003; Figure 49A). The deletion of Rad53 disrupts
the DNA repair pathway since rad53∆ is sensitive to DNA damage agents and
leads to the loss of viability (Hammet et al., 2000; Pike et al., 2003). During DNA
damage, the activation of Rad53 by phosphorylation requires the upstream
kinase Mec1 and the mediator Rad9 (Sanchez et al., 1996; Sun et al., 1996).
Multiple models for Rad53 activation have been proposed. In the first model,
phosphorylated Rad9 may work as an adaptor to deliver Rad53 to Mec1 at sites
of DNA damage (Sun et al., 1998; Schwartz et al., 2002). In another model, Rad53
is activated through intermolecular autophosphorylation after interaction with
phosphorylated Rad9 (Gilbert et al., 2001; Schwartz et al., 2003). It is unclear
whether the two mechanisms operate together to fully activate Rad53 and the
DNA repair pathway in vivo.

Nevertheless, the activation of the Rad53-

dependent DNA repair pathway requires Rad53’s interaction with
phosphorylated Rad9 (Schwartz et al., 2003). Disruption of their association
leads to the accumulation of DNA damage and failure to restore the continuity of
the DNA duplex; the apoptotic signaling cascade is subsequently activated to
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eliminate such heavily damaged or seriously deregulated cells (Sancar et al.,
2004).
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Figure 49. Activation of Rad53 during DNA damage pathway
(A) DNA damage induces Mec1/Tel1 phosphorylation of the Rad9 complex
which results in its remodeling to the hyperphosphorylated form. Rad9 then
recruits Rad53 to Mec1 by directly binding to the FHA domain of Rad53. This
enables phosphorylation/activation of Rad53, which functions to induce the
DNA repair pathway.
(B) Schematic drawing of the Rad53 protein depicting the different domains.
Note that the kinase domain is located between two forkhead-associated
(FHA) domains positioned in the amino- and carboxyl-termini.
In keeping with the “trans” mechanism leading to chromatin compaction
(Figure 6B), I sought to address the binding partner for H2BS10 phosphorylation
during H2O2-induced yeast apoptosis. In collaboration with Dr. Sheng-Hong
Chen at Ludwig Institute of Cancer, San Diego, CA, we found that Rad53
associates with the nucleosome carrying histone H2B phosphorylated at S10
upon H2O2 insult. Rad53 contains two forkhead-associated homology domains
(FHA1 and FHA2) that are hypothesized to be modular phospho-S/T binding
domains (Hammet et al., 2000; Figure 49B). Using recombinantly-expressed
individual Rad53 FHA domains, I demonstrated that the FHA1 domain of Rad53
binds to H2BS10ph peptide in vitro. Interestingly, during a H2O2-induced
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apoptotic cascade, Rad53 is inactivated and it binds to H2BS10ph. Taken
together, these results, while somewhat preliminary, provide support to the idea
that inactivation of the DNA-damage checkpoint may promote the apoptotic
cascade.
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Results
FHA1 of Rad53 specifically associates with phosphorylated serine 10 of H2B in
vitro
Previously, Dr. Sheng-Hong Chen at the Ludwig Institute of Cancer center (San
Diego, CA), had identified that recombinant FHA1 from Rad53 interacts with
histones upon H2O2 treatment (Dr. Chen, personal communication). To this end,
bacterially expressed recombinant GST-FHA1 or GST was immobilized on
glutathione-sepharose beads and incubated with H2O2-treated or untreated WT
yeast lysates. After the sepharose beads were pelleted by brief centrifugation,
bound proteins were eluted and subjected for MS/MS analysis. Dr. Chen found
that H2B binds specifically to GST-FHA1, but not GST alone (Dr. Chen, personal
communication), suggesting that FHA1 from Rad53 is a possible binding protein
domain for H2BS10ph during H2O2-induced yeast apoptosis.

Therefore, I

initiated a collaboration with Dr. Chen’s group to further test this hypothesis.
To decipher whether FHA1 from Rad53 directly interacts with H2BS10ph,
a peptide pull-down experiment was performed using either biotinylated histone
H2B or H3 peptides each immobilized on avidin beads (Figure 50A). This
method is commonly used in our laboratory and recently, Dr. Joanna Wysocka
has successfully demonstrated the interaction between mammalian Wdr5 protein
and H3K4me2 using this assay (Wysocka et al., 2005). Therefore, I adopted a
similar system where the biotin moiety was attached at the N-terminus of
synthetic peptides. Histone H2B peptides carried amino acids 1-20, with S10
either unmodified or singly phosphorylated; histone H3 peptides also carried
amino acids 1-20 and included either unmodified or singly phosphorylated S10
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(Figure 50B). These peptides were bound to streptavidin beads in a high salt
buffer and then adjusted to a low salt buffer. To ensure specificity, excess BSA
(20 mg) was incubated with a 1:1 mixture of bacterially expressed recombinant
GST-FHA1 and GST-FHA2 from Rad53 (each at 1 mg). This mixture was used as
input for the pull-down assay with the biotinylated histone peptides linked to
streptavidin beads. The beads were washed extensively to remove the unbound
proteins. As shown in Figure 50C, GST-FHA1, but not GST-FHA2, was enriched
in the H2BS10ph peptide. In contrast, neither GST-FHA1 nor GST-FHA2 from
Rad53 was enriched in the unmodified H2B or either of the H3 peptides. BSA
failed to bind to any of these peptides (Figure 50C). Next, I tested binding ability
of the recombinantly-purified FHA domain from Dun1 (GST-Dun1) to H2BS10ph
peptide. Dun1 is a FHA domain kinase, which functions in the DNA damage
and replication block (Zhou and Elledge, 1993; reviewed in Weinert, 1998; Zhou
and Elledge, 2000). However, unlike Rad53, Dun1 contains only one FHA
(Bashkirov et al., 2003). No interaction was observed between GST-Dun1 and
H2BS10ph (Figure 50C). These results indicate that association between FHA1 of
Rad53 and H2BS10ph is both direct and, within the context of the peptides and
proteins used here, specific.

In solution fluorescence polarization assay detects an interaction between FHA1
of Rad53 and H2BS10ph peptide
In order to further test an interaction between FHA1 of Rad53 and H2BS10ph, in
vitro quantitative binding experiments were performed using fluorescently
labeled H2B peptides and recombinant FHA1 or FHA2 of Rad53. As described
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Figure 50. FHA1 of Rad53 is a potential binding effector for H2B serine 10
phosphorylation in vitro.
(A) Schematic drawing of histone peptide pull-down assays. Biotinylated
histone peptides were linked to streptavidin beads and incubated with the
recombinant proteins. After washing, bound proteins were eluted from the
beads by glycine, and eluted fractions were separated on a SDS-PAGE gel.
(B) Amino acid sequence of histone peptides used for the peptide pull-down
assays. Yeast H2B peptides contained amino acids 1-20 either unmodified
(H2Bun) or singly phosphorylated at S10 (H2BS10ph). Yeast H3 peptides
contained amino acids from 1-20 that were either unmodified (H3un), singly
phosphorylated at T3 (H3T3ph) or at S10 (H3S10ph). [P] denotes phosphate.
(C) Excess BSA was incubated with equimolar amounts of purified recombinant
GST-tagged FHA1 or FHA2 of Rad53, and GST-tagged FHA of Dun1. This
mixture was used as input for the pull-down assay with indicated peptides.
Bound proteins were analyzed by SDS-PAGE and silver staining. GST-tagged
FHA1, but not FHA2, specifically binds to H2BS10ph biotinylated peptide (see
red arrow). Note that FHA1 does not bind to other biotinylated peptides tested,
including H3S10ph or H3T3ph peptide. No other band was detected in this gel
assay. Pep, histone peptides.
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in Figure 51A, upon excitation, the fluorescent peptides emit light that is
polarized by a filter and the extent of depolarization of the emitted light (its
anisotropy) depends on the mobility of the fluorescent molecule: the higher the
rotational diffusion of a fluorescent molecule, the stronger the depolarization it
causes. These differences in depolarization are exploited to measure the binding
of a fluorophore-labeled peptide to a protein. If the peptide is bound to a
protein, the rotational mobility of the peptide is drastically reduced compared to
the free peptide. The emitted fluorescence is therefore polarized (Figure 51A).
This method was previously used to measure the binding of chromodomain
proteins such as HP1 and Polycomb (Pc) to H3K9me2 peptide (Jacobs et al., 2001;
Fischle et al., 2003c; Fischle et al., 2005). I labeled various H2B (unmodified,
H2BS10ph, H2BK11ac, or H2BS10phK11ac) and H3S10ph peptides by adding a
FITC group to its N-terminus through NHS-mediated cross-linking. The quality
of FITC labeling at the N-terminus of H2B peptides was verified by mass
spectrometry analysis with help of Rob Diaz.

The binding constants

(dissociation constant, KD m M) were then determined by measuring the
fluorescence anisotropy of the fluorophore-labeled peptides (100 nM) when
different concentrations of recombinant FHA proteins were added. Consistent
with the peptide pull-down experiment showing Rad53 FHA1 as the binding
domain for H2BS10ph (Figure 50C), the fluorescence polarization measurements
indicated a clear preference of the Rad53 FHA1 for the H2BS10ph, but not the
unmodified H2BS10, or H3S10ph (Figure 51B). Specifically, the dissociation
constant for the H2BS10ph peptide was 71 mM, and that for the unmodified H2B
peptide was 13,888 mM (Figure 51B). Likewise, the binding constant for the
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association between FHA1 and H2BK11ac peptide remained as high as the
unmodified peptide. I also detected a significant loss in the affinity of Rad53
FHA1 for a dually modified H2BS10phK11ac peptide (Figure 51B), suggesting a
putative function for the dual-mark combination of H2BS10phK11ac in the
inhibition of Rad53 recruitment. Taken together, these results demonstrate that
FHA1 domain of Rad53 specifically binds to H2BS10ph in vitro.

Rad53 associates with phosphorylated serine 10 H2B
To confirm the interaction between Rad53 and H2BS10ph in vivo, I turned to the
peptide pull-down assay as described in Figure 50. This time, a series of
biotinylated unmodified or appropriately modified H2B peptides (amino acids 120; see Figure 50B for the peptide sequence) immobilized on streptavidin beads
were incubated with H2O2-treated or untreated WT nuclear extracts (Figure 52A).
Bound polypeptides were then eluted from the resin, resolved by SDS-PAGE,
and visualized by silver staining (Figure 52B). Although I observed numerous
bands common between these pull-down eluted fractions, this analysis
consistently revealed the presence of a 95 kDa band that was specifically
enriched in the H2BS10ph peptide purification (See red arrow in Figure 52A).
With the help of Dr. Alan Tackett from Dr. Brian Chait’s laboratory at the
Rockefeller University, we attempted to identify this polypeptide using mass
spectrometry.

Unfortunately, we were not able to identify it due to the

insufficient amount of polypeptide extracted from this gel. However, 95 kDa is
the predicted molecular mass of Rad53, so I tentatively predict that Rad53
associates with H2BS10ph.
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Figure 51. Binding studies of H2B tail peptides to FHA1 of Rad53
(A) Schematic delineation of fluorescence polarization measurement. When
fluorophores are excited with polarized light, they emit polarized light and the
extent of emission depends on the mobility, therefore on the size of the
fluorescent molecule; the higher the rotational diffusion of a fluorescent
molecule, the stronger is the depolarization it causes. These differences in the
depolarization are exploited to measure the binding of a fluorophore-labeled
peptide to a protein. If a fluorophore-labeled peptide does not bind to a protein,
then the mobility of the fluorophore remains high, therefore, displays strong
depolarization (Top panel). However, when there is an interaction between
fluorophore-labeled peptide and a protein, then the rotational mobility of the
peptide is drastically reduced compared to the free peptide, therefore results in
little depolarization and change in its anisotropy (Bottom panel) (adapted from
Holger Dorman).
(B) Binding of the FHA1 or FHA2 of Rad53 to H2B peptides containing residues
from 1-20 with unmodified or S10ph, in a fluorescence polarization assay. KD
(mM) values are listed in the bottom. Note that FHA1 of Rad53 interacts with
H2BS10ph peptide. Neither FHA domains interact with the unmodified H2B
tail.
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To confirm the specificity of the association between Rad53 and H2B tail
phosphorylated at S10 during H2O2-induced yeast apoptosis, I performed a
similar peptide pull-down assay with yeast extracts, but this time the eluted
polypeptides were separated on SDS-PAGE gel and then subjected to
immunoblotting to detect Rad53 (anti-Rad53 antibody). As expected, Rad53
associates specifically with the H2BS10ph, but not unmodified H2BS10 upon
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Figure 52. Rad53 is H2B-serine10-Phos-associated protein
(A) Peptide pull-down assays were performed using nuclear extracts purified
from H2O2-treated, untreated WT or H2B S10A yeast cells and H2B peptides
either unmodified or S10ph. Polypeptides were resolved on a SDS-PAGE gel
and visualized by silver staining. As a control, biotinylated H3S10ph peptides
were used for the peptide pull-down experiments. Note a polypeptide of 100
kDa was specifically enriched in the H2BS10ph peptide (see red arrow).
Molecular weight markers (kDa) are indicated on the left.
(B) Eluted factions from the above peptide pull-down assays were separated
on a SDS-PAGE gel and analyzed by immunoblotting with anti-Rad53, and
anti-H2BS10ph. Rad53 specifically associated with H2BS10ph, demonstrating
that the 100 kD polypeptide was Rad53. Ten percent of the input wild-type
(WT) nuclear extract was used as a control.
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also consistently present in the absence of H2O2 treatment or phosphorylation at
S10 (H2B S10A) suggesting that synthetic H2BS10ph peptide can serve as a
preferential binding substrate for Rad53 even in the absence of endogenous
histone H2B with S10 phosphorylation. As a control, the same peptide pulldown experiments were performed with H3S10ph peptides. No interaction
between Rad53 and H3S10ph were observed (Figure 52A and 52B),
demonstrating that Rad53 is a major H2BS10ph associated protein.
To confirm the functional significance of Rad53 association with
H2BS10ph, I sought to address whether an in vivo association of Rad53 with
H2BS10 phosphorylated nucleosome exists. To this end, I employed a yeast
strain expressing TAP -tagged full-length endogenous Rad53, in which the Cterminus of Rad53 was tagged with TAP. The functionality of this strain was
tested by its growth rate and H2O2 sensitivity. The level of cell viability and
death was similar to WT (Figure 53A). Nuclei purified from H2O2-treated or
untreated Rad53-TAP strains were used for immunoprecipitation experiments
with glutathione-linked to sepharose beads, followed by glutathione elution. To
monitor the specificity, nuclei from WT yeast cells untagged with Rad53 were
used in parallel mock purifications. Immunoprecipitates were subsequently
analyzed with antibodies against (1) Rad53 or (2) TAP to monitor
immunoprecipitation efficiency; (3) Rad9, a known Rad53 associated protein, as a
positive control; (4) H2BS10ph (Figure 53B). Consistent with published results of
Rad53 activation upon DNA damage (Schwartz et al., 2003; 2002), I observed an
electrophoretic mobility shift due to DNA-damage activated Rad53
phosphorylation upon treatment with a DNA damage agent, such as methyl
methane sulfonate (MMS) (Figure 53B). In comparison, upon 1 mM H2O2
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treatment for 200 minutes, phosphorylation of Rad53 was significantly reduced
suggesting that H2O2-induced yeast apoptosis leads to inactivation of Rad53
(Figure 53B). On the other hand, the phosphorylation of Rad9 was present in
both MMS and H2O2 treatments, as indicated by the electrophoretic mobility shift
(Figure 53B). H2BS10ph was observed

with

H2O2-treated, but not

MMS-

treated, yeast cells (Figure 53B).
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Figure 53. In vivo interaction between Rad53 and nucleosome carrying H2B
serine 10 phosphorylation
(A) The functionality of yeast cells expressing TAP-tagged Rad53, in which
the C-terminus of Rad53 was tagged with TAP (Rad53-TAP), was tested by its
H2O2 sensitivity. The level of cell viability by plating assay and cell death by
phloxin B staining upon H2O2 treatment was similar to wild-type (WT) cells.
(B) The nuclei was purified from mock or Rad53-TAP yeast cells that were
either treated with or without MMS or H2O2 and

used

for

immunoprecipitation with IgG-sepharose beads followed by TEV cleavage.
Immunoprecipitates were analyzed by Western blot with anti-Rad53, antiTAP, anti-Rad9, and anti-H2BS10ph. Note the activation of Rad53 and Rad9
as displayed by electrophoretic shift due to phosphorylation in MMS-treated
nuclei, but Rad53 is dephosphorylated in H2O2-treated nuclei. While Rad53
interacts with Rad9 upon MMS treatment, Rad53 binds to nuclei containing
H2BS10ph upon H2O2 treatment.
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Consistent with previous results showing the interaction between Rad53 and
Rad9 (Sun et al., 19998; Schwartz et al., 2002), Rad53 coimmunoprecipitates with
phosphorylated Rad9, but not with the phosphorylated H2B tail upon MMS
treatment (Figure 53B).

Interestingly, H2O2-treated Rad53-TAP specifically

coimmunoprecipitated with the nuclei containing H2BS10ph, but it failed to
interact with Rad9 (Figure 53B).

These data illustrate that the

nonphosphorylated form of Rad53 binds to H2B tail phosphorylated at S10 in
vivo in the context of native nucleosomes during H2O2-induced yeast apoptosis.

Rad53 is inactivated during hydrogen peroxide-induced yeast cell death
pathway
The H2O2 treatment condition that resulted in dephosphorylated Rad53, as
shown by electrophoretic mobility (Figure 53B), prompted me to determine the
kinetics for Rad53 and Rad9. I harvested WT nuclei at different times post H2O2
treatment and subjected them to Western analysis.

The mobility shift

characterizing Rad53 phosphorylation occurred early in H2O2 treatments
coinciding with the appearance of DSB, as indicated by the presence of antiH2A.XS139 antibody (Figure 54A). Although the DSB signal remained constant
throughout the H2O2 treatment, the mobility shift due to phosphorylation of
Rad53 was lost at the time point when the H2BS10ph signal first appeared (90
min post induction; Figure 54A).

Rad9, on the other hand, remained

phosphorylated throughout the H2O2 treatment. These results suggest that
Rad53 binds to phosphorylated Rad9 as an early consequence of the appearance
of H2O2-induced DSBs.

However, after 90 minutes of post induction,
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dephosphorylated Rad53 interacts with H2BS10ph and subsequently inactivates
the Rad53-dependent repair pathway and promotes apoptotic cascade.
To support this claim, immunoprecipitation analysis was carried out as

A
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described in Figure 53, but this time using nucleosomes purified from yeast
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Figure 54. Rad53 is dephosphorylated during hydrogen peroxide-induced
yeast apoptosis.
Rad53-TAP yeast strains were harvested after treatment with H2O2 at the
indicated times and split into two fractions.
(A) Half of the cells were harvested in SDS-loading buffer and then subjected
to Western analysis using the indicated antibodies. Consistent with the
previous result showing that H2A.X preceded H2BS10ph (Figure 18), H2A.X
was detected at 10 minutes, whereas H2BS10ph was at 90 minute time point.
Phosphorylation of Rad53 occurred early in H2O2 treatment, but the
dephosphorylation of Rad53 coincides with the appearance of H2BS10ph.
Rad9, however, remained phosphorylated throughout the H2O2-treatment.
(B) The other half of the cells were harvested and nuclear extracts were used
for immunoprecipitation. Immunoprecipitates were analyzed by Western
analysis with anti- Rad53, anti-Rad9, anti- H2BS10ph.

While Rad53

coimmunoprecipitating with phosphorylated Rad9 correlates with the
hyperphosphorylation of Rad53 at 10 minutes post H2O2 treatment, the
appearance of dephosphorylated Rad53 correlates with the interaction
between Rad53 and H2BS10ph, but not Rad9.
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Rad53-TAP cells collected at different times post H2O2 induction. A similar
signaling pattern to that of WT was observed with Rad53-TAP in which the onset
of H2BS10ph correlated with the disappearance of electrophoretic shift due to
Rad53 phosphorylation (Figure 54B). As expected, Rad53 coimmunoprecipitates
with nucleosomes containing phosphorylated Rad9 at early time points,
suggesting that the DNA repair pathway is activated to remove DSBs (Figure
54B). In contrast, a direct interaction between Rad53 and the phosphorylated
H2B tail, but not with phosphorylated Rad9, was observed at the 90 minutes time
point (Figure 54B). Since the Rad53-Rad9 complex mediates the induction of the
Rad53-dependent DNA repair pathway, these results support the idea that
Rad53 binding to H2BS10ph, instead of Rad9, leads to the downregulation of
DNA repair cascade, and activation of apoptosis.

Loss of FHA1 of Rad53 abrogates hydrogen peroxide-induced yeast apoptosis
I wanted to address whether FHA1 of Rad53 is necessary for yeast cell death in
vivo. A yeast strain lacking Rad53 (rad53∆) is lethal, since the essential function
of Rad53 is to promote deoxyribonucleotide triphosphate (dNTP) production
during S phase to facilitate DNA replication (Zhao et al., 1998). This is achieved
by phosphorylation and degradation of Sml1, a stoichiometric inhibitor of
ribonucleotide reductase (Zhao et al., 1998). Therefore, the lethality of rad53∆
mutant is rescued by elevating dNTP levels through disruption of the SML1 gene
(Zhao et al., 2001). The yeast strain lacking Sml1 (sml1∆) is in the four histone
plasmid-shuffle strain background. As determined by cell viability and cell
death as described in Figure 11, sml1∆ was as sensitive to H2O2 treatment similar
as WT (Figure 55). Next, I generated a yeast strain lacking either Rad53 FHA1
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(amino acids 6-66; FHA1D), Rad53 FHA2 (amino acids 601-664; FHA2D) or full
length Rad53 (rad53∆) in sml1∆ background and tested for cell viability upon
H2O2 induction. Similar to the survival pattern observed with the H2B S10A
mutant cells, FHA1D and rad53∆, but not FHA2D, cells had a significant reduction
of phloxin B stained cells followed by a significant increase in cell viability as
compared to its isogenic WT or sml1∆ (Figure 55). These results demonstrate that
the FHA1 of Rad53 is important for promoting cell death.
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Figure 55. FHA1 of Rad53 is required for hydrogen peroxide-induced yeast
apoptosis.
Log phase yeast wild-type (WT), cells lacking Rad53 FHA1 (residues 6-116;
FHA1D), cells lacking Rad53 FHA2 (residues 601-664; FHA2D), or cells lacking
full length Rad53 (rad53D), were treated with 1 mM H2O2 for 200 minutes, and
measured the level of cell survival and cell death. Cell viability was judged
by plating assay and cell death by phloxin B staining
Figure as
55described in Figure
11. The FHA2D mutants were sensitive, but FHA1D and rad53D were resistant
to H2O2 treatment.
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Discussion
The discovery of binding modules that “read” covalent marks on histones, a
trans mechanism, has been crucial in our present understanding of gene
regulation in the context of chromatin polymers (Seet et al., 2006). In this
chapter, I have extended the understanding of this “trans-mechanism” by
identifying Rad53 as a binding partner for yeast H2BS10ph during H2O2-induced
yeast apoptosis. Although during the DNA damage pathway the interaction
between Rad53 and Rad9 is important for the phosphorylation and subsequent
activation of Rad53 (Sanchez et al., 1996; Sun et al., 1996), Rad53 becomes
dephosphorylated during H2O2-induced yeast apoptosis (Figures 53 and 54). In
vivo, this dephosphorylated form of Rad53 fails to interact with Rad9 (Figures 53
and 54). Instead, Rad53 coimmunoprecipitates with nucleosome carrying H2O2induced H2BS10ph (Figures 53B and 54B). FHA1 of Rad53, but not FHA2,
specifically associates with H2BS10ph peptide in vitro (Figures 50C and 51B).
Moreover, H2O2-induced yeast apoptosis is abrogated in yeast cells lacking FHA1
(Figure 55). Taken together, these results allowed me to conclude that FHA1 of
Rad53 is a binding domain for H2BS10ph in vivo. The consequence of this
interaction may include the downregulation of DNA repair pathway and
subsequently promotion of apoptotic cascade (Figure 56).

FHA1 of Rad53 as H2BS10ph binding effector protein
Sequence-dependent phospho-serine/phospho-threonine specific binding
domains include 14-3-3, BRCT, and FHA domains play essential roles in many
cellular processes (reviewed in Yaffe and Elia, 2001). Recently, 14-3-3 has been

226

MMS
?

DNA damage

H2O2

Rad53
Rad53-Rad9

Rad53-H2BS10ph

Dun1 Pds1
Apoptosis

DNA repair

Figure 56. Model for Rad53’s role in yeast apoptosis
During MMS-induced DNA damage, the direction association between
phosphorylated Rad9 and Rad53 leads to the phosphorylation/activation of
Rad53. Rad53 then activates downstream targets such as Dun1 or Pds1, and
arrests the cell cycle and activates the DNA repair pathway. Upon H2O2
treatment, Rad53 is initially activated and may promote DNA repair pathway
similar to MMS induction. However, as DSB break accumulates, Rad53
dissociates from Rad9, and instead interacts with H2BS10ph via Rad53’s
FHA1 domain. Their interaction may inactivate DNA repair pathway and
subsequently promote the apoptotic cascade.
identified as H3S10ph-specific binding protein and the BRCT domain from
MDC1 as a binding protein for H2A.XS139ph (Macdonald et al., 2005; Stucki et
al., 2005). I have now added FHA as a phospho-serine histone binding protein to
this growing list of modular phosphate-binding domains. FHA domains contain
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100–180 amino acid residues forming an 11-stranded b-sandwich (Durocher and
Jackson, 2002). FHA domains are present in a large number of proteins in all
phyla from bacteria to mammals and seem to be prevalent among proteins with
cell cycle and DNA damage response functions. The FHA domain proteins
include Nbs1 and Chk2, which are human DNA damage checkpoint proteins
(Tauchi et al., 2001; Matsuoka et al., 1998). The yeast homolog of the Chk2
kinase, Rad53, is the only known protein to contain two FHA domains (Hammet
et al., 2000). The Rad53 FHA1 domain is mapped to residues 14-164, which form
11 b strands with 2 large twisted and anti-parallel b-sheets folding into a bsandwich, a similar structure to that of FHA2 (Liao et al., 2000). However,
several loops that link b-strands are significantly different between FHA1 and
FHA2, and it has been proposed that this difference may contribute to the
specificity of binding substrate (Byeon et al., 2001; Liao et al., 2000). In support, I
have observed that only FHA1, but not FHA2, has binding affinity for the
H2BS10ph peptide (Figures 50C and 51B). In addition, FHA of Dun1, which
displays a different loop structure than the Rad53 FHA domains (Blanchard et
al., 2001), did not interact with H2BS10ph peptide (Figures 50C and 51B),
suggesting that structural difference in loops could be the key element in
distinguishing the binding substrate.
Surface-plasmon resonance analysis has revealed that a pocket formed
between residues (G69, R70, S85, N107, G133, G135) in this variable loop region
and outside of the core FHA region is responsible for the interaction between
FHA1 Rad53 and Rad9 (Liao et al., 2000; Yongkiettrakul et al., 2004). In vitro, a
peptide containing a short stretch of Rad9 surrounding the threonine residue at
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192 binds to FHA1 with a KD value of 0.36 mM (Liao et al., 2000). In this study, D
at the +3 position and A at the +2 position to phospho-threonine, T(phos)XAD, is
thought to be the absolute requirement for binding to the loop of Rad53 FHA1.
In contrast, R70, S85 and N86, also located in the loop of FHA1, are thought to be
responsible for binding to Rad9 peptide spanning amino acid residues from 188200 that is singly phosphorylated at T192 in vitro (Liao et al., 2000). It remains to
be established whether the FHA1 domain of Rad53 binds to a phospho-T192 of
Rad9 in vivo. As for phospho-serine peptide, H2BS10ph peptide interacts with
FHA1 in vitro as shown by the peptide pull down experiments and fluorescence
anisotropy analysis (Figures 50C and Figure 51B). The latter measured the
dissociation constant (KD) for their interaction to be 71 mM (Figure 51B). The
differences between KD value for H2BS10ph peptide and phospho-T192 Rad9
peptide may reflect differences in detection sensitivity for binding analysis.
Nevertheless, the KD for binding of methylated H3 tail peptides to
chromodomains of HP1 (Jacobs et al., 2001) and chromomethylase 3 (Lindroth et
al., 2004) range from 10 to 100 µM. In addition, KD values for the association of
multiple acetylated H4 tails and the hTAFII250 double bromodomains are
between 1 and 50 µM when measured by the fluorescent anisotropy (Jacobson et
al., 2000).

Moreover, the interaction between 14-3-3 and H3S10ph was

determined to have KD of 78 mM (Macdonald et al., 2005). Thus, the strength of
the FHA1/ H2BS10ph interaction is comparable to those of other chromatin
binding modules to their respective histone modifications. Taken together, these
results provide evidence that FHA1 of Rad53 is the binding effector of H2BS10ph
in vitro.
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Using yeast genetic approaches, I demonstrated that their interactions
extends in vivo and correlate with H2O2-induced yeast apoptosis. Indeed, yeast
cells lacking the FHA1 domain of Rad53 were resistant to H2O2 treatment (Figure
55), demonstrating that the FHA1 domain plays a critical role during H2O2induced yeast apoptosis. It is likely that the H2BS10ph may interact with the
residues found in the loop of FHA1 and mediate yeast apoptosis. Detailed
structural analysis using H2BS10ph peptide will provide better insights into
understanding the structural basis of ligand specificity of FHA1 of Rad53.

Role of Rad53 and H2B serine 10 phosphorylation in yeast apoptosis
What is the function of the association between Rad53 and H2BS10ph during
yeast apoptosis? It is tempting to speculate that their interaction is important for
disrupting DNA repair pathway and, as a result, mediate apoptosis and
subsequently eliminate cells with damage beyond repair. Indeed, the activation
of the Mec1- and Rad53-dependent DNA repair pathway has been correlated
with the induction of apoptosis upon extensive MMS-induced DNA damage in
both mammalian and yeast cells (Weinberger et al., 2005; Yoshida et al., 2002).
As mentioned earlier, the activation of Rad53 in response to DSBs requires direct
phosphorylation by Mec1, which is recruited by Rad9 upon Rad53-Rad9
interaction (Sun et al., 1998; Kondo et al., 2001; Schwartz et al., 2003; Lee et al.,
2004). Accordingly, the direct interaction between phosphorylated Rad9 and
Rad53 via its FHA domains is observed as DSBs are generated upon H2O2
treatment

(Figures

53B

and

54).

This

may

enable

Rad53

phosphorylation/activation, and therefore, initiate the repairing of DSB. As
H2O2 treatment results in continuous DSBs, the H2BS10 is phosphorylated and
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Rad53 is dephosphorylated (Figure 54), both of which are linked to the
inactivation of DNA repair and cell death (Sancar et al., 2004). It is likely that
heavily damaged cells exceeding the capacity for repair induce apoptosis by
mediating the H2BS10ph and binding of Rad53. Whether their interaction
directly affects the downstream targets of the DNA repair pathway or recruits
apoptotic regulators or both is unknown at this time.
At this time, the mechanism behind the dephosphorylation of Rad53 is
unknown.

It could be mediated by a unknown phosphatase or simply a

consequence of interaction with H2BS10ph. In the latter case, an interaction
between Rad53 FHA1 and H2BS10ph may cause dissociation from Rad9. As a
consequence, Rad53 would be no longer phosphorylated by Mec1 kinase. If this
is the case, then H2BS10ph should have a binding affinity for both the
phosphorylated and dephosphorylated form of Rad53.

Since only

dephosphorylated Rad53 interacts with the H2BS10ph (Figures 50, 53 and 54), in
my hands, I favor the view that Rad53 is dephosphorylated by a phosphatase
before binding to H2BS10ph. Detailed time course studies should determine the
sequence of these events.
Both FHA1 and FHA2 of Rad53 interact with phosphorylated Rad9 and
their interaction mediates the DNA repair pathway by phosphorylation and
activation of Rad53 (Durocher et al., 1999). For example, mutations of both
Rad53 FHA domains result in a strong reduction of the interaction of Rad53 with
phosphorylated Rad9, and subsequently affect Rad9-dependent phosphorylation
of Rad53. Thus, both Rad53 FHA domains are required for the robust interaction
with Rad9 in vivo (Schwartz et al., 2003; Pike et al., 2003). Then what happens
during yeast apoptosis? Since the initial reaction to H2O2 induces DSBs, which
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are similar to DSBs found during DNA damage/repair pathway, both FHA
domains of Rad53 may be responsible for facilitating Rad53’s interaction with
Rad9. Therefore, I envision that FHA1 binding to H2BS10ph is antagonistic to
the association between FHA2 and Rad9. As DSB break accumulates, FHA1, but
not FHA2, of Rad53 is sufficient to downregulate Rad53-dependent DNA repair
pathway and promote apoptotic cascade by docking at the phosphorylated H2B
tail. Whether the FHA1-H2B tail complex causes conformation change on FHA2
of Rad53 or Rad9 leading to their dissociation remains to be seen.
A Rad53 homolog, Chk2, exists in mammalian cells and functions
downstream of ATM (ataxia telangiectasia mutated) and ATR (ATM related)
proteins during the DNA damage response pathway (reviewed in Rouse and
Jackson, 2002; Rhind and Russel1, 2000). Chk2 also participates in apoptosis via
phosphorylation of the pro-apoptotic protein PML (Yang et al., 2002), E2F1
(Stevens et al., 2003), and the tumor suppressor protein p53 (Hirao et al., 2002).
Unlike Rad53, Chk2 has one FHA domain and it is similar to FHA1 of Rad53
(Hofmann et al., 1995). Taken together, these relationships indicate an apoptotic
mechanism with Chk2 as a binding protein for mammalian H2BS14ph.
Employing similar peptide pull-down and immunoprecipitation experiments
should determine their interaction.
In summary, I have provided necessary evidence supporting the assertion
that Rad53 is the binding partner of H2BS10ph during H2O2-induced yeast
apoptosis. Identifying the phospho-binding effector further strengthens the
existence of a trans mechanism in mediating the role of H2BS10ph, and
illustrates an intricate relationship between the DNA repair pathway and the
apoptotic cascade. Whether the docking of Rad53 onto H2BS10ph directly
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terminates the activation of DNA repair pathway is still debatable, but my
results pave the way for a better understanding of apoptosis by defining a novel
role of FHA1 of Rad53 and H2BS10ph.
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Materials and Methods
Recombinant FHA domain proteins
Rad53 FHA1 (residues 2-279), Rad53 FHA2 (residues 543-801), Dun1 FHA
(residues 2-264) cloned into pGEX4T1 were gifts from Dr. Sheng Hong Chen at
the Ludwig Instituted, CA.

These glutathione S-transferase (GST) fusion

proteins were produced in E. coli BL21. Bacterial lysates were purified over
glutathione Sepharose 4B (Amersham) as recommended by the manufacturer.

Plasmids and Yeast strains
Yeast strains are listed in Table 1 and all strains are derived from W303C
(BY4741; Research Genetics) background. Yeast strains carrying FHA1 deletion
(residues 6-66; SAY 213), FHA2 deletion (residues 601-664; SAY 214) were
constructed by PCR amplication of a PTEF promoter-driven bacterial kanamycinresistance gene as described by Longtine et al., 1998. PCR products were then
transformed into SAY210 (MATa ura3-52 leu2::hisG sml1∆::URA3) to create strains
that lacked the full ORF (ATG-Stop).

Peptide-pull down
Peptide pull-down assays were performed as described previously (Wysocka et
al., 2005). About 1 mg of peptide that were prebound to avidin beads for 3 hr at
4°C, was incubated with 1 mg of recombinant protein plus 20-fold excess of
bovine serum albumin (internal control) in assay buffer (100 mM KCl, 20 mM
HEPES, and 0.2% Triton X-100), and beads were washed six times in assay
buffer. Bound proteins were eluted from the resin two times with 100 mM
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glycine (pH 2.8). Elutes were combined, neutralized using 1/10 volume of 1 M
Tris (pH 8), and analyzed by SDS PAGE.
Yeast nuclear extracts were prepared as described in Yeast nuclei
extraction (Chapter 2; Material and Methods) and the peptide pull-down assay
was performed as described previously (Wysocka et al., 2005). These nuclear
extracts were then incubated with 150 mM NaCl, 0.2% Triton X-100 with 25 ml of
avidin beads for 1 hr at room temperature. Meanwhile, 25 mg biotinylated
peptides were pre-bound to 100 ml of avidin beads with 200 ml 1X PBS for 3 hr at
the room temperature. The bound peptides were separated from unbound
peptides by washing 3 times in 1X PBS and resuspended in 100 ml 1X PBS. The
nuclear extracts were then spun and the supernatant was incubated with 20 ml of
bound biotinylated peptides (5 mg of peptide per 108 cells were used per pulldown) for 5 hr at 4°C. Beads were then washed eight times by incubating beads
with buffer containing 20 mM HEPES (pH 7.9), 150 mM KCl, 0.2% Triton X-100, 1
mM PMSF, and protease inhibitor cocktail (Roche) for 5 min at 4°C with gentle
rotation and then pelleting the beads. A final wash was performed with buffer
containing 4 mM HEPES (pH 7.9), 10 mM NaCl, 1 mM PMSF, and protease
inhibitor cocktail (Roche). Bound proteins were eluted from the resin two times
with 100 mM glycine (pH 2.8). Elutes were combined, neutralized using 1/10
volume of 1 M Tris-HCl pH 8.0, and analyzed by SDS PAGE.

TAP-immunoprecipitation
Nuclear extracts were prepared as described in Chapter 2 (Methods and
Materials) from yeast cells stably expressiong-Rad53TAP and as a control from
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yeast cells lacking ectopic Rad53. The TAP fusion proteins were precipitated by
incubating nuclear extracts with IgG Sepharose 4 Fast Flow (Amersham
Biosciences) with IP buffer (20 mM Hepes, pH 7.4, 5% glycerol, 5 mM MgCl2, 0.1
M KCl, 1 mM EDTA, 0.1% NP-40, protease inhibitor cocktail (Roche), and
phosphatase inhibitor cocktail (Roche)) and incubated for 2 hr at 4°C with gentle
rotation. Beads were collected by spinning at 1000 rpm and washed beads with
IP buffer, each time incubating it for 5 min at 4°C with gentle rotation and then
pelleting beads by centrifugation. For TEV protease cleavage, beads were
washed with TEV cleavage buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1%
NP50, 0.5 mM EDTA, 1 mM DTT), each time incubating it for 5 min at 4°C with
gentle rotation and then pelleting beads by centrifugation, for three times. The
TEV protease (Sigma) were added to the beads, rotated it for 2 hr at 4°C and then
collected the supernatent by the centrifugation.

Test for Apoptosis and Western Blot
Yeast apoptotic induction by H2O2, the cell survival, cell death analysis, TUNEL
staining, immunofluorescense, yeast nuclei preparation and Western analysis
were carried out as described in Chapter 2; Materials and Methods.

Fluorescence polarization assay
Protein concentrations were determined by absorbance spectroscopy using
predicted extinction coefficients (for FHA1 of Rad53 e280= 16980 cm-1 M-1; for
FHA2 of Rad53 e280= 15700 cm-1 M-1). Peptide concentrations were estimated
from the mass.
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Fluorescence anisotropy binding assays were performed essentially as
described previously (Fischle et al., 2003 Genes and Dev). Peptides were Nterminally labeled with fluorescein-5-EX succinimidyl ester (Molecular Probes)
as recommended by the manufacturer. Fluorescinated peptides were then
passed over a 0.5 ml G10 Sephadex (Pharmacia) column that has been preequilibrated with 100 mM KPO4 pH 7.5 to remove free fluorescein and hydroxyl
succinamide. Fractions containing the peptide were purified further by reversed
phase chromatography. Binding assays were performed in 100. Fluorescence
polarization binding measurements were performed under conditions of 20 mM
imidazole (pH 8.0), 25 mM NaCl, 2 mM DTT, and 100 nM fluorescein-labeled
peptide. For competition experiments, the competing peptide was unlabeled and
added in excess to the final concentration of 200 nM. Fluorescence polarization
(P) values were converted to anisotropy (A) values by the equation: A=2P/(3-P).
Binding curves were analyzed by non-linear least-squares fitting of the data
using KaleidaGraph (Synergy Software). Data were fitted using the equation
A=[Af-(Ab-Af)][protein]/KD + [protein], where Af and Ab represent the
anisotropy of the free and bound peptides, respectively.
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CHAPTER 6

H2B SERINE 10 PHOSPHORYLATION IS INDUCED
DURING MEIOSIS

Introduction
To date, histone H2B phosphorylation has been best characterized during
apoptosis. Chromatin condensation and DNA fragmentation, hallmark features
of apoptosis, have been firmly linked to mammalian H2BS14ph catalyzed by
Mst1 (Cheung et al., 2003). In the previous chapter, I uncovered an analogous
serine (yeast H2BS10) catalyzed by Ste20 kinase that has a “death” function,
which provides evidence for a chromatin-mediated apoptotic pathway that is
remarkably well conserved between yeast and humans. The Nussenzweig group
has previously shown that the phosphorylation of mammalian H2BS14 colocalizes with H2A.XS139ph in DNA-damage foci induced by g-irradiation
(Fernandez-Capetillo et al., 2004a).

These results suggest that H2B

phosphorylation in both mammalian (S14) and yeast (S10) may serve as markers
for DNA double stranded breaks (DSBs), along with H2A.XS139ph. Besides
ionizing radiation, DSBs can arise by the programmed action of endonucleases
during meiosis (Haber, 2000). In particular, meiotic DSBs are generated by an
evolutionarily conserved, meiosis-specific endonuclease, Spo11, which cuts the

238

DNA through a topoisomerase-like mechanism during meiotic prophase when
chromatin is mostly condensed (Keeney, 2001). Since H2A.XS139ph correlates
with DSBs during meiotic prophase (Mahadevaiah et al., 2001; Baarends et al.,
2003), this suggests a link between DSBs and chromatin condensation arising
from meiosis and DNA damage. From the following data, I propose that yeast
H2BS10ph could play a role in mediating DSBs and chromatin condensation
during meiosis.
In this chapter, I will characterize H2BS10ph during meiosis.

In

collaboration with Kiersten Henderson in Dr. Scott Keeny’s laboratory at Cornell
Medical Center, NY, we found that H2BS10ph is enriched during pachytene
stage of meiotic prophase where chromosomes are condensed. In addition,
deletion of Spo11 did not affect the H2BS10ph pattern, indicating that the
H2BS10ph was not induced in response to the formation of the DSBs that initiate
meiotic recombination. Taken together these results support that H2BS10ph
correlates with meiotic chromosome condensation.
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Results
Histone H2B is specifically phosphorylated at serine 10 during yeast meiosis
In mammalian cells, H2BS14ph co-localized with H2A.XS139ph in DNA-damage
foci induced by g-irradiation (IR; Fernandez-Capetillo et al., 2004a). Thus, we
were interested in the possibility that the role of yeast H2BS10ph may extend to
meiosis, and in particular, to the stage of meiotic prophase when DSBs are
known to occur (Mahadevaiah et al., 2001).
To test this hypothesis, nuclear extracts were prepared from diploid yeast
cells derived from rapidly-sporulating SK1 strains that were induced for
synchronous sporulation (Bishop, 1994). Extracts from different meiotic stages
were then resolved on an SDS-PAGE gel and examined by Western blotting
using mitotic H3S10ph-specific (anti-H3S10ph) as well as apoptotic H2BS10phspecific antibodies (anti-H2BS10ph). Interestingly, both H2BS10 and H3S10
phosphorylation events were enhanced at 2 hour and declined after 7 hour
following induction into meiosis (Figure 57A), suggesting that similar to
H3S10ph (Hsu et al., 2000), H2BS10ph occurs during meiotic prophase. Not all
phosphorylation marks on core histones follow the above pattern suggesting
some specificity. For example, S1 phosphorylation of histone H4 (H4S1ph), a
mark known to correlate with mitosis (Barber et al., 2004) and damaged DNA
(MMS-induced; Cheung et al., 2005), is induced at much later stages (9-11 hr) of
meiosis (Figure 57A).
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Figure 57. H2B serine 10 phosphorylation is induced during meiotic prophase
Synchronous meiotic yeast culture (diploid SK1 strains) were harvested at the
indicated times and subjected for Western analysis using indicated antibodies
(A) H2BS10ph is strongly induced during meiotic prophase. Antibodies to
H3S10ph and H4S1ph demonstrate the unique timing and robustness of the
signal obtained from anti-H2BS10ph. A general H3 antibody is used as a loading
control.
(B) The wild-type-like H2BS10ph pattern is observed in spo11 deletion mutants,
whereas this phosphorylation level is maintained in ndt80 deletion mutants.

H2B serine 10 phosphorylation is enriched in condensed meiotic chromosomes
To better define the precise stage(s) of meiotic prophase when H2BS10ph is
maximal, we performed double immunostaining of surface spread meiotic nuclei
for H2BS10ph and Zip1, a component of the synaptonemal complex. The pattern
of Zip1 localization indicates the stage in meiotic prophase, with extensive linear
Zip1 staining denoting fully synapsed chromosomes (Sym et al., 1993), the
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hallmark of the pachytene stage of prophase where chromosomes are condensed
(Dresser and Giroux, 1988). As shown in Figure 58, prior to entry into meiosis
(premeiotic), when Zip1 was absent, H2BS10ph was largely absent (93%; 63/70
nuclei). Consistent with the kinetics of H3S10ph (Hsu et al., 2000), H2BS10ph
gradually increased as cells progressed through prophase and by pachytene the
vast majority of nuclei (98%; 52/53) stained brightly with H2BS10ph-specific
antibody. The H2BS10ph signal was specific as it was eliminated from pachytene
nuclei upon competition with H2BS10ph (amino acids 4-14) peptide (Figure 58);
this staining is not diminished when unmodified (control) H2B peptides were
used in parallel competition experiments. Also consistent with the kinetics of
H3S10ph, H2BS10ph, as detected by Western blot (Figure 57A), declined rapidly
around the first meiotic division, which occurred at 8 hour in this culture. We
further tested the correlation between high levels of H2BS10ph and the
pachytene stage of meiosis by examining H2B phosphorylation in a ndt80
mutant, which arrests at pachytene with condensed chromosomes (Chu and
Herskowitz, 1998). The ndt80 mutant failed to undergo meiotic divisions and
maintained phosphorylated H2B at high levels (Figure 57B), suggesting that, like
H3S10ph, maximal H2BS10ph occurs at the pachytene stage of meiotic prophase.
Contrary to our initial expectation, H2BS10ph was not induced in
response to the formation of the DSBs that initiate meiotic recombination. The
WT profile of H2B phosphorylation was observed in a mutant lacking Spo11, the
protein that forms meiotic DSBs (Figure 57B; Keeney, 2001). These results
demonstrate that H2BS10ph correlates with progression through meiotic
prophase and perhaps with meiotic chromosome condensation, rather than other
events associated with meiotic DSB repair.
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Figure 58. Anti-H2BS10ph stains pachytene stage of meiotic prophases
Chromosomes from a time course through meiotic prophase of WT diploid SK1
strains were spread onto glass slides and examined for Zip1 and H2B Ser10
phosphorylation signal by double immunostaining.

At pachytene, anti-

H2BS10ph brightly stains nucleoids that contain extended Zip1 structures. This
H2B signal is competed away with the H2BS10ph (amino acids 4-14) peptide.
These data were provided by Kiersten Henderson in Dr. Scott Keeny’s laboratory
at Cornell Medical Center, NY.
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Discussion
In this Chapter, we first provided evidence for meiotic histone H2B
phosphorylation in budding yeast. Similar to histone H3S10ph, H2BS10ph is
induced at pachytene stage of meiotic prophase when chromosomes are
maximally condensed.

In addition, H2BS10ph correlates with meiotic

chromosome condensation rather than meiotic DSB repair during prophase.
Although H2BS10ph is also present during apoptosis, the reduction of this
modification correlates with the end of meiotic division when chromosomes are
decondensd.

Therefore, these results point to H2BS10ph as a meiotic

chromosome condensation marker.

H2BS10ph in apoptosis and meiosis
Our findings indicate that H2BS10ph is a common feature of both apoptosis and
meiosis, and is thus a mark used more broadly in biological pathways that
involve large-scale changes in chromatin structure. Is there a common theme
linking these different physiological processes? One possible link may be
through effects of histone phosphorylation on chromatin condensation. In the
case of apoptosis, chromatin becomes compacted and this compaction is
associated with processes that ultimately lead to permanent elimination of the
genome through cell death. In meiosis, in contrast, there is a constant interplay
between the condensed and decondensed states of chromatin demanded by the
multiple cycles of chromosome segregation that lead to the production of
haploid gametic cells. In particular, in prophase I of meiosis, the cyclical changes
in chromatin compaction coordinate and/or promote chromosome dynamics
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(e.g. recombination; higher-order chromosome structures such as the
synaptonemal complex and axial elements (specialized meiotic chromosome
axes); and chiasmata (Kleckner et al., 2004)).
Another possible link may involve the enzymes responsible for adding
and/or removing the H2BS10ph mark during apoptosis and meiosis. Although
Ste20 has no known role in meiosis, it could be a candidate kinase for meiotic
H2BS10ph. Another possible kinase candidate is Ipl1/aurora kinase, which
governs histone H3 phosphorylation at S10 during mitosis and meiosis in several
organisms (de la Barre et al., 2000; De Souza et al., 2000; Hsu et al., 2000; Giet and
Gloveral., 2001). The action of this particular kinase is required for the proper
recruitment of the condensin complex, and assembly of the mitotic spindle in a
phosphorylated histone H3-dependent manner (Giet and Glover, 2001).
Considering that Ipl1 can phosphorylate both H3 and H2B in vitro (Hsu et al.,
2000), H2BS10ph mediated by Ipl1 and/or Ste20, may be functionally redundant
with meiotic H3S10ph, a possibility that remains to be addressed.
Even though the H2BS10ph mark correlates with chromatin condensation
in yeast apoptosis and meiosis, the enzymes responsible for these modifications
and the biological context of each condensation event may be different. During
meiosis, chromatin condensation is thought to be required to minimize the
entanglement of chromosomes with one another while being moved by the
meiotic apparatus. Reversibility of this condensed state after chromosome
separation is critical. In contrast, chromatin condensation in apoptosis leads to
degradation of DNA, a final commitment step beyond which effective repair is
impossible and cell death becomes inevitable. Hence, the precise role of this
phosphorylation mark, whether inducing “cis” structural effects on chromatin
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folding alone, or allowing the binding of different “trans” effectors that in turn
bring about different downstream effects, remains an open area of considerable
interest (see Chapter 5-6). Following the paradigm established for histone
acetylation and methylation, I predict that a focused attack on H2B
phosphorylation, the enzyme systems responsible for its steady-state balance,
and the “effectors” that “read” this mark, if they exist, will lead to valuable
insights into how the genome is condensed during meiosis, and apoptosis.

Role of H2BS10ph during meiosis
Since the pattern of H3S10ph correlates with H2BS10ph (Figure 57 and 58),
H2BS10ph might involve regulating chromatin condensation during meiotic
prophase. Previously, SPO76 of Sordaria has shown to be essential for sister
chromatid cohesion, and chromatin condensation in meiosis (van Heemst et al.,
1999). Pds5, the SPO76 homologue in S. cerevisiae, is a cohesin-related gene and
failure in function of Pds5 causes premature separation of chromosomes. Pds5 is
required for meiotic prophase chromosome condensation (Yu and Koshland,
2003, Zhang et al., 2005), ensuring the correct chromosome folding by condensins
(Lavoie et al, 2002). Condensin is an evolutionarily conserved protein complex
and mediates mitotic and meiotic chromosome condensation through axial
length compaction (Yu and Koshland, 2003). Since the loading of Pds5 onto
chromosome requires the function of a cohesin, Scc1/Mcd1 and Rec8 (Zhang et
al., 2005), and cohesin binding to chromatin is dependent on a specific site of
histone modifications (Guacci et al., 1997; Nonaka et al., 2002; Sonoda et al., 2001;
Bernard et al., 2001), H2BS10ph may play an active role in establishment of
cohesin and Pds5 onto chromosome to regulate meiosis.
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Materials and Methods
Yeast Strains, and Culture Conditions
Diploid strains in SK1 background include: SKY165 (MATa/MATa
ho::LYS2/ho::LYS2 lys2/lys2 ura3/ura3 leu2::hisG/leu2::hisG).

SKY169

(ndt80∆::URA3) and SKY10 (spo11∆::URA3) were derived from SKY165. For the
induction of meiosis, log phase cultures in SPS medium (0.5% yeast extract, 1.0%
peptone, 0.17% yeast nitrogen base, 1.0% potassium acetate, 0.5% ammonium
sulfate, 0.05 M potassium biphthalate, pH 5.5) were diluted to about 1 x 105
cells/ml in fresh SPS and were grown for 16 hr to about 5 x 107 cells/ml (OD600
1.5-2.0). Cells were then washed with water and resuspended in an equal
volume of prewarmed SPM-1/5COM sporulation medium (0.2% potassium
acetate, 0.02% raffinose, and 0.015% complete amino acid powder as described in
media and reagents in Chapter 2 Materials and Methods).

Yeast Nuclei and Histone Extraction, Western Blot, and Immunofluorescence
Staining
Yeast nuclei and histones were extracted, and used for Western analysis as
described Chapter 2 Materials and Methods. Antibodies were diluted as follows:
anti-H2BS10ph: 1:5000, anti-H4: 1:5000, anti-H3S10ph: 1:1000, anti-H3: 1:1000.
For synaptonemal complex and anti-H2BS10ph immunofluorescence analysis,
chromosomes were surface spread and stained as described (Henderson and
Keeney, 2004). Guinea pig anti-Zip1 antibody was used at 1:1,000 dilution and
anti-guinea pig-Alexa 546 at 1:1,000 (Molecular Probes). Rabbit anti-H2BS10ph
was used at 1:100, and anti-Rabbit Alexa 488 at 1: 1,000 (Molecular Probes). For
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peptide competition, H2BS10ph 1-20 peptide was added to the diluted antiH2BS10ph antibody (1.4 mg/ml final concentration). Slides were mounted with
cover slips in Prolong antifade (Molecular Probes). Images were captured on a
Zeiss Axiophot microscope with a 100x objective using a Cooke Sensicam cooled
CCD camera. Data capture and image processing were performed using the
Slidebook software package (Intelligent Imaging Innovations).
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CHAPTER 7

GENERAL DISCUSSION

Yeast apoptotic cascade
In this thesis, I have identified and characterized a pair of interacting histone
modification marks that regulate chromatin condensation and/or alter
chromatin structure during yeast apoptosis.

My data supports a model

presented in Figure 59. I envision that, upon H2O2 induction, Hos3 HDAC
directly catalyzes the deacetylation of H2BK11 and, in turn, allows H2BS10ph by
Ste20 kinase in a caspase-independent fashion. H2BS10ph can then either
directly affect internucleosomal contacts and histone DNA interactions (“cis”
mechanism; Figure 6A) and may also indirectly affect downstream functions
(“trans” mechanism; Figure 6B) by recruiting a phospho-specific binding protein.
In support of the “cis” mechanism, H2BS10ph is essential for the condensation of
chromatin fiber in vitro. In support of the “trans” mechanism, I have identified
Rad53 as the H2BS10ph binding partner. The latter interaction leads to the
inactivation of the DNA damage checkpoint, thereby promoting the apoptotic
cascade. Whether chromatin condensation, a hallmark of apoptosis, is mediated
by cis, trans, or both mechanisms remains to be explored.
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Figure 59. Model for regulation of Histone H2B in yeast apoptosis
1) K11 in H2B is acetylated in exponentially growing yeast cells. 2) Upon H2O2
treatment, Hos3 HDAC directly catalyzes the deacetylation of H2BK11 (“crosstalk”). 3) Ste20 kinase translocates into the nucleus in a caspase-independent
fashion. Once in the nucleus, Ste20 kinase directly phosphorylates H2B at S10.
4) H2BS10ph elicits apoptotic chromatin condensation either by directly affecting
the internucleosomal contact (“cis” mechanism) and/or by recruiting Rad53 to
H2BS10ph (“trans” mechanism). 5) These events ultimately lead to cell death.
N denotes nucleus and V refers to the vacuole. Arrows denote chromatin
condensation. (see Figure 21 for the detail).
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Function of H2B serine 10 phosphorylation
Formation of condensed pycnotic chromatin is a hallmark of apoptosis, but the
mechanisms underlying these large-scale chromatin changes are unknown. A
previous study suggested that the H2B tail could play an essential role in
promoting chromatin condensation in Xenopus cell-free extracts (de la Barre et al.,
2001). However, no specific residue was identified as being responsible for this
effect. In 2003, Cheung et al. suggested that H2BS14ph might facilitate chromatin
compaction during mammalian apoptosis (Cheung et al., 2003). However this
study was unable to address, due to lack of genetic tools in mammalian cells,
whether or not this event is required for apoptosis, nor did it address the
function of H2BS10ph. By utilizing the well-established genetic and biochemical
tools developed for the yeast system, I have identified yeast H2BS10 as a yeast
apoptotic phosphorylation mark. Unlike H2BS14, H2BS10ph is essential for
yeast apoptosis in vivo, as indicated by the resistance of H2O2-induced cell death
by the H2B S10A mutant (Figure 14). Condensed chromatin is not observed in
the H2B S10A mutant, suggesting that H2BS10ph is required for these dramatic
changes in chromatin structure (Figure 21). In support, a phospho-mimic of
H2BS10, S10E, is able to induce ‘constitutive’ properties of apoptosis including
widespread chromatin condensation in vivo (Figure 21). In vitro, H2B S10E
displays an intrinsic ability to form unusual peptide “aggregates” (Figure 39) and
is critical for the condensation of chromatin fibers (Figure 44). It is unknown
whether there is a direct correlation between peptide aggregation and the
chromatin condensation in vivo. However, my peptide data correlates precisely
with the chromatin compaction in vitro and in vivo so far.
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Therefore, I

hypothesize that H2BS10ph plays a direct role in mediating chromatin
compaction.
Additional support for the role of H2BS10ph in chromatin compaction
comes from studies in meiosis. As discussed earlier, H2BS10ph is a common
feature of both apoptosis and meiosis.

Though seemingly different, both

biological processes involve large-scale changes in chromatin structure.
However, the chromatin compaction in these processes lead to different cell
fates. In the case of apoptosis, compacted chromatin is associated with processes
that ultimately lead to cell death, whereas in meiosis, a constant interplay
between the condensed and decondensed states of chromatin leads to the
production of haploid gametic cells. Interestingly, chromatin is maximally
compacted during prophase I of meiosis and a sharp peak of H2BS10ph is
present at a time point corresponding to prophase I (Figure 57). Since the level of
H2BS10ph declines rapidly around the time that meiotic divisions occur (Figure
57), when the chromatin is decondensed, H2BS10ph appears to be tightly
regulated during meiosis, which further supports its role in chromatin
condensation.
There are two models for yeast apoptotic signaling: 1) caspase-dependent,
2) caspase-independent pathways. In the caspase-dependent pathway, caspases
such as Yca1 regulate cell death (Madeo et al., 2000). H2BS10ph seems to fall into
the caspase-independent pathway since Yca1 is not involved in its cascade
(Figure 28C). Although chromatin compaction is a hallmark of apoptosis, only
the caspase-independent pathway seems to require H2BS10ph for this apoptotic
characteristic. Since H2BS10ph is also present during meiotic prophase when
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chromatin is mostly compacted, this invokes an interesting possibility that the
caspase-independent apoptotic pathway and meiosis may be conserved.

Why the H2B tail for a potential apoptotic “histone code”?
As discussed in Chapter 2, I have found a highly conserved phosphorylation
mark in the yeast H2B N-terminal tail that plays a role in apoptosis. My genetic
experiments in yeast suggest that this “death” function is unique to the H2B Nterminal tail, as no other histone tail (H2A, H3 or H4) has the capacity to
influence the cell survival and death properties in my assays. In support, earlier
studies, using the Xenopus cell-free system, have implicated the H2B tail in
chromatin condensation (de la Barre et al., 2001). This leads to the following
question: why would one use H2B tails in cells to mark cell death? Recall that
H2B histones do not self associate. Hence, they cannot preferentially form a
H2B-variant only nucleosome. Accordingly, there are no H2B variants in
somatic cells. To date, no H2B variants are found in yeast. Therefore, all the
nucleosomes in the genome would contain a similar, if not identical, H2B
molecules. If death signals need to be marked on histones, then it may be easier
for apoptotic pathways to modify a histone that is similar in all the nucleosomes.

H3 serine 10 phosphorylation and H2B serine 10 phosphorylation
Unlike the apoptotic pathway, the regulation of the level of histone H2B
phosphorylation might be directly linked to H3S10ph in meiosis. In yeast, the
strongest peak in H3S10ph is observed during meiotic pachytene when
chromosomes are dramatically compacted (Hsu et al., 2000). However, H3 S10A
mutations do not result in a major defect in meiotic chromosome transmission in
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yeast (Hsu et al., 2000).

One potential explanation is that other histone

modifications may compensate for the loss of H3S10ph and allow proper
chromosome dynamics. Because the pattern of H2BS10ph coincides with that of
H3S10ph (Figure 57 and 58), H2BS10 might compensate for the mutation of
H3S10 and promote proper chromosomal condensation and segregation during
meiosis. Future yeast genetic experiments may provide more insights into the
functional redundancy of meiotic phospho-marks.
The functional redundancy between H3 and H2B in meiosis is further
supported by the fact that Ipl1 kinase can phosphorylate both H3 and H2B in
vitro (Hsu et al., 200). Considering that Ste20 kinase has no known role in
meiosis, this raises the possibility that Ipl1 kinase is the enzyme responsible for
H2BS10ph during meiosis. If this hypothesis is correct, then the differences
between the effect of H2BS10ph in apoptosis versus meiosis may be dictated by
the kinase that mediates it.

During apoptosis, Ste20 kinase directly

phosphorylates H2BS10 but not H3S10 (Figure 22B). This is supported by the
observation that H3S10ph is absent during apoptosis (Figure 22B). On the other
hand, a kinase other than Ste20, for example Ipl1 kinase, may directly facilitate
the onset of both H3S10 and H2BS10 phosphorylation and mediate proper
chromatin condensation during meiosis. In support, the action of Ipl1 kinase
phosphorylating the H3S10 is thought to be required for proper recruitment of
the condensin complex and assembly of the mitotic spindle leading to chromatin
condensation (Giet and Glover, 2001). Since Ipl1 kinase is not involved in yeast
apoptosis or H2BS10ph during that process (Figure 22B), the identification and
characterization of the enzyme responsible for adding phosphate groups to
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H2BS10 during meiosis should help to address how one modification may lead
to different cell fates.
Another difference between apoptosis and meiosis is that the reduction of
H2BS10ph level is present only during meiotic division when chromatin is
decondensed. On the other hand, apoptotic cells are characterized by the
presence of condensed chromatin. Therefore, the dephosphorylation of H2BS10
might be another key to promoting the production of haploid gametic cells,
hence, cell proliferation rather than cell death. If correct, this brings up the
intriguing possibility that the reversal of the H2BS10ph event by unknown
phosphatase may rescue the apoptotic cells. As for the phosphatase, assuming
that Ipl1 kinase directly phosphorylates H2BS10 during meiosis, the
phosphorylation can be removed by phosphatase PP1, which is known to
counterbalance the activity of Ipl1 kinase (Hsu et al., 2000; Murnion et al., 2001).
Although this interplay between these two enzymes needs to be investigated in
the near future, the phosphatase may play a role in mediating the chromatin
decondensation by recruiting the machinery that blocks the cleavage of
structural proteins such as lamins (reviewed in Moir and Goldman, 1993). It
should also be noted that H3S10ph might contribute to the dephosphorylation of
H2BS10 and vice versa.

In other words, the regulation of H3 and H2B

(de)phosphorylation may be reciprocal; specifically, the absence of H3S10ph may
inhibit the dephosphorylation of H2BS10 during yeast apoptosis. In support,
there is no H3S10ph during apoptosis when H2BS10ph is maintained (Figure 23).
However, H3S10ph and H2BS10ph are both present during a specific stage of
meiosis before H2BS10ph is removed (Figure 57). Therefore, I predict that H3S10
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is important for the regulation of H2BS10ph and somehow separates its function
in apoptosis versus meiosis.

Role of H2B lysine 11
As discussed in Chapter 3, I have found a covalent histone modification “crosstalk” between H2BS10ph and K11ac during H2O2- induced yeast apoptosis. In
particular, histone H2BK11ac inhibits the phosphorylation of its adjacent site,
Ser10, by Ste20 kinase (Figures 32, 34 and 37). Therefore, I propose a model for
regulated cross-talk in H2B wherein Hos3 directly catalyzes the deacetylation of
H2BK11 that, in turn, mediates H2BS10ph by Ste20 kinase during H2O2-induced
yeast cell death (see Figures 38 and 59). If this model is correct, what upstream
role does Hos3 serve leading to S10ph in H2B? The simplest explanation for my
results is likely to involve an altered substrate recognition site for Ste20 kinase.
In support, K11ac inhibits S10ph by Ste20, whereas deacetylation of preacetylated (K11) peptides by the addition of Hos3 promotes S10ph (Figure 37B
and 37C). Other more indirect roles are also possible. For example, Hos3 may
regulate Ste20 translocation into the nucleus, and in turn, mediate S10ph. I have
observed that the translocation of Ste20 into the nucleus precedes the onset of
S10ph (Figures 29). K11 deacetylation and Ste20 translocation occur before
H2BS10ph (Figure 34). Lastly, Hos3 may play a role in the activation of Ste20
catalytic activity, although little, if anything is known about the acetylation status
of Ste20 kinase.
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Functional mechanism of H2B serine 10 phosphorylation during yeast apoptosis
One of the aims of my thesis has been to understand the mechanism by which
H2BS10ph causes chromatin condensation. As discussed earlier, there are two
general mechanisms that are thought to mediate the function of histone
modifications (Figure 6): modifications could modulate chromatin structure in cis
by directly affecting the nucleosomal contacts and histone DNA interactions, or it
could act in trans by recruiting binding partners that then induce and direct
downstream functions. Although thought to be mutually exclusive, I have found
evidence supporting the existence of both mechanisms in concert during
apoptosis.
In support of the cis mechanism, the addition of a single phosphate group
is thought to cause changes in chromatin structure and thereby induce
condensation.

However, a mechanism that works merely through a

conformation change of the histone tails itself is difficult to imagine, as it is
commonly accepted that the tails do not have any specific secondary structure
but instead are relatively disordered. It is also difficult to imagine that the
modification could directly cause a stronger interaction with DNA leading to
compaction in a mechanism reverse to histone acetylation: adding a phosphate
group means increasing the negative charge of the tail, which should weaken or
disrupt electrostatic interactions between the histone tails and result in a more
accessible chromatin structure rather than a highly condensed form. Despite
these paradoxes (reasons that oppose the existence of cis mechanism for
H2BS10ph), I have found that a nucleosome array containing the phospho-mimic
of H2BS10, S10E, yields a structure more highly compacted than even 30-nm
chromatin fibers seen during mitosis (Figure 44). While it is unclear what type of
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structure this nucleosome represents, I suspect that H2B N-terminal tails are
interacting with themselves in a way that is similar to the aggregation of the
peptides carrying H2BS10ph or H2B S10E. Because the effect of the H2B S10E
mutant on compaction is more pronounced when looking at a 36-mer array
compared to a 12-mer (Dr. Thomas Schalch, personal communication), I
speculate that the H2B N-terminal tails somehow reach from one nucleosome to
the next across the gyres of the higher order structure. This structure would then
theoretically be more compacted than a mitotic 30-mn chromatin fiber, and may
be representative of an apoptotic chromatin fiber. It is plausible that apoptotic
chromatin fibers are more compacted than even mitotic fibers since apoptosis
features the massive cleavage of structural components including chromatin.
Detailed structural analysis should determine the influence of H2BS10ph on the
site of the chromatin fiber.
A mechanism by which phosphorylation of the H2B N-terminal tail is a
platform for interactions with other proteins (e.g. trans mechanism) has gained
much interest since it is reminiscent of the heterochromatinization mediated by
the chromodomain protein HP1 interaction with the H3 tail. This could either
lead to an alteration in histone-histone interactions between neighboring
nucleosomes or result in the recruitment of additional effector molecules that in
turn mediate chromatin condensation.

For example, one or more protein

complexes could bridge different nucleosomes and thus cause chromatin to
condense. Since apoptosis features the formation of pycnotic and condensed
chromatin bodies typical of apoptotic chromatin condensation (Clifford et al.,
1996; Kerr et al., 1972), it is possible that the function of H2BS10ph is to mediate
chromatin condensation in a trans fashion by the induction of such protein260

protein interactions. In support, I have identified Rad53 as a H2BS10ph binding
partner. Rad53 is the DNA damage checkpoint and its activation by Rad9 leads
to the activation of the DNA repair pathway (Sanchez et al., 1996; Sun et al.,
1996). Considering that an inactive Rad53 inhibits the DNA repair cascade (Pike
et al., 2003; Hammet et al., 2000), a Rad53-H2BS10ph interaction might lead to the
disruption of the DNA repair pathway. As a consequence, the DNA damage
would accumulate and cells would become damaged beyond repair, promoting
an apoptotic cascade to eliminate damaged cells. This model is consistent with
the observation that the inactivated form of Rad53 is the H2BS10ph binding
partner (Figure 53 and 54), although the direct relationship between the
H2BS10ph and the accumulation of DNA damage is unknown. It should be also
noted that the interaction between H2BS10ph and Rad53 might also promote
chromatin condensation, although Rad53 has no known role in altering
chromatin structure. Despite these uncertainties, it could be argued that their
interaction may serve both purposes: 1) DNA repair disruption and 2) chromatin
condensation. If correct, this “trans” mechanism via a phospho-binding partner
may be the functional mechanism of H2BS10ph in promoting yeast apoptosis.
The uncertainty of the existence of a cis mechanism of chromatin
condensation occurring in vivo makes the above hypothesis attractive. However,
the nucleosome array system, which best represents histones in their proper and
native setting, indicates that H2BS10ph can cause chromatin condensation in a
cis fashion. Therefore, I described several possible models that include both
trans and cis mechanisms mediating the function of H2BS10ph in the apoptotic
cascade. In the first model, H2BS10ph interacts with Rad53 and disrupts repair
of the damaged cells (trans). As the heavily damaged cells accumulate, Rad53
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dissociates from H2B and H2BS10ph directly mediates the chromatin
condensation (cis). This hypothesis assumes that interaction between H2BS10ph
and Rad53 occurs before chromatin condensation, which is still unknown at this
time. It also suggests that H2BS10ph triggers apoptosis itself in that it prevents
repair, if so, S10ph should precede apoptotic DNA fragmentation. Since the
onset of S10ph coincides with the apoptotic DNA fragmentation (Figure 18), I
suspect this model is an unlikely mechanism for H2BS10ph. The second model
consists of cis then trans mechanisms. Chromatin condenses as a result of
H2BS10ph and facilitates the binding of Rad53. These events downregulate the
DNA repair pathway and consequently promote the apoptotic pathway.
Therefore, S10ph should occur before its interaction with Rad53. Although this
model is consistent with the association between Rad53 and H2BS10ph, it is
inconsistent with the onset of H2BS10ph and its interaction with Rad53. As
shown in Figure 54A, the appearance of H2BS10ph and its interaction with
Rad53 coincide; 90 minutes post H2O2 induction. Therefore, this model is
unlikely to occur. In the third model, H2BS10ph can simultaneously mediate
chromatin condensation and the apoptosis of damaged cells through both cis and
trans mechanisms. This model is consistent with my results, but based on a high
abundance of H2BS10ph compared to Rad53 in the cell. Therefore, it could
efficiently compete for Rad53 from other phosphorylated proteins, such as Rad9,
and regulate chromatin condensation. Since their abundance has not been
addressed at this time, a model that explains the mechanism of H2B Ser10
phosphorylation in yeast apoptosis still remains to be fully elucidated.
Nevertheless, my studies support the possibility that both cis and trans
mechanisms exist to effect chromatin alterations.
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Conservation of yeast and mammalian apoptotic cascade
Phosphorylation of S10 in yeast H2B serves a comparable role to
phosphorylation of mammalian H2B at S14 and is catalyzed by Ste20 kinase, a
yeast homolog of mammalian Mst1 kinase (Chapter 2; Cheung et al., 2003).
Therefore, the conservation of these targeted H2B phosphorylation sites and the
enzyme systems responsible for bringing it about point to an ancient apoptotic
mechanism that is conserved from yeast to humans. This mechanism might
consist of regulated phos/acetyl interplay between mammalian H2BS14 and it’s
neighboring lysine residues. As shown in Figure 31A, numerous lysines are
found around the mammalian H2BS14. In particular, K14, located adjacent to
S14, is acetylated in asynchronously-growing HeLa cells (Throne et al., 1990)
reminiscent of H2BK11ac in growing yeast (Suka et al., 2001). I suggest the
intriguing possibility that phos/acetyl cross-talk also exist in mammalian cell
H2B between S14 and K15.
In addition, this conserved apoptotic mechanism might include a “trans”
mechanism in which Rad53 binding to phosphorylated H2BS10 in yeast or
H2BS14 in mammalian cells regulates apoptosis. A Rad53 homolog, Chk2, exists
in mammalian cells and functions downstream of ATM (ataxia telangiectasia
mutated) and ATR (ATM related) proteins during the DNA damage response
pathway (reviewed in Rouse and Jackson, 2002; Rhind and Russel1, 2000). Chk2
also participates in apoptosis via phosphorylation of the pro-apoptotic protein
PML (Yang et al., 2002), E2F1 (Stevens et al., 2003), and the tumor suppressor
protein p53 (Hirao et al., 2002). Unlike Rad53, Chk2 has one FHA domain and it
is similar to FHA1 of Rad53 (Hofmann et al., 1995). Since my data suggest that
the FHA1 domain of Rad53 binds to H2BS10ph, I hypothesize Chk2 as a binding
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protein for mammalian H2BS14ph. Using mammalian apoptotic nuclear extracts
and employing similar peptide pull-down and immunoprecipitation experiments
should determine their interactions.

Perspective
Finally, my thesis work sheds light on a pair of histone modifications mediating,
in particular, yeast apoptosis. In addition, my work presented here has led to the
formulation of “cross-talk”, “cis” and “trans” mechanisms.

Since H2B

phosphorylation and the enzyme system responsible for this process are
conserved between higher and lower eukaryotes, the mammalian apoptotic
cascade may mirror the yeast apoptotic mechanism.
Although both the upstream deacetylation event and binding factor for
H2BS14ph has to be worked out in detail, my results may elucidate the
mechanism of HDAC inhibitors used in cancer therapy. Considerable evidence
has suggested that HDAC inhibitors can trigger cell death in cancer cells (Medina
et al., 1997; Qui et al., 2000; Zhang et al., 2004; Shao et al., 2004; Ungerstedt et al.,
2005). However, the exact mechanisms of how HDAC inhibitors regulate cell
death remain to be elucidated. Some studies have shown that HDAC inhibitors
can induce caspase-dependent apoptosis via upregulation of tumor suppressor
genes including p21 (Sawa et al., 2004; Archer et al., 2005; Komata et al., 2005;
Zhao et al., 2006) or upregulation of pro-apoptoic genes including Bax, Bid, tBid
(Ogawa et al., 2004; Choi, 2006). Interestingly, others have shown that HDACi
not only upregulates gene expression, but also downregulates a significant
number of anti-apoptotic genes, such Bcl-2 (Ogawa et al., 2004; Sawa et al., 2004;
Choi, 2006). Moreover, it has been shown that there is a differential regulation of
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HDAC mRNA levels by HDACi (TSA or sodium butyrate) in both neurons and
lymphocytes (Dangond and Gullans, 1998; Ajamian et al., 2004). It has been
shown that with HDACi treatment, the mRNA levels of HDAC1, 3, 5, and 6 are
increased, but the mRNA levels of HDAC2 remain unchanged (Ajamian et al.,
2004). Perhaps, these HDAC inhibitors might also upregulate the expression of
Hos3 like HDAC, HDAC11 in mammalian cells. Based on my findings regarding
the cross-talk between H2BS10 and K11 in yeast apoptosis (Chapter 3), it is
conceivable that upregulation of Hos3 or its mammalian homologue with
HDACi treatment may facilitate apoptosis. Further, if similar mechanism is
proven in mammalian cells, it will provide insight in the design of clinical trials
invovling HDACi, especially when it is combined with cytoreductive
chemotherapy.
Similar to yeast apoptosis, the deacetylation of lysines in histones
mediated by HDAC11 may be necessary for the Mst1 mediated H2BS14ph.
Moreover, the Rad53 counterpart Chk2 is a tumor suppressor and the list of
Chk2 mutations in cancer cells is continuously expanding (reviewed in Damia
and Broggini. 2004). Since Chk2 is activated mainly by ATM in response to
DSBs, if unrepaired results in apoptosis, the interaction between Chk2 H2BS14ph
may facilitate the apoptosis via dephosphorylation of Chk2. The same principle
might follow in killing cancer cells, because the inhibition of Chk2 sensitizes
cancer cells to genotoxic agents (Bartek et al., 2001; McGowan 2002; Bartek and
Lukas, 2003). Many questions still need to be answered including the exact
molecular mechanisms involved in mammalian apoptosis.

Once these

components are identified, their regulation and roles in apoptosis, and/or
meiosis should be addressed. It is hoped that in the coming years, answers to
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this and other questions will provide many more exciting insights into the
apoptosis and histone modification in general, which could be of great relevance
for potential medical applications including cancer.
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APPENDIX
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Appendix Figure A1. Substitution of yeast H2A leucine 132 with tyrosine
strongly react with antibodies to mammalian H2A.X tyrosine 142
phosphorylation
(A) Primary sequence alignment of H2A carboxy-terminus from a select group
of organisms shows that Tyr142 is conserved in “higher” (mammals and flies)
but not in “lower” eukaryotes (yeast). With the help of Andrew Xiao, yeast
strain was generated expressing H2A in which L132 was mutated to tyrosine,
hereafter referred to as H2A L132Y mutant. (courtesy of Dr. Andrew Xiao ).
(B) Exponentially growing WT, and H2A L132Y strains were treated with the
DNA-damaging agent 0.1% MMS for 2 hr. Total nuclear protein was then
prepared from these cells before being resolved on SDS-PAGE gel for Western
analysis; blots were then proved with anti-H2A.XY142ph, and anti-H2A.XS139ph
antibodies. Anti-H2A.XS139ph reacted strongly with WT and H2A L132Y cells
following DNA damage. As expected, WT cells did not have affinity for antiH2A.XY142ph. In contrast, anti-H2A.XY142ph only reacted with nuclear extracts
from untreated H2A L132Y cultures, but did not react with extracts from MMStreated cells. The equal loading of histone proteins were judged by anti-H3.
Together, these results demonstrate that Y132 is dephosphorylated upon DNA
damage in H2A L132Y mutant background.
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